Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Publications: Institute for Immunology and Infectious Diseases

Export as [feed] RSS
Group by: Item Type | Year
Jump to: 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000
Number of items at this level: 1125.

2022

Almaazmi, S.Y., Singh, H., Dutta, T. and Blatch, G.L. (2022) Exported J domain proteins of the human malaria parasite. Frontiers in Molecular Biosciences, 9 . Art. 978663.

Bruusgaard-Mouritsen, M.A., Koo, G., Heinrichsen, A.S., Melchiors, B.B., Krantz, M.S., Plager, J.H., Boxer, M., Phillips, E.J., Stone, C.A. and Garvey, L.H. (2022) Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy. The Journal of Allergy and Clinical Immunology: In Practice, 10 (3). P859-862.

Cheng, X., Zhou, L., Li, Z., Shen, S., Zhao, Y., Liu, C., Zhong, X., Chang, Y., Kermode, A.G. and Qiu, W. (2022) Gut microbiome and bile acid metabolism induced the activation of CXCR5+ CD4+ T Follicular Helper Cells to participate in Neuromyelitis Optica Spectrum Disorder recurrence. Frontiers in Immunology, 13 . Art. 827865.

Collins, K., Rueter, K., Lucas, M., Sommerfield, D., Sommerfield, A., Khan, N. and Ungern‐Sternberg, B.S. (2022) Penicillin allergy SHACK : Survey of hospital and community knowledge. Journal of Paediatrics and Child Health, 58 (8). pp. 1414-1419.

Copaescu, A-M, James, F., Vogrin, S., Rose, M., Chua, K., Holmes, N.E., Turner, N.A., Stone, C., Phillips, E. and Trubiano, J. (2022) Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population (PALACE): study protocol. BMJ Open, 12 (8). Art. e063784.

Copaescu, A.M., Rosa Duque, J.S. and Phillips, E.J. (2022) What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccine. Annals of Allergy, Asthma & Immunology, 129 (1). P40-51.

Corey, K.B., Koo, G. and Phillips, E.J. (2022) Adverse Events and Safety of SARS-Cov2 Vaccines: What’s New and What’s Next. The Journal of Allergy and Clinical Immunology: In Practice .

Corey, K.B., Koo, G., Stone, C.A., Kroop, S.F., Fissell, W.H., Kozlowski, S., Zhou, Z-H and Phillips, E.J. (2022) A case of coronavirus disease 2019 messenger RNA vaccine tolerance and immune response despite presence of anti-polyethylene glycol antibodies. Annals of Allergy, Asthma & Immunology . In Press.

Deshpande, P., Li, Y., Thorne, M., Palubinsky, A.M., Phillips, E.J. and Gibson, A. (2022) Practical Implementation of Genetics: New Concepts in Immunogenomics to Predict, Prevent, and Diagnose Drug Hypersensitivity. The Journal of Allergy and Clinical Immunology: In Practice .

Dutta, T., Singh, H., Edkins, A.L. and Blatch, G.L. (2022) Hsp90 and associated co-chaperones of the Malaria parasite. Biomolecules, 12 (8). Art. 1018.

Fazal, Z.Z., Sen, P., Joshi, M., Ravichandran, N., Lilleker, J.B., Agarwal, V., Kardes, S., Kim, M., Day, J., Makol, A., Milchert, M., Gheita, T., Salim, B., Velikova, T., Gracia-Ramos, A.E., Parodis, I., Nikiphorou, E., Tan, A.L., Chatterjee, T., Cavagna, L., Saavedra, M.A., Shinjo, S.K., Ziade, N., Selva-O’Callaghan, A., Nune, A., Knitza, J., Kuwana, M., Gutiérrez, C-E.T., Caballero-Uribe, C.V., Dey, D., Distler, O., Chinoy, H., Agarwal, V., Aggarwal, R., Gupta, L., Barman, B., Singh, Y.P., Ranjan, R., Jain, A., Pandya, S.C., Pilania, R.K., Sharma, A., Manoj, M.M., Gupta, V., Kavadichanda, C.G., Patro, Pr.S., Ajmani, S., Phatak, S., Goswami, R.P., Chowdhury, A.C., Mathew, A.J., Shenoy, P., Asranna, A., Bommakanti, K.T., Shukla, A., Pandey, A.K.R., Gaur, P.S., Mamadapur, M., Ghodke, A., Chandwar, K., Jagtap, K., Fazal, Z.Z., Cansu, D.Ü., Yıldırım, R., Patel, A., Pauling, J.D., Wincup, C., Giannini, M., Maurier, F., Campagne, J., Meyer, A., Del Papa, N., Sambataro, G., Fabiola, A., Govoni, M., Parisi, S., Bocci, E.B., Sebastiani, G.D., Fusaro, E., Sebastiani, M., Quartuccio, L., Franceschini, F., Sainaghi, P.P., Orsolini, G., De Angelis, R., Danielli, M.G., Venerito, V., Grignaschi, S., Giollo, A., Traboco, L.S., Shaharir, S.S., Wibowo, S.A.K., Tehozol, E.A.Z., Serrano, J.R., De La Torre, I.G., Colunga‑Pedraza, I.J., Merayo-Chalico, J., Loarce-Martos, J., Prieto-González, S., Gil-Vila, A., Aranega, R., Hoff, L.S., Nakashima, R., Sato, S., Kimura, N., Kaneko, Y., Tomaras, S., Proft, F.N., Holzer, M-T, Gromova, M.A., Aharonov, O., Nagy-Vincze, M., Griger, Z., Hmamouchi, I., El bouchti, P.I., Baba, Z., Ima-Edomwonyi, U., Dedeke, I., Airenakho, E., Madu, N.H., Yerima, A., Olaosebikan, H., Chibuzo, O.C., Becky, A., Koussougbo, O.D., Palalane, E., Langguth, D., Limaye, V., Needham, M., Srivastava, N., Hudson, M., Landon-Cardinal, O., Zuleta, W.G.R., Arbeláez, Á., Cajas, J., Silva, J.A.P., Fonseca, J.E., Zimba, O., Bohdana, D., So, H., Ugarte-Gil, M.F., Chinchay, L., Bernaola, J.P., Pimentel, V., Tanveer Hasan, A.T.M., Saha, S., Vaidya, B., Fathi, H.M., Mohammed, R.H.A., Chen, Y-M, Harifi, G., El Kibbi, L., Halabi, H.M., Akawatcharangura, P., Katchamart, W., Fuentes-Silva, Y., Cabriza, K., Losanto, J., Colaman, N., Cachafeiro-Vilar, A., Bautista, G.G., Ho, E.J.G., González, R.A., Nunez, L.S., Vergara, C.M., Báez, J.T., Alonzo, H., Pastelin, C.B.S., Salinas, R.G., Obiols, A.Q., Chávez, N., Ordóñez, A.B., Argueta, S., Quijivix, D., Llerena, G.A.R., Sierra-Zorita, R., Arrieta, D., Hidalgo, E.R., Saenz, R., M., I.E., Morales, R., Calapaqui, W., Quezada, I. and Arredondo, G. (2022) COVAD survey 2 long-term outcomes: unmet need and protocol. Rheumatology International .

Files, J.K., Sterrett, S., Henostroza, S., Fucile, C., Maroney, K., Fram, T., Mallal, S., Kalams, S., Carlson, J., Rosenberg, A., Erdmann, N., Bansal, A., Goepfert, P.A. and Silvestri, G. (2022) HLA-II-Associated HIV-1 Adaptation Decreases CD4 + T-Cell Responses in HIV-1 Vaccine Recipients. Journal of Virology, 96 (17).

Gibson, A., Li, Y., Thorne, M., Ram, R., Palubinsky, A., Choshi, P., Porter, M., Trubiano, J., Deshpande, P., Chopra, A., Leary, S., Gangula, R., White, K., Pilkington, M., Konvinse, K., Wang, C-W, Pan, R-Y, Hung, S-I, Chung, W-H, Peter, J., Mallal, S. and Phillips, E. (2022) Single-cell multi-omic approaches define common molecular and cellular signals of dominant antigen-driven cells at the site of drug-induced Stevens Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN) tissue damage. Journal of Allergy and Clinical Immunology, 149 (2). Art. AB181.

Goldman, J.L., Miller, J.O., Miller, N., Eveleigh, R., Gibson, A., Phillips, E.J. and Pastinen, T. (2022) HLA-B*07:02 and HLA-C*07:02 are associated with trimethoprim-sulfamethoxazole respiratory failure. The Pharmacogenomics Journal, 22 . pp. 124-129.

Guyer, A.C., Macy, E., White, A.A., Kuruvilla, M.E., Robison, R.G., Kumar, S., Khan, D.A., Phillips, E.J., Ramsey, A. and Blumenthal, K. (2022) Allergy Electronic Health Record Documentation: A 2022 Work Group Report of the AAAAI Adverse Reactions to Drugs, Biologicals, and Latex Committee. The Journal of Allergy and Clinical Immunology: In Practice . In Press.

Hama, N., Abe, R., Gibson, A. and Phillips, E.J. (2022) Drug-Induced Hypersensitivity Syndrome (DIHS)/ Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis. The Journal of Allergy and Clinical Immunology: In Practice, 10 (5). pp. 1155-1167.

Harris, A., Abdul-Rahman, A., Morgan, W., Khoo, Y.J., Lind, C., Kermode, A., Carroll, W. and Yu, D-Y (2022) Linear interactions between intraocular, intracranial pressure, and retinal vascular pulse amplitude in the fourier domain. PLoS ONE, 17 (6). Art. e0270557.

Hertzman, R.J., Deshpande, P., White, K.D., Gangula, R., Chopra, A., Ram, R., Zic, J.A., Zwerner, J.P., Gibson, A. and Phillips, E.J. (2022) Single-cell immunopathology of systemic contact allergy associated with corticosteroids. Journal of Dermatological Science, 105 (2). pp. 137-140.

Hop, P.J., Zwamborn, R.A.J., Hannon, E., Shireby, G.L., Nabais, M.F., Walker, E.M., van Rheenen, W., van Vugt, J.J.F.A., Dekker, A.M., Westeneng, H-J, Tazelaar, G.H.P., van Eijk, K.R., Moisse, M., Baird, D., Al Khleifat, A., Iacoangeli, A., Ticozzi, N., Ratti, A., Cooper-Knock, J., Morrison, K.E., Shaw, P.J., Basak, A.N., Chiò, A., Calvo, A., Moglia, C., Canosa, A., Brunetti, M., Grassano, M., Gotkine, M., Lerner, Y., Zabari, M., Vourc’h, P., Corcia, P., Couratier, P., Mora Pardina, J.S., Salas, T., Dion, P., Ross, J.P., Henderson, R.D., Mathers, S., McCombe, P.A., Needham, M., Nicholson, G., Rowe, D.B., Pamphlett, R., Mather, K.A., Sachdev, P.S., Furlong, S., Garton, F.C., Henders, A.K., Lin, T., Ngo, S.T., Steyn, F.J., Wallace, L., Williams, K.L., Neto, M.M., Cauchi, R.J., Blair, I.P., Kiernan, M.C., Drory, V., Povedano, M., de Carvalho, M., Pinto, S., Weber, M., Rouleau, G.A., Silani, V., Landers, J.E., Shaw, C.E., Andersen, P.M., McRae, A.F., van Es, M.A., Pasterkamp, R.J., Wray, N.R., McLaughlin, R.L., Hardiman, O., Kenna, K.P., Tsai, E., Runz, H., Al-Chalabi, A., van den Berg, L.H., Van Damme, P., Mill, J., Veldink, J.H., Heijmans, B.T., t Hoen, P.A.C., van Meurs, J., Jansen, R., Franke, L., Boomsma, D.I., Pool, R., van Dongen, J., Hottenga, J.J., van Greevenbroek, M.M.J., Stehouwer, C.D.A., van der Kallen, C.J.H., Schalkwijk, C.G., Wijmenga, C., Franke, L., Zhernakova, S., Tigchelaar, E.F., Slagboom, P.E., Beekman, M., Deelen, J., Van Heemst, D., Veldink, J.H., van den Berg, L.H., van Duijn, C.M., Hofman, B.A., Isaacs, A., Uitterlinden, A.G., van Meurs, J.B.C., Jhamai, P.M., Verbiest, M., Suchiman, H.E.D., Verkerk, M., van der Breggen, R., van Rooij, J., Lakenberg, N., Mei, H., van Iterson, M., van Galen, M., Bot, J., Zhernakova, D.V., Jansen, R., van ‘t Hof, P., Deelen, P., Nooren, I., t Hoen, P.A.C., Heijmans, B.T., Moed, M., Franke, L., Vermaat, M., Zhernakova, D.V., Luijk, R., Jan Bonder, M., van Iterson, M., Deelen, P., van Dijk, F., van Galen, M., Arindrarto, W., Kielbasa, S.M., Swertz, M.A., van Zwet, E.W., Jansen, R., Hoen, P.A.C., Heijmans, B.T., Al-Chalabi, A., Wray, N.R., Bensimon, G., Hardiman, O., Chio, A., Veldink, J.H., Smith, G.D. and Mill, J. (2022) Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS. Science Translational Medicine, 14 (633). Art. abj0264.

James, F., Goh, M.S.Y., Mouhtouris, E., Vogrin, S., Chua, K.Y.L., Holmes, N.E., Awad, A., Copaescu, A-M, De Luca, J.F., Zubrinich, C., Gin, D., Cleland, H., Douglas, A., Kern, J.S., Katelaris, C.H., Thien, F., Barnes, S., Yun, J., Tong, W., Smith, W.B, Carr, A., Anderson, T., Legg, A., Bourke, J., Mackay, L.K., Aung, A.K., Phillips, E.J. and Trubiano, J. (2022) Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR). BMJ Open, 12 (8). Art. e055906.

Joseph, K.W., Halvas, E.K., Brandt, L.D., Patro, S.C., Rausch, J.W., Chopra, A., Mallal, S., Kearney, M.F., Coffin, J.M., Mellors, J.W. and Kirchhoff, F. (2022) Deep sequencing analysis of individual HIV-1 proviruses reveals frequent asymmetric long terminal repeats. Journal of Virology, 96 (13).

Kermode, W., De Santis, D., Truong, L., Della Mina, E., Salman, S., Thompson, G., Nolan, D., Loh, R., Mallon, D, McLean-Tooke, A., John, M., Tangye, S.G., O'Sullivan, M. and D'Orsogna, L.J. (2022) A novel targeted amplicon Next-Generation sequencing gene panel for the diagnosis of common variable immunodeficiency has a high diagnostic yield. The Journal of Molecular Diagnostics, 24 (6). pp. 586-599.

Khan, D.A., Banerji, A., Blumenthal, K.G., Phillips, E.J., Solensky, R., White, A.A., Bernstein, J.A., Chu, D.K., Ellis, A.K., Golden, D.B.K., Greenhawt, M.J., Horner, C.C., Ledford, D., Lieberman, J.A., Oppenheimer, J., Rank, M.A., Shaker, M.S., Stukus, D.R., Wallace, D. and Wang, J. (2022) Drug Allergy: A 2022 Practice Parameter Update. Journal of Allergy and Clinical Immunology .

Koo, G., Plager, J., Fahrenholz, J.M., Phillips, E. and Stone, C. (2022) Reactivity to heparin in patients with alpha-gal allergy. Annals of Allergy, Asthma & Immunology, 129 (4). pp. 515-517.

Koo, G., Stollings, J.L., Lindsell, C., Dear, M.L., Kripalani, S., Nelson, G.E., McCoy, A.B., Rice, T.W., Phillips, E.J. and Stone, C.A. (2022) Low-Risk penicillin allergy delabeling through direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting. The Journal of Allergy and Clinical Immunology: In Practice, 10 (6). pp. 1660-1663.

Koo, G., Yu, R., Phillips, E. and Stone, C.A. (2022) Retrospective stratification of cephalosporin allergy label risk using validated penicillin allergy frameworks. The Journal of Allergy and Clinical Immunology: In Practice .

Krantz, M.S. and Phillips, E.J. (2022) COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA. The Lancet Infectious Diseases, 22 (6). P747-748.

Leffler, J., Trend, S., Ward, N.C., Grau, G.E., Hawke, S., Byrne, S.N., Kermode, A.G., French, M.A. and Hart, P.H. (2022) Circulating memory B Cells in early Multiple Sclerosis exhibit increased IgA+ Cells, globally decreased BAFF-R expression and an EBV-related IgM+ cell signature. Frontiers in Immunology, 13 . Art. 812317.

Lehloenya, R.J., Phillips, E.J., Pasieka, H.B. and Peter, J. (2022) Recognizing Drug Hypersensitivity in Pigmented Skin. Immunology and Allergy Clinics of North America, 42 (2). pp. 219-238.

Li, R., Li, C., Huang, Q., Liu, Z., Chen, J., Zhang, B., Liu, C., Shu, Y., Wang, Y., Kermode, A.G. and Qiu, W. (2022) Immunosuppressant and neuromyelitis optica spectrum disorder: Optimal treatment duration and risk of discontinuation. European Journal of Neurology . Early View.

Li, Y., Deshpande, P., Chopra, A., Choo, L., Gibson, A. and Phillips, E.J. (2022) A low‐cost, sensitive and specific PCR ‐based tool for rapid clinical detection of HLA‐B*35 alleles associated with delayed drug hypersensitivity reactions. HLA .

Loh, J.T., Shuman, J.H.B., Lin, A.S., Favret, N., Piazuelo, M.B., Mallal, S., Chopra, A., McClain, M.S., Cover, T.L. and Brodsky, I.E. (2022) Positive selection of mutations in the Helicobacter pylori katA 5′ untranslated region in a Mongolian Gerbil Model of gastric disease. Infection and Immunity, 90 (7). Art. e0000422.

Lorenzo, J.P.P., Sollano, M.H.M.Z., Salido, E.O., Li‐Yu, J., Tankeh‐Torres, S.A., Wulansari Manuaba, I.A.R., Rahman, M.M., Paul, B.J., Mok, M.Y., de Silva, M., Padhan, P., Lim, A.L., Marcial, M., Vicera, J.J., Haq, S.A., Salman, S., Liyanage, C.K., Keen, H.I., Yew Kuang, C., Wei, J.C‐C, Hellmi, R.Y., Chan, C.E. and Louthrenoo, W. (2022) 2021 Asia‐Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout. International Journal of Rheumatic Diseases, 25 (1). pp. 7-20.

Ma, X., Lu, Y., Peng, F., Wang, Y., Sun, X., Luo, W., Shen, S., Liu, Z., Kermode, A.G., Qiu, W. and Shu, Y. (2022) Serum NfL associated with anti-NMDA receptor encephalitis. Neurological Sciences .

Miller, A.L., Fuller-Carter, P.I., Masarini, K., Samardzija, M., Carter, K.W., Rashwan, R., Lim, X.R., Brunet, A.A., Chopra, A., Ram, R., Grimm, C., Ueffing, M., Carvalho, L.S. and Trifunović, D. (2022) Increased H3K27 trimethylation contributes to cone survival in a mouse model of cone dystrophy. Cellular and Molecular Life Sciences, 79 (8). Art. 409.

Morgan, W.H., Vukmirovic, A., Abdul-Rahman, A., Khoo, Y.J., Kermode, A.G., Lind, C.R., Dunuwille, J. and Yu, D.Y. (2022) Zero retinal vein pulsation amplitude extrapolated model in non-invasive intracranial pressure estimation. Scientific Reports, 12 (1). Art. 5190.

Mukherjee, E.M. and Phillips, E.J. (2022) Where to place etanercept and combination treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis? Annals of Allergy, Asthma & Immunology, 129 (3). pp. 269-270.

Paramalingam, S., Needham, M., Harris, S., O’Hanlon, S., Mastaglia, F. and Keen, H. (2022) Correction to: Muscle B mode ultrasound and shear-wave elastography in idiopathic inflammatory myopathies (SWIM): criterion validation against MRI and muscle biopsy findings in an incident patient cohort. BMC Rheumatology, 6 (1). Art. 72.

Paramalingam, S., Needham, M., Harris, S., O’Hanlon, S., Mastaglia, F. and Keen, H. (2022) Muscle B mode ultrasound and shear-wave elastography in idiopathic inflammatory myopathies (SWIM): criterion validation against MRI and muscle biopsy findings in an incident patient cohort. BMC Rheumatology, 6 (1). Art. 47.

Parker, M.D., Stewart, H., Shehata, O.M., Lindsey, B.B., Shah, D.R., Hsu, S., Keeley, A.J., Partridge, D.G., Leary, S., Cope, A., State, A., Johnson, K., Ali, N., Raghei, R., Heffer, J., Smith, N., Zhang, P., Gallis, M., Louka, S.F., Hornsby, H.R., Alamri, H., Whiteley, M., Foulkes, B.H., Christou, S., Wolverson, P., Pohare, M., Hansford, S.E., Green, L.R., Evans, C., Raza, M., Wang, D., Firth, A.E., Edgar, J.R., Gaudieri, S., Mallal, S., Collins, M.O., Peden, A.A. and de Silva, T.I. (2022) Altered subgenomic RNA abundance provides unique insight into SARS-CoV-2 B.1.1.7/Alpha variant infections. Communications Biology, 5 (1). Art. 666.

Phillips, E.J., Bouchard, C.S. and Divito, S.J. (2022) Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis—Coordinating Research Priorities to Move the Field Forward. JAMA Dermatology, 158 (6). pp. 607-608.

Porter, M., Choshi, P., Pedretti, S., Chimbetete, T., Smith, R., Meintjes, G., Phillips, E., Lehloenya, R. and Peters, J. (2022) IFN-γ ELISpot in severe cutaneous adverse reactions to First-line Antituberculosis drugs in an HIV endemic setting. Journal of Investigative Dermatology . In Press.

Restuadi, R., Steyn, F.J., Kabashi, E., Ngo, S.T., Cheng, F-F, Nabais, M.F., Thompson, M.J., Qi, T., Wu, Y., Henders, A.K., Wallace, L., Bye, C.R., Turner, B.J., Ziser, L., Mathers, S., McCombe, P.A., Needham, M., Schultz, D., Kiernan, M.C., van Rheenen, W., van den Berg, L.H., Veldink, J.H., Ophoff, R., Gusev, A., Zaitlen, N., McRae, A.F., Henderson, R.D., Wray, N.R., Giacomotto, J. and Garton, F.C. (2022) Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1. Genome Medicine, 14 (1). Art. 7.

Roy, P., Sidney, J., Lindestam Arlehamn, C.S., Phillips, E., Mallal, S., Armstrong Suthahar, S.S., Billitti, M., Rubiro, P., Marrama, D., Drago, F., Vallejo, J., Suryawanshi, V., Orecchioni, M., Makings, J., Kim, P.J., McNamara, C.A., Peters, B., Sette, A. and Ley, K. (2022) Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B. Circulation Research, 131 (3). pp. 258-276.

Sharmin, S., Bovis, F., Malpas, C., Horakova, D., Havrdova, E.K., Izquierdo, G., Eichau, S., Trojano, M., Prat, A., Girard, M., Duquette, P., Onofrj, M., Lugaresi, A., Grand'Maison, F., Grammond, P., Sola, P., Ferraro, D., Terzi, M., Gerlach, O., Alroughani, R., Boz, C., Shaygannejad, V., van Pesch, V., Cartechini, E., Kappos, L., Lechner‐Scott, J., Bergamaschi, R., Turkoglu, R., Solaro, C., Iuliano, G., Granella, F., Van Wijmeersch, B., Spitaleri, D., Slee, M., McCombe, P., Prevost, J., Ampapa, R., Ozakbas, S., Sanchez‐Menoyo, J.L., Soysal, A., Vucic, S., Petersen, T., de Gans, K., Butler, E., Hodgkinson, S., Sidhom, Y., Gouider, R., Cristiano, E., Castillo‐Triviño, T., Saladino, M.L., Barnett, M., Moore, F., Rozsa, C., Yamout, B., Skibina, O., van der Walt, A., Buzzard, K., Gray, O., Hughes, S., Sempere, A.P., Singhal, B., Fragoso, Y., Shaw, C., Kermode, A., Taylor, B., Simo, M., Shuey, N., Al‐Harbi, T., Macdonell, R., Dominguez, J.A., Csepany, T., Sirbu, C.A., Sormani, M.P., Butzkueven, H. and Kalincik, T. (2022) Confirmed disability progression as a marker of permanent disability in multiple sclerosis. European Journal of Neurology, 29 (8). pp. 2321-2334.

Sooda, A., Rwandamuriye, F., Wanjalla, C.N., Jing, L., Koelle, D.M., Peters, B., Leary, S., Chopra, A., Calderwood, M.A., Mallal, S.A., Pavlos, R., Watson, M.ORCID: 0000-0002-6438-9225, Phillips, E.J. and Redwood, A.J. (2022) Abacavir inhibits but does not cause self-reactivity to HLA-B*57:01-restricted EBV specific T cell receptors. Communications Biology, 5 (1). Art. 133.

Stollings, J.L., Koo, G., Lindsell, C.J., Dear, M.L., McCoy, A., Rice, T.W., Phillips, E.J. and Stone, C.A. (2022) Risk-Stratified Management to Remove Low-Risk Penicillin Allergy Labels in the Patients with COVID-19 in the Intensive Care Unit. The Journal of Allergy and Clinical Immunology: In Practice . In Press.

Tarke, A., Coelho, C.H., Zhang, Z., Dan, J.M., Yu, E.D., Methot, N., Bloom, N.I., Goodwin, B., Phillips, E., Mallal, S., Sidney, J., Filaci, G., Weiskopf, D., da Silva Antunes, R., Crotty, S., Grifoni, A. and Sette, A. (2022) SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron. Cell, 185 (5). P847-859.

Theunissen, F., Anderton, R.S., Mastaglia, F.L., James, I., Bedlack, R. and Akkari, P.A. (2022) Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onset. Scientific Reports, 12 (1). Art. 14739.

Thompson, G., Boan, P., Purtill, D., Cooney, J., Cannell, P., Wright, M. and John, M. (2022) QuantiFERON‐cytomegalovirus to predict clinically significant cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Transplant Infectious Disease . Early View.

Wanjalla, C.N., Temu, T.M., Mashayekhi, M., Warren, C.M., Shepherd, B.E., Gangula, R., Fuseini, H., Bailin, S., Gabriel, C.L., Gangula, P., Madhur, M.S., Kalams, S., Mallal, S.A., Harrison, D.G., Beckman, J.A. and Koethe, J.R. (2022) Interleukin-17A is associated with flow-mediated dilation and interleukin-4 with carotid plaque in persons with HIV. AIDS, 36 (7). pp. 963-973.

Waters, S., Lee, S., Ariyanto, I., Kresoje, N., Leary, S., Munyard, K., Gaudieri, S., Irish, A., Keil, A.D., Allcock, R.J.N. and Price, P. (2022) Sequencing of the viral UL111a gene directly from clinical specimens reveals variants of HCMV-encoded IL-10 that are associated with altered immune responses to HCMV. International Journal of Molecular Sciences, 23 (9). Article 4644.

Waters, S., Lee, S., Ariyanto, I., Leary, S., Munyard, K., Gaudieri, S., Irish, A., Allcock, R.J.N. and Price, P. (2022) Variants of HCMV UL18 sequenced directly from clinical specimens associate with antibody and T-cell responses to HCMV. International Journal of Molecular Sciences, 23 (21). Article 12911.

Wilson, Y.A., Smithers‐Sheedy, H., Ostojic, K., Waight, E., Kruer, M.C., Fahey, M.C., Baynam, G., Gecz, J., Badawi, N. and McIntyre, S. (2022) Common data elements to standardize genomics studies in cerebral palsy. Developmental Medicine & Child Neurology . Early View.

Wu, P., Feng, Q., Kerchberger, V.E., Nelson, S.D., Chen, Q., Li, B., Edwards, T.L., Cox, N.J., Phillips, E.J., Stein, C.M., Roden, D.M., Denny, J.C. and Wei, W-Q (2022) Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension. Nature Communications, 13 (1). Art. 46.

Yin, W., Pham, C.V., Wang, T., Al Shamaileh, H., Chowdhury, R., Patel, S., Li, Y., Kong, L., Hou, Y., Zhu, Y., Chen, S., Xu, H., Jia, L., Duan, W. and Xiang, D. (2022) Inhibition of autophagy promotes the elimination of liver cancer stem cells by CD133 aptamer-targeted delivery of doxorubicin. Biomolecules, 12 (11). Article 1623.

Zarnegar‐Lumley, S., Stone, C.A., Smith, C.M., Hall, L.L., Luck, K.E., Koo, G., Plager, J.H., Phillips, E.J. and Friedman, D.L. (2022) Oncologist counseling practice and COVID‐19 vaccination outcomes for patients with history of PEG‐asparaginase hypersensitivity. Pediatric Blood & Cancer, 69 (7). Art. e29686.

2021

Alves, E., Taifour, S., Dolcetti, R., Chee, J., Nowak, A.K., Gaudieri, S. and Blancafort, P. (2021) Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing. Molecular Therapy - Methods & Clinical Development, 21 (11). pp. 592-606.

Arnold, A., Trevenen, M., Murray, K., Ong, J., Haywood, Z., Rueter, K., von Ungern-Sternberg, B. and Lucas, M. (2021) P26: Drug allergy reporting: Are we playing it safe in paediatrics? Internal Medicine Journal, 51 (S4). pp. 12-13.

Ashton, C., Paramalingam, S., Stevenson, B., Brusch, A. and Needham, M. (2021) Idiopathic inflammatory myopathies: A review. Internal Medicine Journal, 51 (6). pp. 845-852.

Awad, A., Mouhtouris, E., Nguyen-Robertson, C.V., Holmes, N., Chua, K.Y.L., Copaescu, A., James, F., Goh, M.S., Aung, A.K., Godfrey, D.I., Phillips, E.J., Gibson, A., Almeida, C.F. and Trubiano, J.A. (2021) Blister fluid as a cellular input for ex vivo diagnostics in drug-induced severe cutaneous adverse reactions improves sensitivity and explores immunopathogenesis. Journal of Allergy and Clinical Immunology: Global . In Press.

Bacchus-Souffan, C., Fitch, M., Symons, J., Abdel-Mohsen, M., Reeves, D.B., Hoh, R., Stone, M., Hiatt, J., Kim, P., Chopra, A., Ahn, H., York, V.A., Cameron, D.L., Hecht, F.M., Martin, J.N., Yukl, S.A., Mallal, S., Cameron, P.U., Deeks, S.G., Schiffer, J.T., Lewin, S.R., Hellerstein, M.K., McCune, J.M. and Hunt, P.W. (2021) Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART. PLoS Pathogens, 17 (1). e1009214.

Bailin, S.S., Ram, R., Chopra, A., Gangula, R., Leary, S., Mashayekhi, M., Gabriel, C.L., Woodward, B.O., Lima, M., Hannah, L., Kalams, S.A., Mallal, S.A., Koethe, J.R. and Wanjalla, C.N. (2021) Defining an adipose tissue single cell atlas to understand metabolic disease in HIV. Journal of the International AIDS Society . p. 4.

Bluestein, S.B., Yu, R., Stone, C.A. and Phillips, E.J. (2021) Reporting of Drug Reaction with Eosinophilia and Systemic Symptoms from 2002-2019 in the FDA Adverse Event Reporting System (FAERS). The Journal of Allergy and Clinical Immunology: In Practice, 9 (8). 3208-3211.e1.

Bukhari, W., Khalilidehkordi, E., Mason, D.F., Barnett, M.H., Taylor, B.V., Fabis-Pedrini, M., Kermode, A.G., Subramanian, S., Waters, P., Broadley, S.A., Abernethy, D., Bhuta, S., Blum, S., Boggild, M., Boundy, K., Brew, B.J., Brilot, F., Brownlee, W.J., Bundell, C.S., Butzkueven, H., Carroll, W.M., Chen, C., Clarke, L., Coulthard, A., Dale, R.C., Das, C., Dear, K., Fulcher, D., Gillis, D., Hawke, S., Heard, R., Henderson, A.P.D., Heshmat, S., Hodgkinson, S., Jimenez Sanchez, S., Kilpatrick, T.J., King, J., Kneebone, C., Kornberg, A.J., Lechner-Scott, J., Lin, M-W, Lynch, C., Macdonell, R.A.L., Marriott, M.P., McCombe, P.A., O’Gorman, C., Parratt, J.D.E., Pender, M.P., Pereira, J., Pollard, J.D., Prain, K.M., Ramanathan, S., Reddell, S.W., Shaw, C., Silvestrini, R.A., Slee, M., Spies, J., Stankovich, J., Sutton, I., Vincent, A., Vucic, S., Walsh, M., Willoughby, E., Wong, R.C., Woodhall, M. and Yiu, E.M. (2021) NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand. Journal of Neurology .

Caballero, M.L., Krantz, M.S., Quirce, S., Phillips, E. and Stone Jr., C.A. (2021) Hidden Dangers: Recognizing excipients as potential causes of drug and vaccine hypersensitivity reactions. The Journal of Allergy and Clinical Immunology: In Practice, 9 (8). pp. 2968-2982.

Chang, W-C, Abe, R., Anderson, P., Anderson, W., Ardern-Jones, M.R., Beachkofsky, T.M., Bellón, T., Biala, A.K., Bouchard, C., Cavalleri, G.L., Chapman, N., Chodosh, J., Choi, H.K., Cibotti, R.R., Divito, S.J., Dewar, K., Dehaeck, U., Etminan, M., Forbes, D., Fuchs, E., Goldman, J.L., Holmes, J.H., Hope, E.A., Hung, S-L, Hsieh, C-L, Iovieno, A., Jagdeo, J., Kim, M.K., Koelle, D.M., Lacouture, M.E., Le Pallec, S., Lehloenya, R.J., Lim, R., Lowe, A., McCawley, J., McCawley, J., Micheletti, R.G., Mockenhaupt, M., Niemeyer, K., Norcross, M.A., Oboh, D., Olteanu, C., Pasieka, H.B., Peters, J., Pirmohamed, M., Rieder, M., Saeed, H.N., Shear, N.H., Shieh, C., Straus, S., Sukasem, C., Sung, C., Trubiano, J.A., Tsou, S-Y, Ueta, M., Volpi, S., Wan, C., Wang, H., Wang, Z-Q, Weintraub, J., Whale, C., Wheatley, L.M., Whyte-Croasdaile, S., Williams, K.B., Wright, G., Yeung, S.N., Zhou, L., Chung, W-H, Phillips, E.J. and Carleton, B.C. (2021) Corrigendum to ‘SJS/TEN 2019: From science to translation’ [J. Dermatol. Sci. 98/1 (2020) 2–12]. Journal of Dermatological Science, 104 (2). pp. 146-147.

Clarke, L., Bukhari, W., O'Gorman, C.M., Khalilidehkordi, E., Arnett, S., Woodhall, M., Prain, K.M., Parratt, J.D.E., Barnett, M.H., Marriott, M.P., McCombe, P.A., Sutton, I., Boggild, M., Brownlee, W., Carroll, W.M., Hodgkinson, S., Macdonell, R.A.L., Mason, D.F., Pereira, J., Slee, M., Das, C., Henderson, A.P.D., Kermode, A.G., Lechner-Scott, J., Waters, P., Sun, J. and Broadley, S.A. (2021) Response to treatment in NMOSD: the Australasian experience. Multiple Sclerosis and Related Disorders, 58 . Art. 103408.

Copaescu, A., Gibson, A., Li, Y., Trubiano, J.A. and Phillips, E.J. (2021) An updated review of the diagnostic methods in delayed drug hypersensitivity. Frontiers in Pharmacology, 11 . Art. 573573.

Copaescu, A., Mouhtouris, E., Vogrin, S., James, F., Chua, K.Y.L., Holmes, N.E., Douglas, A., Slavin, M.A., Cleland, H., Zubrinich, C., Aung, A.K., Goh, M.S.Y., Phillips, E.J. and Trubiano, J.A. (2021) The role of In Vivo and Ex Vivo diagnostic tools in severe delayed Immune-Mediated adverse antibiotic drug reactions. The Journal of Allergy and Clinical Immunology: In Practice, 9 (5). 2010-2015.e4.

Copaescu, A.M., Phillips, E.J. and Trubiano, J.A. (2021) Antifungal hypersensitivity reactions and cross-reactivity patterns. Current Opinion in Infectious Diseases, 34 (6). pp. 559-572.

Currenti, J., Law, B.M.P., Qin, K., John, M., Pilkinton, M.A., Bansal, A., Leary, S., Ram, R., Chopra, A., Gangula, R., Yue, L., Warren, C., Barnett, L., Alves, E., McDonnell, W.J., Sooda, A., Heath, S.L., Mallal, S., Goepfert, P., Kalams, S.A. and Gaudieri, S. (2021) Cross-Reactivity to mutated viral immune targets can influence CD8+ T cell functionality: An alternative viral adaptation strategy. Frontiers in Immunology, 12 . Art. 746986.

Deshpande, P., Hertzman, R.J., Palubinsky, A.M., Giles, J.B., Karnes, J.H., Gibson, A. and Phillips, E.J. (2021) Immunopharmacogenomics: Mechanisms of HLA‐Associated Drug Reactions. Clinical Pharmacology & Therapeutics, 110 (3). pp. 607-615.

Dutta, T., Pesce, E-R, Maier, A.G. and Blatch, G.L. (2021) Role of the J domain protein family in the survival and pathogenesis of plasmodium falciparum. In: Shonhai, A., Picard, D. and Blatch, G.L., (eds.) Heat Shock Proteins of Malaria. Springer, Cham, pp. 97-123.

Hammond, S., Olsson-Brown, A., Grice, S., Gibson, A., Gardner, J., Castrejón-Flores, J.L., Jolly, C., Fisher, B.A., Steven, N., Betts, C., Pirmohamed, M., Meng, X. and Naisbitt, D.J. (2021) Checkpoint inhibition reduces the threshold for Drug-Specific T-Cell priming and increases the incidence of sulfasalazine hypersensitivity. Toxicological Sciences, 186 (1). pp. 58-69.

Hertzman, R., Deshpande, P., White, K., Gangula, R., Chopra, A., Ram, R., Leary, S., Zic, J., Zwerner, J., Gibson, A. and Phillips, E. (2021) Single-cell immunopathology of systemic contact allergy associated with corticosteroids. Journal of Allergy and Clinical Immunology, 147 (2). AB31.

Hertzman, R.J., Deshpande, P., Gibson, A. and Phillips, E.J. (2021) Role of pharmacogenomics in T-cell hypersensitivity drug reactions. Current Opinion in Allergy & Clinical Immunology, 21 (4). pp. 327-334.

Hertzman, R.J., Deshpande, P., Leary, S., Li, Y., Ram, R., Chopra, A., Cooper, D., Watson, M.ORCID: 0000-0002-6438-9225, Palubinsky, A.M., Mallal, S., Gibson, A. and Phillips, E.J. (2021) Visual genomics analysis studio as a tool to analyze multiomic data. Frontiers in Genetics, 12 . Art. 642012.

Koo, G., Anvari, S., Friedman, D.L., Zarnegar-Lumley, S., Szafron, V., Kahwash, B.M., Onasch, K.M., Hall, L., Phillips, E.J. and Stone, C.A. (2021) mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to Pegaspargase. The Journal of Allergy and Clinical Immunology: In Practice, 10 (1). P322-P325.

Krantz, M.S., Stone, C.A., Abreo, A. and Phillips, E.J. (2021) Reply to ‘‘The safety and efficacy of direct oral challenge in trimethoprim-sulfamethoxazole antibiotic allergy”. The Journal of Allergy and Clinical Immunology: In Practice, 9 (10). pp. 3849-3850.

Leary, S., Gaudieri, S., Parker, M.D., Chopra, A., James, I., Pakala, S., Alves, E., John, M., Lindsey, B.B., Keeley, A.J., Rowland-Jones, S.L., Swanson, M.S., Ostrov, D.A., Bubenik, J.L., Das, S., Sidney, J., Sette, A., de Silva, T.I., Phillips, E. and Mallal, S. (2021) Generation of a novel SARS-CoV-2 sub-genomic RNA due to the R203K/G204R variant in nucleocapsid: homologous recombination has potential to change SARS-CoV-2 at both protein and RNA level. bioRxiv: The preprint server for Biology .

Leary, S., Gaudieri, S., Parker, M.D., Chopra, A., James, I., Pakala, S., Alves, E., John, M., Lindsey, B.B., Keeley, A.J., Rowland-Jones, S.L., Swanson, M.S., Ostrov, D.A., Bubenik, J.L., Das, S.R., Sidney, J., Sette, A., de Silva, T.I., Phillips, E. and Mallal, S. (2021) Generation of a novel SARS-CoV-2 Sub-genomic RNA due to the R203K/G204R variant in Nucleocapsid: Homologous recombination has potential to change SARS-CoV-2 at both protein and RNA level. Pathogens and Immunity, 6 (2). pp. 27-49.

Li, C., Wang, J., Sun, X., Li, R., Chang, Y., Wang, Y., Zhong, X., Kermode, A.G., Mao, Z. and Qiu, W. (2021) The current situation of diagnosis and treatment of neuromyelitis optica spectrum disorder: Experience with 461 cases from a single centre in South China. Journal of Neuroimmunology, 353 . Art. 577506.

Li, Y., Deshpande, P., Hertzman, R.J., Palubinsky, A.M., Gibson, A. and Phillips, E.J. (2021) Genomic Risk Factors Driving Immune-Mediated Delayed Drug Hypersensitivity Reactions. Frontiers in Genetics, 12 . Art. 641905.

Luo, W., Li, R., Chang, Y., She, H., Kermode, A.G. and Qiu, W. (2021) Myelin oligodendrocyte glycoprotein antibody-associated disorders coexisting with ankylosing spondylitis: Potential association between demyelination and tumor necrosis factor inhibitors. Multiple Sclerosis and Related Disorders, 51 . Art. 102889.

Maltby, V.E., Lea, R.A., Monif, M., Fabis-Pedrini, M.J., Buzzard, K., Kalincik, T., Kermode, A.G., Taylor, B., Hodgkinson, S., McCombe, P., Butzkueven, H., Barnett, M. and Lechner-Scott, J. (2021) Efficacy of Cladribine Tablets as a treatment for people with Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study). JMIR Research Protocols, 10 (10). Art. e24969.

Nakkam, N., Trubiano, J., Gibson, A. and Phillips, E.J. (2021) Considerations for cross-reactivity between vancomycin and other glycopeptides. The Journal of Allergy and Clinical Immunology: In Practice, 9 (8). Art. 3233.

Paramalingam, S., Needham, M., Raymond, W., Mastaglia, F., Lightowler, D., Morin, N., Counsel, P. and Keen, H.I. (2021) Muscle shear wave elastography, conventional B mode and power doppler ultrasonography in healthy adults and patients with autoimmune inflammatory myopathies: A pilot cross-sectional study. BMC Musculoskeletal Disorders, 22 (1). Art. 537.

Parker, M.D., Lindsey, B.B., Leary, S., Gaudieri, S., Chopra, A., Wyles, M., Angyal, A., Green, L.R., Parsons, P., Tucker, R.M., Brown, R., Groves, D., Johnson, K., Carrilero, L., Heffer, J., Partridge, D.G., Evans, C., Raza, M., Keeley, A.J., Smith, N., Filipe, A.D., Shepherd, J.G., Davis, C., Bennett, S., Sreenu, V.B., Kohl, A., Aranday-Cortes, E., Tong, L., Nichols, J., Thomson, E.C., Wang, D., Mallal, S. and de Silva, T.I. (2021) Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data. Genome Research, 31 (4). pp. 645-658.

Pilkinton, M.A., McDonnell, W.J., Barnett, L., Chopra, A., Gangula, R., White, K.D., Leary, S., Currenti, J., Gaudieri, S., Mallal, S.A., Kalams, S.A. and Silvestri, G. (2021) In chronic infection, HIV Gag-Specific CD4+ T cell receptor diversity is higher than CD8+ T cell receptor diversity and is associated with Less HIV quasispecies diversity. Journal of Virology, 95 (8). Art. e02380-20.

Restuadi, R., Garton, F.C., Benyamin, B., Lin, T., Williams, K.L., Vinkhuyzen, A., van Rheenen, W., Zhu, Z., Laing, N.G., Mather, K.A., Sachdev, P.S., Ngo, S.T., Steyn, F.J., Wallace, L., Henders, A.K., Visscher, P.M., Needham, M., Mathers, S., Nicholson, G., Rowe, D.B., Henderson, R.D., McCombe, P.A., Pamphlett, R., Blair, I.P., Wray, N.R. and McRae, A.F. (2021) Polygenic risk score analysis for amyotrophic lateral sclerosis leveraging cognitive performance, educational attainment and schizophrenia. European Journal of Human Genetics .

Ruknarong, L., Boonthongkaew, C., Chuangchot, N., Jumnainsong, A., Leelayuwat, N., Jusakul, A., Gaudieri, S. and Leelayuwat, C. (2021) Vitamin C supplementation reduces expression of circulating miR-451a in subjects with poorly controlled type 2 diabetes mellitus and high oxidative stress. PeerJ, 9 . Art. e10776.

Seedat, F., James, I., Loubser, S., Waja, Z., Mallal, S., Hoffmann, C., Tiemessen, C.T., Chaisson, R.E. and Martinson, N.A. (2021) Human leukocyte antigen associations with protection against tuberculosis infection and disease in human immunodeficiency virus-1 infected individuals, despite household exposure and immune suppression. Tuberculosis, 126 . Art. 102023.

Shonhai, A. and Blatch, G.L. (2021) Heat shock proteins of malaria: Highlights and future prospects. In: Shonhai, A., Picard, D. and Blatch, G.L., (eds.) Heat Shock Proteins of Malaria. Springer, Cham, pp. 237-246.

Singhania, A., Dubelko, P., Kuan, R., Chronister, W.D., Muskat, K., Das, J., Phillips, E.J., Mallal, S.A., Seumois, G., Vijayanand, P., Sette, A., Lerm, M., Peters, B. and Lindestam Arlehamn, C. (2021) CD4+CCR6+ T cells dominate the BCG-induced transcriptional signature. EBioMedicine, 74 . Art. 103746.

Singhania, A., Pham, J., Dhanwani, R., Frazier, A., Rezende Dutra, J., Marder, K.S., Phillips, E., Mallal, S., Amara, A.W., Standaert, D.G., Sulzer, D., Peters, B., Sette, A. and Lindestam Arlehamn, C.S. (2021) The TCR repertoire of α-synuclein-specific T cells in Parkinson’s disease is surprisingly diverse. Scientific Reports, 11 (1). Art. 302.

Tarke, A., Sidney, J., Kidd, C.K., Dan, J.M., Ramirez, S.I., Yu, E.D., Mateus, J., da Silva Antunes, R., Moore, E., Rubiro, P., Methot, N., Phillips, E., Mallal, S., Frazier, A., Rawlings, S.A., Greenbaum, J.A., Peters, B., Smith, D.M., Crotty, S., Weiskopf, D., Grifoni, A. and Sette, A. (2021) Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases. Cell Reports Medicine, 2 (2). Art. 100204.

Theunissen, F., Anderton, R.S., Mastaglia, F.L., Flynn, L.L., Winter, S.J., James, I., Bedlack, R., Hodgetts, S., Fletcher, S., Wilton, S.D., Laing, N.G., MacShane, M., Needham, M., Saunders, A., MacKay-Sim, A., Melamed, Z., Ravits, J., Cleveland, D.W. and Akkari, P.A. (2021) Novel STMN2 variant linked to amyotrophic lateral sclerosis risk and clinical phenotype. Frontiers in Aging Neuroscience, 13 . Art. 658226.

Tian, J.ORCID: 0000-0001-9887-7211, Adams, M.J.ORCID: 0000-0002-7743-4515, Tay, J.W.T., James, I., Powell, S., Hughes, Q.W., Gilmore, G., Baker, R.I. and Tiao, J.Y-H. (2021) Estradiol-responsive miR-365a-3p interacts with tissue factor 3′UTR to modulate tissue factor-initiated thrombin generation. Thrombosis and Haemostasis, 121 (11). pp. 1483-1496.

Trend, S., Leffler, J., Jones, A.P., Cha, L., Gorman, S., Brown, D.A., Breit, S.N., Kermode, A.G., French, M.A., Ward, N.C. and Hart, P.H. (2021) Associations of serum short-chain fatty acids with circulating immune cells and serum biomarkers in patients with multiple sclerosis. Scientific Reports, 11 (1). Art. 5244.

Wanjalla, C.N., McDonnell, W.J., Ram, R., Chopra, A., Gangula, R., Leary, S., Mashayekhi, M., Simmons, J.D., Warren, C.M., Bailin, S., Gabriel, C.L., Guo, L., Furch, B.D., Lima, M.C., Woodward, B.O., Hannah, L., Pilkinton, M.A., Fuller, D.T., Kawai, K., Virmani, R., Finn, A.V., Hasty, A.H., Mallal, S.A., Kalams, S.A. and Koethe, J.R. (2021) Single-cell analysis shows that adipose tissue of persons with both HIV and diabetes is enriched for clonal, cytotoxic, and CMV-specific CD4+ T cells. Cell Reports Medicine, 2 (2). Art. 100205.

Waters, S., Agostino, M., Lee, S., Ariyanto, I., Kresoje, N., Leary, S., Munyard, K., Gaudieri, S., Gaff, J., Irish, A., Keil, A.D., Price, P., Allcock, R.J.N. and Campos, S.K. (2021) Sequencing directly from clinical specimens reveals genetic variations in HCMV-Encoded Chemokine Receptor US28 that may influence antibody levels and interactions with human chemokines. Microbiology Spectrum, 9 (2). Art. e00020-21.

Wilson, Y.A., McIntyre, S., Waight, E., Thornton, M., van Otterloo, S., Marmont, S.R., Kruer, M., Baynam, G., Gecz, J. and Badawi, N. (2021) People with cerebral palsy and their family’s preferences about genomics research. Public Health Genomics . Online First.

Zhong, M., Van der Walt, A., Stankovich, J., Kalincik, T., Buzzard, K., Skibina, O., Boz, C., Hodgkinson, S., Slee, M., Lechner-Scott, J., Macdonell, R., Prevost, J., Kuhle, J., Laureys, G., Van Hijfte, L., Alroughani, R., Kermode, A.G., Butler, E., Barnett, M., Eichau, S., van Pesch, V., Grammond, P., McCombe, P., Karabudak, R., Duquette, P., Girard, M., Taylor, B., Yeh, W., Monif, M., Gresle, M., Butzkueven, H. and Jokubaitis, V.G. (2021) Prediction of multiple sclerosis outcomes when switching to ocrelizumab. Multiple Sclerosis Journal . Online First.

2020

Abed, A., Calapre, L., Lo, J., Correia, S., Bowyer, S., Chopra, A., Watson, M.ORCID: 0000-0002-6438-9225, Khattak, M., Millward, M. and Gray, E. (2020) 301MO Genomic HLA as a predictive biomarker for survival among non-small cell lung cancer patient treated with single agent immunotherapy. Annals of Oncology, 31 (Supp. 6). S1359-S1360.

Abed, A., Calapre, L., Lo, J., Correia, S., Bowyer, S., Chopra, A., Watson, M.ORCID: 0000-0002-6438-9225, Khattak, M.A., Millward, M. and Gray, E.S. (2020) Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy. Journal for ImmunoTherapy of Cancer, 8 (2). Art. e001620.

Ashton, C., Banham, N. and Needham, M. (2020) Acute spontaneous spinal cord infarction: Utilisation of hyperbaric oxygen treatment, cerebrospinal fluid drainage and pentoxifylline. Diving and Hyperbaric Medicine Journal, 50 (4). pp. 325-331.

Barakat, L., Torres, M.J., Phillips, E.J., Caminati, M., Chang, Y-S, Caimmi, D., Sanchez-Borges, M., Rosenwasser, L., Didier, A., de Blay, F., Fontaine, J-F, Bosse, I., Lefevre, S., Bassani, C., De Filippo, M., Ansotegui, I., Morais-Almeida, M., Ebisawa, M., Martin, B., Yu-Hor Thong, B., Demoly, P. and Tanno, L.K. (2020) Biological treatments in allergy: Prescribing patterns and management of hypersensitivity reactions. The Journal of Allergy and Clinical Immunology: In Practice, 9 (3). 1396-1399.e2.

Blumenthal, K.G., Harkness, T., Phillips, E.J., Ramsey, A., Banerji, A., Samarakoon, U., Stone, C., Fu, X., Khan, D.A., Otani, I., Camargo, C.A., Zhang, Y. and Donelan, K. (2020) Patient characteristics and concerns about drug allergy: A report from the United States drug allergy registry. The Journal of Allergy and Clinical Immunology: In Practice, 8 (9). pp. 2958-2967.

Blumenthal, K.G. and Phillips, E. (2020) Positioning drug allergy delabeling as a critical tool for precision medicine, quality improvement, and public health. The Journal of Allergy and Clinical Immunology: In Practice, 8 (9). pp. 2916-2919.

Broadley, S.A., Bukhari, W., Khalilidehkordi, E., Mason, F., Barnett, M.H., Taylor, B.V., Fabis-Pedrini, M., Kermode, A.G., Subramanian, S. and Waters, P. (2020) Prevalence of NMOSD and MS in the indigenous populations of Australia and New Zealand. Multiple Sclerosis Journal, 26 (9). NP44.

Chang, W-C, Abe, R., Anderson, P., Anderson, W., Ardern-Jones, M.R., Beachkofsky, T.M., Bellón, T., Biala, A.K., Bouchard, C., Cavalleri, G.L., Chapman, N., Chodosh, J., Choi, H.K., Cibotti, R.R., Divito, S.J., Dewar, K., Dehaeck, U., Etminan, M., Forbes, D., Fuchs, E., Goldman, J.L., Holmes, J.H., Hope, E.A., Hung, S-I, Hsieh, C-L, Iovieno, A., Jagdeo, J., Kim, M.K., Koelle, D.M., Lacouture, M.E., Le Pallec, S., Lehloenya, R.J., Lim, R., Lowe, A., McCawley, J., McCawley, J., Micheletti, R.G., Mockenhaupt, M., Niemeyer, K., Norcross, M.A., Oboh, D., Olteanu, C., Pasieka, H.B., Peter, J., Pirmohamed, M., Rieder, M., Saeed, H.N., Shear, N.H., Shieh, C., Straus, S., Sukasem, C., Sung, C., Trubiano, J.A., Tsou, S-Y, Ueta, M., Volpi, S., Wan, C., Wang, H., Wang, Z-Q, Weintraub, J., Whale, C., Wheatley, L.M., Whyte-Croasdaile, S., Williams, K.B., Wright, G., Yeung, S.N., Zhou, L., Chung, W-H, Phillips, E.J. and Carleton, B.C. (2020) SJS/TEN 2019: From Science to Translation. Journal of Dermatological Science, 98 (1). pp. 2-12.

Chen, C., Wu, Y., Cui, C., Zhao, Y., Sun, X., Wang, Y., Liu, C., Wu, H., Zhong, X., Kermode, A.G., Peng, L. and Qiu, W. (2020) Identification of a Distinct Exosomal microRNA Profile in Neuromyelitis Optica Spectrum Disorders by Next-generation Sequencing. Multiple Sclerosis Journal, 26 (9). NP75-NP76.

Chen, C., Wu, Y., Li, M., Cui, C., Zhao, Y., Sun, X., Wang, Y., Liu, C., Wu, H., Zhong, X., Kermode, A.G., Peng, L. and Qiu, W. (2020) Different exosomal microRNA profile in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders. Frontiers in Immunology, 11 . Art. 1064.

Chua, K.Y.L., Vogrin, S., Bury, S., Douglas, A., Holmes, N.E., Tan, N., Brusco, N.K., Hall, R., Lambros, B., Lean, J., Stevenson, W., Devchand, M., Garrett, K., Thursky, K., Grayson, M.L., Slavin, M.A., Phillips, E.J. and Trubiano, J.A. (2020) The penicillin allergy delabeling program: A Multicenter Whole-of-Hospital health services intervention and comparative effectiveness study. Clinical Infectious Diseases, 73 (3). pp. 487-496.

Cimino, C., Allos, B.M. and Phillips, E.J. (2020) A Review of β-Lactam–Associated Neutropenia and Implications for Cross-reactivity. Annals of Pharmacotherapy, 55 (8). pp. 1037-1049.

Coleman, D.T., Stone, C.A., Wei, W-Q and Phillips, E.J. (2020) Penicillin allergy labels drive perioperative prophylactic antibiotic selection in orthopedic procedures. The Journal of Allergy and Clinical Immunology: In Practice . In Press.

Coleman, D.T., Stone, C.A., Wei, W-Q and Phillips, E.J. (2020) Readiness for PENicillin allergy testing: Perception of Allergy Label (PEN-PAL) Survey. The Journal of Allergy and Clinical Immunology: In Practice, 8 (9). 3180-3182.e4.

Copaescu, A., Rose, M., Mouhtouris, E., Chua, K.Y., Holmes, N.E., Phillips, E.J. and Trubiano, J.A. (2020) Delayed hypersensitivity associated with amoxicillin‐clavulanate. Allergy . Early View.

Copaescu, A., Smibert, O., Gibson, A., Phillips, E.J. and Trubiano, J.A. (2020) The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection. Journal of Allergy and Clinical Immunology, 146 (3). 518-534.e1.

Deshpande, P., Bundell, C., McKinnon, E., Hellard, M., Ffrench, R., Wilkinson, A.L., Drummer, H., Gaudieri, S. and Lucas, M. (2020) Frequent occurrence of low-level positive autoantibodies in chronic hepatitis C. Pathology, 52 (5). pp. 576-583.

Dutta, T., Singh, H., Gestwicki, J.E. and Blatch, G.L. (2020) Exported plasmodial J domain protein, PFE0055c, and PfHsp70-x form a specific co-chaperone-chaperone partnership. Cell Stress and Chaperones .

Esfandiary, T., Park, J.K., Alexanderson, H., Regardt, M., Needham, M., de Groot, I., Sarver, C., Lundberg, I.E., de Visser, M., Song, Y.W., DiRenzo, D., Bingham, C.O., Christopher-Stine, L. and Mecoli, C.A. (2020) Assessing the content validity of patient-reported outcome measures in adult myositis: A report from the OMERACT myositis working group. Seminars in Arthritis and Rheumatism, 50 (5). pp. 943-948.

Fuller-Carter, P.I., Brunet, A., Carter, K., Chopra, A., Hunt, D. and Carvlho, L. (2020) Comparative transcriptome analysis of cone photoreceptors from inherited retinal degeneration mouse models using single cell RNA-seq. Investigative Ophthalmology & Visual Science, 61 (7). Art. 726.

Habermann, A.C., Gutierrez, A.J., Bui, L.T., Yahn, S.L., Winters, N.I., Calvi, C.L., Peter, L., Chung, M-I, Taylor, C.J., Jetter, C., Raju, L., Roberson, J., Ding, G., Wood, L., Sucre, J.M.S., Richmond, B.W., Serezani, A.P., McDonnell, W.J., Mallal, S., Bacchetta, M.J., Loyd, J.E., Shaver, C.M., Ware, L.B., Bremner, R., Walia, R., Blackwell, T.S., Banovich, N.E. and Kropski, J.A. (2020) Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis. Science Advances, 6 (28). Art. eaba1972.

Kidman, J., Principe, N., Watson, M.ORCID: 0000-0002-6438-9225, Lassmann, T., Holt, R.A., Nowak, A.K., Lesterhuis, W.J., Lake, R.A. and Chee, J. (2020) Characteristics of TCR repertoire associated with successful immune checkpoint therapy responses. Frontiers in Immunology, 11 . Art. 587014.

Krantz, M.S., Stone, C.A., Yu, R., Adams, S.N. and Phillips, E.J. (2020) Criteria for intradermal skin testing and oral challenge in patients labeled as fluoroquinolone allergic. The Journal of Allergy and Clinical Immunology: In Practice, 9 (2). 1024-1028.e3.

Krebs, K., Bovijn, J., Zheng, N., Lepamets, M., Censin, J.C., Jürgenson, T., Särg, D., Abner, E., Laisk, T., Luo, Y., Skotte, L., Geller, F., Feenstra, B., Wang, W., Auton, A., Raychaudhuri, S., Esko, T., Metspalu, A., Laur, S., Roden, D.M., Wei, W-Q, Holmes, M.V., Lindgren, C.M., Phillips, E.J., Mägi, R., Milani, L., Fadista, J., Agee, M., Aslibekyan, S., Bell, R.K., Bryc, K., Clark, S.K., Elson, S.L., Fletez-Brant, K., Fontanillas, P., Furlotte, N.A., Gandhi, P.M., Heilbron, K., Hicks, B., Hinds, D.A., Huber, K.E., Jewett, E.M., Jiang, Y., Kleinman, A., Lin, K-H, Litterman, N.K., Luff, M.K., McCreight, J.C., McIntyre, M.H., McManus, K.F., Mountain, J.L., Mozaffari, S.V., Nandakumar, P., Noblin, E.S., Northover, C.A.M., O’Connell, J., Petrakovitz, A.A., Pitts, S.J., Poznik, G.D., Sathirapongsasuti, J.F., Shastri, A.J., Shelton, J.F., Shringarpure, S., Tian, C., Tung, J.Y., Tunney, R.J., Vacic, V., Wang, X. and Zare, A.S. (2020) Genome-wide study identifies association between HLA-B∗55:01 and Self-Reported Penicillin Allergy. The American Journal of Human Genetics, 107 (4). pp. 612-621.

Learmonth, Y.C.ORCID: 0000-0002-4857-8480, Chan, Z., Correia, H.ORCID: 0000-0003-2717-2294, Hathorn, D., Kermode, A., Smith, C. and Walker, D. (2020) Exercise participation and promotion in the multiple sclerosis community; perspectives across varying socio-ecological levels. Disability and Rehabilitation . Latest Article.

Learmonth, Y.C.ORCID: 0000-0002-4857-8480, Chan, Z., Scholes-Robertson, E., Correia, H.ORCID: 0000-0003-2717-2294, Hathorn, D., Kermode, A., Smith, C. and Walker, D. (2020) Motivation to engage in and promote exercise is driven by availability and education; Perspectives of the multiple sclerosis community. Multiple Sclerosis Journal, 26 (3). NP1-NP35.

Lehloenya, R.J., Peter, J.G., Copascu, A., Trubiano, J.A. and Phillips, E.J. (2020) Delabeling delayed drug hypersensitivity: How far can you safely go? The Journal of Allergy and Clinical Immunology: In Practice, 8 (9). 2878-2895.e6.

Li, R., Wang, J., Li, J., Wang, Y., Wu, H., Fan, P., Lau, A.Y., Kermode, A.G. and Qiu, W. (2020) Treatment patterns of patients with multiple sclerosis in Guangzhou, China. Neurology Asia, 25 (2). pp. 173-182.

Li, R., Wang, J., Li, J., Wang, Y., Wu, H., Fan, P., Zhong, X., Lau, A.Y., Kermode, A.G. and Qiu, W. (2020) Treatment patterns of patients with multiple sclerosis in China: A single-center experience. Multiple Sclerosis Journal, 26 (9). NP45-NP46.

Lindestam Arlehamn, C.S., Dhanwani, R., Pham, J., Kuan, R., Frazier, A., Rezende Dutra, J., Phillips, E., Mallal, S., Roederer, M., Marder, K.S., Amara, A.W., Standaert, D.G., Goldman, J.G., Litvan, I., Peters, B., Sulzer, D. and Sette, A. (2020) α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease. Nature Communications, 11 (1). pp. 1-11.

Ma, X., Kermode, A.G., Hu, X. and Qiu, W. (2020) NMOSD acute attack: Understanding, treatment and innovative treatment prospect. Journal of Neuroimmunology, 348 . Art. 577387.

Ma, X., Kermode, A.G., Hu, X. and Qiu, W. (2020) Risk of relapse in patients with neuromyelitis optica spectrum disorder: Recognition and preventive strategy. Multiple Sclerosis and Related Disorders, 46 . Art. 102522.

Mangan, B.L., McAlister, R.K., Balko, J.M., Johnson, D.B., Moslehi, J.J., Gibson, A. and Phillips, E.J. (2020) Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy. British Journal of Clinical Pharmacology . Early View.

Marsh‐Wakefield, F., Ashhurst, T., Trend, S., McGuire, H.M., Juillard, P., Zinger, A., Jones, A.P., Kermode, A.G., Hawke, S., Grau, G.E., Hart, P.H. and Byrne, S.N. (2020) IgG 3 + B cells are associated with the development of multiple sclerosis. Clinical & Translational Immunology, 9 (5).

Mateus, J., Grifoni, A., Tarke, A., Sidney, J., Ramirez, S.I., Dan, J.M., Burger, Z.C., Rawlings, S.A., Smith, D.M., Phillips, E., Mallal, S., Lammers, M., Rubiro, P., Quiambao, L., Sutherland, A., Yu, E.D., da Silva Antunes, R., Greenbaum, J., Frazier, A., Markmann, A.J., Premkumar, L., de Silva, A., Peters, B., Crotty, S., Sette, A. and Weiskopf, D. (2020) Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science, 370 (6512). pp. 89-94.

Mateus, J., Grifoni, A., Voic, H., Angelo, M.A., Phillips, E., Mallal, S., Sidney, J., Sette, A. and Weiskopf, D. (2020) Identification of novel yellow fever Class II epitopes in YF-17D vaccinees. Viruses, 12 (11). Article 1300.

Mathew, V., Wencel, M., Habib, A.A., Goyal, N.A., Needham, M. and Mozaffar, T. (2020) Attitudes toward non-interventional observational studies in US and Australian patients with sporadic inclusion body myositis. Journal of Clinical Neuromuscular Disease, 21 (4). pp. 246-247.

Mohannak, N., Pattison, G., Radich, B., Hird, K., Godecke, E., Mastaglia, F. and Needham, M. (2020) Exploring the efficacy of the expiratory muscle strength trainer to improve swallowing in inclusion body myositis: A pilot study. Neuromuscular Disorders, 30 (4). pp. 294-300.

Morgan, W.H., Khoo, Y.J., Kermode, A.G., Lind, C.R., Hazelton, M.L.., Parsons, K.E. and Yu, D.Y. (2020) Utilisation of retinal vein photoplethysmography to measure intracranial pressure. Journal of Neurology, Neurosurgery & Psychiatry, 92 (1). pp. 104-106.

Nabais, M.F., Lin, T., Benyamin, B., Williams, K.L., Garton, F.C., Vinkhuyzen, A.A.E., Zhang, F., Vallerga, C.L., Restuadi, R., Freydenzon, A., Zwamborn, R.A.J., Hop, P.J., Robinson, M.R., Gratten, J., Visscher, P.M., Hannon, E., Mill, J., Brown, M.A., Laing, N.G., Mather, K.A., Sachdev, P.S., Ngoh, S.T., Steyn, F.J., Wallace, L., Henders, A.K., Needham, M., Veldink, J.H., Mathers, S., Nicholson, G., Rowe, D.B., Henderson, R.D., McCombe, P.A., Pamphlett, R., Yang, J., Blair, I.P., McRae, A.F. and Wray, N.R. (2020) Significant out-of-sample classification from methylation profile scoring for amyotrophic lateral sclerosis. Genomic Medicine, 5 (1). Art. 10.

Naisbitt, D.J., Park, B.K., Sakatis, M.Z., Hillegas, A., Gibson, A., Faulkner, L., Lister, A., Watkinson, J. and Ogese, M.O. (2020) Development of an Improved T-cell assay to assess the intrinsic immunogenicity of haptenic compounds. Toxicological Sciences, 175 (2). pp. 266-278.

Nakkam, N., Gibson, A., Mouhtouris, E., Konvinse, K., Holmes, N., Chua, K.Y., Deshpande, P., Li, D., Ostrov, D.A., Trubiano, J. and Phillips, E.J. (2020) Cross-reactivity between vancomycin, teicoplanin and telavancin in HLA-A*32:01 positive vancomycin DRESS patients sharing an HLA-Class II haplotype. Journal of Allergy and Clinical Immunology, 147 (1). P403-P405.

Nicoletti, P., Carr, D.F., Barrett, S., McEvoy, L., Friedmann, P.S., Shear, N.H., Nelson, M.R., Chiriac, A.M., Blanca-López, N., Cornejo, J.A., Gaeta, F., Nakonechna, A., Torres, M.J., Caruso, C., Valluzzi, R.L., Floratos, A., Shen, Y., Pavlos, R.K., Phillips, E.J., Demoly, P., Romano, A., Blanca, M. and Pirmohamed, M. (2020) Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohort. Journal of Allergy and Clinical Immunology, 147 (5). 1830-1837.e15.

Pavlos, R., Deshpande, P., Chopra, A., Leary, S., Strautins, K., Nolan, D., Thorborn, D., Shaefer, M., Rauch, A., Dunn, D., Montaner, J., Rachlis, A., Almeida, C.M., Choo, L., James, I., Redwood, A.J., Li, Y., Gaudieri, S., Mallal, S.A. and Phillips, E.J. (2020) New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individuals. Human Immunology, 81 (6). pp. 300-304.

Principe, N., Kidman, J., Goh, S., Tilsed, C.M., Fisher, S.A., Fear, V.S., Forbes, C.A., Zemek, R.M., Chopra, A., Watson, M.ORCID: 0000-0002-6438-9225, Dick, I.M., Boon, L., Holt, R.A., Lake, R.A., Nowak, A.K., Lesterhuis, W.J., McDonnell, A.M. and Chee, J. (2020) Tumor infiltrating effector memory Antigen-Specific CD8+ T Cells predict response to immune checkpoint therapy. Frontiers in Immunology, 11 . Art. 584423.

Pytte, J., Anderton, R.S., Flynn, L.L., Theunissen, F., Jiang, L., Pitout, I., James, I., Mastaglia, F.L., Saunders, A.M., Bedlack, R., Siddique, T., Siddique, N. and Akkari, P.A. (2020) Association of a structural variant within the SQSTM1 gene with amyotrophic lateral sclerosis. Neurology Genetics, 6 (2). Art. e406.

Pytte, J., Flynn, L.L., Anderton, R.S., Mastaglia, F.L., Theunissen, F., James, I., Pfaff, A.ORCID: 0000-0002-2231-9800, Kõks, S., Saunders, A.M., Bedlack, R., Burns, D.K., Lutz, M.W., Siddique, N., Siddique, T., Roses, A.D. and Akkari, P.A. (2020) Disease-modifying effects of an SCAF4 structural variant in a predominantly SOD1 ALS cohort. Neurology Genetics, 6 (4). e470.

Redwood, A.J., Masters, L.L., Chan, B., Leary, S., Forbes, C., Jonjic, S., Juranić Lisnić, V., Lisnić, B., Smith, L.M. and Jung, J.U. (2020) Repair of an attenuated low-passage murine cytomegalovirus bacterial artificial chromosome identifies a novel spliced gene essential for salivary gland tropism. Journal of Virology, 94 (22). Art. e01456-20.

Stone, C.A., Stollings, J.L., Lindsell, C. J., Dear, M.L., Buie, R.B., Rice, T.W. and Phillips, E.J. (2020) Risk-stratified Management to Remove Low-Risk Penicillin Allergy Labels in the ICU. American Journal of Respiratory and Critical Care Medicine, 201 (12). pp. 1572-1575.

Stone, C.A., Trubiano, J., Coleman, D.T., Rukasin, C.R.F. and Phillips, E.J. (2020) The challenge of de‐labeling penicillin allergy. Allergy, 75 (2). pp. 273-288.

Stone, C.A., Trubiano, J.A. and Phillips, E.J. (2020) Testing strategies and predictors for evaluating immediate and delayed reactions to cephalosporins. The Journal of Allergy and Clinical Immunology: In Practice, 9 (1). 435-444.e13.

Sun, X., Qiu, W., Wang, J., Wang, S., Wang, Y., Zhong, X., Liu, C., Cui, C., Hong, H., Yang, H., Li, X-J, Lu, Z., Hu, X., Kermode, A.G. and Peng, L. (2020) Myelin oligodendrocyte glycoprotein-associated disorders are associated with HLA subtypes in a Chinese paediatric-onset cohort. Journal of Neurology, Neurosurgery & Psychiatry, 91 (7). pp. 733-739.

Sun, X., Wang, S., Wang, J., Wang, Y., Zhong, X., Liu, C., Cui, C., Hong, H., Yang, H., Li, X., Lu, Z., Hu, X., Kermode, A.G., Peng, L. and Qiu, W. (2020) Myelin oligodendrocyte glycoprotein encephalomyelitis is associated with HLA subtypes in a Chinese paediatric-onset cohort. Multiple Sclerosis Journal, 26 (9). NP87.

Sutton, E., De Santis, D., Hay, L., McKinnon, E., D'Orsogna, L. and Joske, D. (2020) Correlating HLA associations with follicular lymphoma in an Australian data set: A pilot study. HLA . Early View.

Tchan, M., Henderson, R., Kornberg, A., Kairaitis, K., Fuller, M., Davis, M., Ellaway, C., Reardon, K., Corbett, A., Needham, M. and McKelvie, P. (2020) Is it Pompe Disease? Australian diagnostic considerations. Neuromuscular Disorders, 30 (5). P389-P399.

Trend, S., Jones, A.P., Fabis-Pedrini, M.J., Carroll, W.M., Booth, D.R., Lucas, R.M., French, M., Byrne, S.N., Kermode, A.G. and Hart, P.H. (2020) Narrowband UVB phototherapy alters peripheral blood immune cell frequencies in people with clinically isolated syndrome. Multiple Sclerosis Journal, 26 (9). NP52-NP53.

Trend, S., Jones, A.P., Fabis-Pedrini, M.J., Carroll, W.M., Booth, D.R., Lucas, R.M., French, M.A., Byrne, S.N., Kermode, A.G. and Hart, P.H. (2020) Narrowband UVB phototherapy alters peripheral blood immune cell frequencies in people with clinically isolated syndrome. Multiple Sclerosis Journal, 26 (3). NP16-NP17.

Trend, S., Leffler, J., Cooper, M.N., Byrne, S.N., Kermode, A.G., French, M.A. and Hart, P.H. (2020) Narrowband UVB phototherapy reduces TNF production by B‐cell subsets stimulated via TLR7 from individuals with early multiple sclerosis. Clinical & Translational Immunology, 9 (10).

Triplett, J.D., Vijayan, S., Rajanayagam, S., Tuch, P. and Kermode, A.G. (2020) Pregnancy outcomes amongst multiple sclerosis females with third trimester natalizumab use. Multiple Sclerosis and Related Disorders, 40 . Art. 101961.

Trubiano, J.A., Vogrin, S., Chua, K.Y.L., Bourke, J., Yun, J., Douglas, A., Stone, C.A., Yu, R., Groenendijk, L., Holmes, N.E. and Phillips, E.J. (2020) Development and validation of a penicillin allergy clinical decision rule. JAMA Internal Medicine, 180 (5). pp. 745-752.

Trubiano, J.A., Vogrin, S., Chua, K.Y.L., Bourke, J., Yun, J., Douglas, A., Stone, C.A., Yu, R., Groenendijk, L., Holmes, N.E., Phillips, E.J. and Resnick, M.J. (2020) Re: Development and validation of a penicillin allergy clinical decision rule. Journal of Urology, 204 (4). p. 869.

Valenzuela, J.L., Lloyd, S.S.ORCID: 0000-0002-0118-3094, Mastaglia, F.L. and Dawkins, R.L. (2020) Adipose invasion of muscle in Wagyu cattle: Monitoring by histology and melting temperature. Meat Science, 163 . Article 108063.

Vethody, C., Yu, R., Keck, J.M., Onasch, M.K., Stone, C.A. and Phillips, E.J. (2020) Safety, efficacy and effectiveness of delabeling in patients with multiple drug allergy labels. The Journal of Allergy and Clinical Immunology: In Practice, 9 (2). pp. 922-928.

Voic, H., de Vries, R.D., Sidney, J., Rubiro, P., Moore, E., Phillips, E., Mallal, S., Schwan, B., Weiskopf, D., Sette, A., Grifoni, A. and Goodrum, F. (2020) Identification and characterization of CD4+ T cell epitopes after Shingrix vaccination. Journal of Virology, 94 (24).

Vucic, S., Ryder, J., Mekhael, L., Henderson, R.D., Mathers, S., Needham, M., Schultz, D.W. and Kiernan, M.C. (2020) Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study). Medicine, 99 (6). e18904.

2019

Abed, A., Khattak, A., Millward, M., Chopra, A. and Gray, E. (2019) Genomic HLA heterozygosity as a predictive marker for survival in lung cancer patients post immunotherapy. Asia-Pacific Journal of Clinical Oncology, 15 (S9). pp. 161-162.

Almeida, C-A, van Miert, P., O’Driscoll, K., Zoet, Y.M., Chopra, A., Witt, C., John, M., Claas, F.H.J. and D’Orsogna, L.J. (2019) Virus-specific T cell clonotypes may contribute to drug hypersensitivity reactions via heterologous immunity. Journal of Allergy and Clinical Immunology, 144 (2). 608-611.e4.

Avila-Rios, S., Carlson, J.M., John, M., Mallal, S. and Brumme, Z.L. (2019) Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure. Current Opinion in HIV and AIDS, 14 (3). pp. 194-204.

Blumenthal, K.G., Peter, J.G., Trubiano, J.A. and Phillips, E.J. (2019) Antibiotic allergy. The Lancet, 393 (10167). pp. 183-198.

Cheng, H., Capponi, S., Wakeling, E., Marchi, E., Li, Q., Zhao, M., Weng, C., Stefan, P.G., Ahlfors, H., Kleyner, R., Rope, A., Lumaka, A., Lukusa, P., Devriendt, K., Vermeesch, J., Posey, J.E., Palmer, E.E., Murray, L., Leon, E., Diaz, J., Worgan, L., Mallawaarachchi, A., Vogt, J., Munnik, S.A., Dreyer, L., Baynam, G., Ewans, L., Stark, Z., Lunke, S., Gonçalves, A.R., Soares, G., Oliveira, J., Fassi, E., Willing, M., Waugh, J.L., Faivre, L., Riviere, J‐B, Moutton, S., Mohammed, S., Payne, K., Walsh, L., Begtrup, A., Guillen Sacoto, M.J., Douglas, G., Alexander, N., Buckley, M.F., Mark, P.R., Adès, L.C., Sandaradura, S.A., Lupski, J.R., Roscioli, T., Agrawal, P.B., Kline, A.D., Wang, K., Timmers, H.T.M. and Lyon, G.J. (2019) Missense variants in TAF1 and developmental phenotypes: Challenges of determining pathogenicity. Human Mutation . Early View.

Currenti, J., Chopra, A., John, M., Leary, S., McKinnon, E., Alves, E., Pilkinton, M., Smith, R., Barnett, L., McDonnell, W.J., Lucas, M., Noel, F., Mallal, S., Conrad, J.A., Kalams, S.A. and Gaudieri, S. (2019) Deep sequence analysis of HIV adaptation following vertical transmission reveals the impact of immune pressure on the evolution of HIV. PLoS Pathogens, 15 (12).

D'Orsogna, L., Almeida, C., van Miert, P., Zoet, Y., Anholts, J., Chopra, A., Watson, M.ORCID: 0000-0002-6438-9225, Witt, C., John, M. and Claas, F. (2019) Drug induced alloreactivity: A new paradigm for allorecognition. American Journal of Transplantation, 19 (9). pp. 2606-2613.

Fabis-Pedrini, M.J., Kuhle, J., Michalak, Z., Walters, S., Trend, S., Jones, A.P., Carroll, W.M., Lucas, R., Hart, P.H. and Kermode, A.G. (2019) Serum neurofilament light chain levels among patients with clinically isolated syndrome. In: PACTRIMS 2019, 13 - 15 November 2019, Singapore

Gaudieri, S., Currenti, J., John, M., McKinnon, E., Leary, S., Chopra, A., Pilkington, M., Smith, R., Barnett, L., McDonnell, W., Lucas, M., Mallal, S., Conrad, J. and Kalams, S. (2019) Deep sequence analysis of HIV adaptation following vertical transmission: Importance of human leucocyte antigen-driven selection on the evolution of HIV. Journal of the International AIDS Society, 22 (S5). p. 39.

Grifoni, A., Moore, E., Voic, H., Sidney, J., Phillips, E., Jadi, R., Mallal, S., De Silva, A.D., De Silva, A.M., Peters, B., Weiskopf, D. and Sette, A. (2019) Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses. Frontiers in Immunology, 10 .

Hanajiri, R., Sani, G.M., Saunders, D., Hanley, P.J., Chopra, A., Mallal, S.A., Sosnovtsev, S.V., Cohen, J.I., Green, K.Y., Bollard, C.M. and Keller, M.D. (2019) Generation of Norovirus-Specific T cells from Human Donors with extensive Cross-Reactivity to variant sequences: implications for Immunotherapy. The Journal of Infectious Diseases, 221 (4). pp. 578-588.

Hanna, M.G., Badrising, U.A., Benveniste, O., Lloyd, T.E., Needham, M., Chinoy, H., Aoki, M., Machado, P.M., Liang, C., Reardon, K.A., de Visser, M., Ascherman, D.P., Barohn, R.J., Dimachkie, M.M., Miller, J.A.L., Kissel, J.T., Oskarsson, B., Joyce, N.C., Van den Bergh, P., Baets, J., De Bleecker, J.L., Karam, C., David, W.S., Mirabella, M., Nations, S.P., Jung, H. H., Pegoraro, E., Maggi, L., Rodolico, C., Filosto, M., Shaibani, A.I., Sivakumar, K., Goyal, N.A., Mori-Yoshimura, M., Yamashita, S., Suzuki, N., Katsuno, M., Murata, K., Nodera, H., Nishino, I., Romano, C.D., Williams, V.S.L., Vissing, J., Auberson, L.Z., Wu, M., de Vera, A., Papanicolaou, D.A. and Amato, A.A. (2019) Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial. The Lancet Neurology, 18 (9). pp. 834-844.

James, T., Salman, S., Stevenson, B., Bundell, C., Kelly, G., Nolan, D. and John, M. (2019) IgE blockade in autoimmunity: Omalizumab induced remission of bullous pemphigoid. Clinical Immunology, 198 . pp. 54-56.

Joshi, S. and Kermode, A.G. (2019) Harding’s disease: an important MS mimic. BMJ Case Reports, 12 (3).

Karnes, J.H., Miller, M.A., White, K.D., Konvinse, K.C., Pavlos, R.K., Redwood, A.J., Peter, J.G., Lehloenya, R., Mallal, S.A. and Phillips, E.J. (2019) Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions. Annual Review of Pharmacology and Toxicology, 59 (1). pp. 463-486.

Konvinse, K.C., Trubiano, J.A., Pavlos, R., James, I., Shaffer, C.M., Bejan, C.A., Schutte, R.J., Ostrov, D.A., Pilkinton, M.A., Rosenbach, M., Zwerner, J.P., Williams, K.B., Bourke, J., Martinez, P., Rwandamuriye, F., Chopra, A., Watson, M.ORCID: 0000-0002-6438-9225, Redwood, A.J., White, K.D., Mallal, S.A. and Phillips, E.J. (2019) HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms. Journal of Allergy and Clinical Immunology, 144 (1). pp. 183-192.

Krantz, M.S., Stone, C.A., Abreo, A. and Phillips, E.J. (2019) Oral Challenge with Trimethoprim-Sulfamethoxazole in Patients with “Sulfa” Antibiotic Allergy. The Journal of Allergy and Clinical Immunology: In Practice, 8 (2). pp. 757-760.

Lammert, C., McKinnon, E.J., Chalasani, N. and Phillips, E.J. (2019) Novel HLA Class I Alleles Outside the Extended DR3 Haplotype Are Protective against Autoimmune Hepatitis. Clinical and Translational Gastroenterology, 10 (6).

Lindestam Arlehamn, C.S., Pham, J., Alcalay, R.N., Frazier, A., Shorr, E., Carpenter, C., Sidney, J., Dhanwani, R., Agin-Liebes, J., Garretti, F., Amara, A.W., Standaert, D.G., Phillips, E.J., Mallal, S.A., Peters, B., Sulzer, D. and Sette, A. (2019) Widespread Tau-Specific CD4 T Cell Reactivity in the General Population. The Journal of Immunology, 203 (1). pp. 84-92.

Mellough, C.M., Ackerman, M., Thompson, J.A., De Roach, J., McLaren, T., Lamey, T., Akkari, A., Ram, R., Leary, S., Chopra, A., Chen, S.C., Zhang, D., McLenachan, S. and Chen, F.K. (2019) Utilising patient-specific retinal organoids to investigate the role of SNRNP200 variants of unknown significance in severe early onset retinitis pigmentosa. Investigative Ophthalmology and Visual Science, 60 (9). p. 2868.

Mohannak, N., Pattison, G., Hird, K. and Needham, M. (2019) Dysphagia in patients with sporadic inclusion body myositis: Management challenges. International Journal of General Medicine, Volume 12 . pp. 465-474.

Nutalai, R., Gaudieri, S., Jumnainsong, A. and Leelayuwat, C. (2019) Regulation of KIR3DL3 Expression via miRNA. Genes, 10 (8). p. 603.

Pan, R-Y, Chu, M-T, Wang, C-W, Lee, Y-S, Lemonnier, F, Michels, A.W., Schutte, R., Ostrov, D.A., Chen, C-B, Phillips, E.J., Mallal, S.A., Mockenhaupt, M., Bellón, T., Tassaneeyakul, W., White, K.D., Roujeau, J-C, Chung, W-H and Hung, S-L (2019) Identification of drug-specific public TCR driving severe cutaneous adverse reactions. Nature Communications, 10 (1). art. no. 3569.

Paramalingam, S., Counsel, P., Mastaglia, F.L., Keen, H. and Needham, M. (2019) Imaging in the diagnosis of idiopathic inflammatory myopathies; indications and utility. Expert Review of Neurotherapeutics, 19 (2). pp. 173-184.

Peng, L., Zhong, X., Sun, X., Shi, Z., Wang, Y., Chang, Y., Chen, C., Wang, J., Hu, X., Kermode, A.G., Zhou, H., Lu, Z. and Qiu, W. (2019) Whole Exome sequencing reveals the major genetic contributors to Chinese patients with NMOSD seropositive for AQP4-IgG. Multiple Sclerosis Journal, 26 (9). NP76.

Redwood, A.J., Rwandamuriye, F., Chopra, A., Leary, S., Ram, R., McDonnell, W., Konvinse, K., White, K., Pavlos, R., Koelle, D.M., Mallal, S. and Phillips, E. (2019) Single cell transcriptomics reveal polyclonal memory T cell responses in abacavir patch test positive skin. Journal of Allergy and Clinical Immunology, 144 (5). 1413-1416.e7.

Rukasin, C.R.F., Phillips, E.J. and Norton, A.E. (2019) Slow graded reintroduction of oxcarbazepine for delayed maculopapular eruption. Annals of Allergy, Asthma & Immunology, 123 (4). pp. 411-412.

Rwandamuriye, F.X., Chopra, A., Konvinse, K.C., Choo, L., Trubiano, J.A., Shaffer, C.M., Watson, M.ORCID: 0000-0002-6438-9225, Mallal, S.A. and Phillips, E.J. (2019) A rapid allele-specific assay for HLA-A*32:01 to identify patients at risk for vancomycin-induced Drug Reaction with Eosinophilia and systemic symptoms. The Journal of Molecular Diagnostics, 21 (5). pp. 782-789.

Saeed, H.N., Bouchard, C., Shieh, C., Phillips, E. and Chodosh, J. (2019) Highlights from the 2nd Biennial Stevens Johnson syndrome symposium 2019: SJS/TEN from Science to Translation. The Ocular Surface, 18 (3). pp. 483-486.

Sneddon, S., Rive, C.M., Ma, S., Dick, I.M., Allcock, R.J.N., Brown, S.D., Holt, R.A., Watson, M.ORCID: 0000-0002-6438-9225, Leary, S., Lee, Y.C.G., Robinson, B.W.S. and Creaney, J. (2019) Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma. OncoImmunology, 9 (1). Art. 1684713.

Somogyi, A.A., Barratt, D.T., Phillips, E.J., Moore, K., Ilyas, F. and Gabb, G.M. (2019) High and variable population prevalence of HLA‐B*56:02 in indigenous Australians and relation to phenytoin‐associated drug reaction with eosinophilia and systemic symptoms. British Journal of Clinical Pharmacology . Early View.

Stevenson, B.R., Thompson, G.A., Watson, M.C., Bundell, C.S., Klinken, E.M., John, M., Lake, F.R. and McLean-Tooke, A.P. (2019) Autoantibodies in interstitial lung diseases. Pathology, 51 (5). pp. 518-523.

Stone, C.A., Choudhary, S., Patterson, M.F., Rukasin, C.R.F., Coleman, D.T., Phillips, E.J. and Commins, S.P. (2019) Tolerance of porcine pancreatic enzymes despite positive skin testing in Alpha-gal allergy. The Journal of Allergy and Clinical Immunology: In Practice . In Press.

Tian, Y., Babor, M., Lane, J., Seumois, G., Liang, S., Goonawardhana, N.D.S., De Silva, A.D., Phillips, E.J., Mallal, S.A., da Silva Antunes, R., Grifoni, A., Vijayanand, P., Weiskopf, D., Peters, B. and Sette, A. (2019) Dengue-specific CD8+ T cell subsets display specialized transcriptomic and TCR profiles. Journal of Clinical Investigation, 129 (4). pp. 1727-1741.

Trend, S., Jones, A.P., Cha, L., Cooper, M.N., Geldenhuys, S., Fabis-Pedrini, M.J., Carroll, W.M., Cole, J.M., Booth, D.R., Lucas, R.M., French, M.A., Byrne, S.N., Kermode, A.G. and Hart, P.H. (2019) Short-term changes in frequencies of circulating leukocytes associated with narrowband UVB phototherapy in people with clinically isolated syndrome. Scientific Reports, 9 (1).

Triplett, J., Vijayan, S., Prince, R. and Kermode, A. (2019) Dimethyl fumarate–associated transient bone marrow oedema syndrome. Multiple Sclerosis Journal, 25 (6). pp. 876-879.

Triplett, J.D., Khor, T.S. and Kermode, A.G. (2019) Recurrent upper limb neuropathies secondary to an epithelioid haemangioendothelioma – A rare mimic of nerve tumours. Journal of Clinical Neuroscience, 73 . pp. 326-328.

Trubiano, J.A., Chua, K.Y.L., Holmes, N.E., Douglas, A., Mouthoris, E., Goh, M. and Phillips, E.J. (2019) Safety of cephalosporins in penicillin class severe delayed hypersensitivity reactions. The Journal of Allergy and Clinical Immunology: In Practice, 8 (3). 1142-1146.e4.

Trubiano, J.A., Devchand, M. and Phillips, E.J. (2019) Reply. The Journal of Allergy and Clinical Immunology: In Practice, 7 (6). pp. 2095-2096.

Trubiano, J.A., Gordon, C.L., Castellucci, C., Christo, S.N., Park, S.L., Mouhtouris, E., Konvinse, K., Rose, M., Goh, M., Boyd, A.S., Phillips, E.J. and Mackay, L.K. (2019) Analysis of Skin-Resident memory T Cells following drug hypersensitivity reactions. Journal of Investigative Dermatology, 140 (7). P1442-1445.

Trubiano, J.A., Ostrov, D.A. and Phillips, E. (2019) Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated with Carbonic Anhydrase Inhibitors: Epidemiology, Genetics, and Insights into Mechanisms. Journal of Allergy and Clinical Immunology: In Practice, 7 (8). pp. 2854-2856.

Trubiano, J.A., Slavin, M.A., Thursky, K.A., Grayson, M.L. and Phillips, E.J. (2019) Beta-Lactam and sulfonamide allergy testing should be a standard of care in immunocompromised host. The Journal of Allergy and Clinical Immunology: In Practice, 7 (7). pp. 2151-2153.

Wanjalla, C.N., McDonnell, W.J., Barnett, L., Simmons, J.D., Furch, B.D., Lima, M.C., Woodward, B.O., Fan, R., Fei, Y., Baker, P.G., Ram, R., Pilkinton, M.A., Mashayekhi, M., Brown, N.J., Mallal, S.A., Kalams, S.A. and Koethe, J.R. (2019) Adipose tissue in persons with HIV is enriched for CD4+ T effector memory and T effector memory RA+ cells, which show higher CD69 expression and CD57, CX3CR1, GPR56 Co-expression With Increasing Glucose Intolerance. Frontiers in Immunology, 10 .

Woodward, K.J., Stampalia, J., Vanyai, H., Rijhumal, H., Potts, K., Taylor, F., Peverall, J., Grumball, T., Sivamoorthy, S., Alinejad-Rokny, H., Wray, J., Whitehouse, A., Nagarajan, L., Scurlock, J., Afchani, S., Edwards, M., Murch, A., Beilby, J., Baynam, G., Kiraly-Borri, C., McKenzie, F. and Heng, J.I.T. (2019) Atypical nested 22q11.2 duplications between LCR22B and LCR22D are associated with neurodevelopmental phenotypes including autism spectrum disorder with incomplete penetrance. Molecular Genetics & Genomic Medicine, 7 (2).

Zhong, X., Chang, Y., Tan, S., Wang, J., Sun, X., Wu, A., Peng, L., Lau, A.Y., Kermode, A.G. and Qiu, W. (2019) Relapsing optic neuritis and meningoencephalitis in a child: case report of delayed diagnosis of MOG-IgG syndrome. BMC Neurology, 19 (1). Article number 94.

Zhong, X., Zhou, Y., Chang, Y., Wang, J., Shu, Y., Sun, X., Peng, L., Lau, A.Y., Kermode, A.G. and Qiu, W. (2019) Seizure and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis in a retrospective cohort of Chinese patients. Frontiers in Neurology, 10 .

Zhong, X.N., Zhou, Y.F., Chang, Y.Y., Wang, J.Q., Shu, Y.Q., Sun, X.B., Peng, L.S., Lau, A.Y., Kermode, A.G. and Qiu, W. (2019) Seizures in Chinese Patients with Myelin Oligodendrocyte Glycoprotein Encephalomyelitis: A retrospective study in single center. Multiple Sclerosis Journal, 25 (3). p. 481.

Zhou, Y., Zhong, X., Shu, Y., Cui, C., Wang, J., Wang, Y., Li, X., Chen, Z., Peng, L., Kermode, A. and Qiu, W. (2019) Clinical course, treatment responses and outcomes in Chinese paediatric neuromyelitis optica spectrum disorder. Multiple Sclerosis and Related Disorders, 28 . pp. 213-220.

2018

Adams, S.N., McKinnon, E. and Phillips, E.J. (2018) Testing strategies for patients labeled as allergic To fluoroquinolones. Journal of Allergy and Clinical Immunology, 141 (2).

Ali, S.B., Jeelall, Y., Pennell, C.E., Hart, R., McLean-Tooke, A. and Lucas, M. (2018) The role of immunological testing and intervention in reproductive medicine: A fertile collaboration? American Journal of Reproductive Immunology, 79 (3). e12784.

Arnold, A., Sommerfield, A., Ramgolam, A., Rueter, K., Muthusamy, S., Noble, V., von Ungern-Sternberg, B.S. and Lucas, M. (2018) The role of skin testing and extended antibiotic courses in assessment of children with penicillin allergy: An Australian experience. Journal of Paediatrics and Child Health, 55 (4). pp. 428-432.

Bilkey, G.A., Baynam, G. and Molster, C. (2018) Changes to the employers' use of genetic information and Non-discrimination for health insurance in the USA: Implications for Australians. Frontiers in Public Health, 6 .

Cha, L., Jones, A.P., Trend, S., Byrne, S.N., Fabis-Pedrini, M.J., Carroll, W.M., Lucas, R.M., Cole, J.M., Booth, D.R., Kermode, A.G. and Hart, P.H. (2018) Tryptophan and arginine catabolic enzymes and regulatory cytokines in clinically isolated syndrome and multiple sclerosis. Clinical & Translational Immunology, 7 (8).

Chang, Y., Shu, Y., Sun, X., Lu, T., Chen, C., Fang, L., He, D., Xu, C., Lu, Z., Hu, X., Peng, L., Kermode, A.G. and Qiu, W. (2018) Study of the placentae of patients with neuromyelitis optica spectrum disorder. Journal of the Neurological Sciences, 387 . pp. 119-123.

Chang, Y., Shu, Y., Sun, X., Xu, C., He, D., Fang, L., Chen, C., Hu, X., Kermode, A. and Qiu, W. (2018) Ectrodactyly in a Chinese patient born to a mother with neuromyelitis optica spectrum disorder. Multiple Sclerosis and Related Disorders, 19 . pp. 70-72.

Chang, Y.Y., Shu, Y.Q., Sun, X.B., Lu, T.T., Chen, C., Fang, L., He, D., Xu, C.F., Lu, Z.Q., Hu, H.Q., Peng, L.S., Kermode, A.G. and Qui, W. (2018) Study of The Placentae of Patients with Neuromyelitis Optica Spectrum Disorder. Multiple Sclerosis Journal, 24 (3). p. 409.

Chang, Y.Y., Shu, Y.Q., Sun, X.B., Xu, C.F., He, D., Fang, L., Chen, C., Hu, X.Q., Kermode, A. and Wei, Q. (2018) Ectrodactyly in A Chinese Patient Born to A Mother with Neuromyelitis Optica Spectrum Disorder. Multiple Sclerosis Journal, 24 (3). pp. 418-419.

Chatterjee, P., Goozee, K., Lim, C.K., James, I., Shen, K., Jacobs, K.R., Sohrabi, H.R.ORCID: 0000-0001-8017-8682, Shah, T., Asih, P.R., Dave, P., ManYan, C., Taddei, K., Lovejoy, D.B., Chung, R., Guillemin, G.J. and Martins, R.N. (2018) Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study. Scientific Reports, 8 . Article number: 8008.

Chee, J., Watson, M.W.ORCID: 0000-0002-6438-9225, Chopra, A., Nguyen, B., Cook, A.M., Creaney, J., Lesterhuis, W.J., Robinson, B.W., Lee, Y.C.G., Nowak, A.K., Lake, R.A. and McDonnell, A.M. (2018) Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors. BMC Research Notes, 11 (1).

Cook, K.M., Gillon, J., Grisso, A.G., Banerjee, R., Jimenez-Truque, N., Phillips, E.J. and Van Driest, S.L. (2018) Incidence of Nephrotoxicity Among Pediatric Patients Receiving Vancomycin With Either Piperacillin–Tazobactam or Cefepime: A Cohort Study. Journal of the Pediatric Infectious Diseases Society . In Press.

Coote, D., Davis, M.R., Cabrera, M., Needham, M., Laing, N.G. and Nowak, K.J. (2018) Clinical Utility Gene Card for: Becker muscular dystrophy. European Journal of Human Genetics, 26 . pp. 1065-1071.

Derrick, M.I.P., Williams, K.B., Shade, L.M and Phillips, E.J. (2018) A survey of drug allergy training opportunities in the United States. The Journal of Allergy and Clinical Immunology: In Practice, 6 (1). pp. 302-304.

Dhillon, S., McKinnon, E., Wrobel, J., Lavender, M., Lawrence, S., Gabbay, E. and Musk, M. (2018) Lung transplant: the Western Australian experience. Internal Medicine Journal, 48 (11). pp. 1337-1345.

Edkins, A.L., Price, J.T., Pockley, A.G. and Blatch, G.L. (2018) Heat shock proteins as modulators and therapeutic targets of chronic disease: An integrated perspective. Philosophical Transactions of the Royal Society B: Biological Sciences, 373 (1738).

Fabis-Pedrini, M.J., Bundell, C., Wee, C-K, Lucas, M., McLean-Tooke, A., Mastaglia, F.L., Carroll, W.M. and Kermode, A.G. (2018) Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia. Journal of Neuroimmunology, 324 . pp. 76-80.

Fabis-Pedrini, M.J., Bundell, C., Wee, C.K., Qui, W., Lucas, M., Carroll, W.M. and Kermode, A.G. (2018) Low Prevalence of Anti Aquaporin 4 Antibody in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis in Western Australia. Multiple Sclerosis Journal, 24 (3). pp. 404-405.

Fabis-Pedrini, M.J., Carroll, W.M. and Kermode, A.G. (2018) Efficacy and safety of mitoxantrone use in aggressive Multiple Sclerosis (P3.414). Neurology, 90 (15 Supp).

Fabis-Pedrini, M.J., James, I., Seewann, A., Yau, W.Y., van de Bovenkamp, A.A., Sanders, F.R.K., Qiu, W., Burton, J., Mastaglia, F.L., Carroll, W.M. and Kermode, A.G. (2018) Natural history of benign multiple sclerosis: Clinical and HLA correlates in a Western Australian cohort. Journal of the Neurological Sciences, 388 . pp. 12-18.

Fabis-Pedrini, M.J., Jeereddy, S., Carroll, W.M. and Kermode, A.G. (2018) Serum Anti-JCV antibody status in Western Australian patients with multiple sclerosis. Multiple Sclerosis Journal, 25 (3). p. 450.

Ghaly, S., Bliuc, D., Centre, J., Clarke, M.W., Jones, A.P., Trend, S., Kermode, A.G., Neale, R.E. and Hart, P.H. (2018) Vitamin D C3-epimer levels are proportionally higher with oral vitamin D supplementation compared to ultraviolet irradiation of skin in mice but not humans. The Journal of Steroid Biochemistry and Molecular Biology, 186 . pp. 110-116.

Goozee, K., Chatterjee, P., James, I., Shen, K., Sohrabi, H.R.ORCID: 0000-0001-8017-8682, Asih, P.R., Dave, P., ManYan, C., Taddei, K., Ayton, S.J., Garg, M.L., Kwok, J.B., Bush, A.I., Chung, R., Magnussen, J.S. and Martins, R.N. (2018) Elevated plasma ferritin in elderly individuals with high neocortical amyloid-β load. Molecular Psychiatry, 23 (8). pp. 1807-1812.

Grifoni, A., Sidney, J., Carpenter, C., Phillips, E., Mallal, S., Scriba, T.J., Sette, A. and Lindestam Arlehamn, C.S. (2018) Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 159 individuals from the Worcester region of the Western Cape province of South Africa. Human Immunology, 79 (3). pp. 143-144.

Gu, J., Hardy, J., Boo, I., Vietheer, P., McCaffrey, K., Alhammad, Y., Chopra, A., Gaudieri, S., Poumbourios, P., Coulibaly, F., Drummer, H.E. and Diamond, M.S. (2018) Escape of Hepatitis C virus from Epitope I neutralization increases sensitivity of other neutralization epitopes. Journal of Virology, 92 (9). e02066-17.

Hart, P.H., Jones, A.P., Trend, S., Cha, L., Fabis-Pedrini, M.J., Cooper, M.N., d’Este, C., Geldenhuys, S., Carroll, W.M., Byrne, S.N., Booth, D.R., Cole, J.M., Lucas, R.M. and Kermode, A.G. (2018) A randomised, controlled clinical trial of narrowband UVB phototherapy for clinically isolated syndrome: The PhoCIS study. Multiple Sclerosis Journal - Experimental, Translational and Clinical, 4 (2).

Hatleberg, C.I., Ryom, L., El-Sadr, W., Mocroft, A., Reiss, P., De Wit, S., Dabis, F., Pradier, C., D'Arminio Monforte, A., Kovari, H., Law, M., Lundgren, J.D., Sabin, C.A. and Nolan, D. (2018) Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study. Journal of the International AIDS Society, 21 (3).

Huang, K., Li, Q.X., Bi, F.F., Duan, H-Q, Mastaglia, F., Luo, Y.B. and Yang, H. (2018) Comparative immunoprofiling of polymyositis and dermatomyositis muscles. International Journal of Clinical and Experimental Pathology, 11 (8). pp. 3984-3993.

Kamien, B., Ronan, A., Poke, G., Sinnerbrink, I., Baynam, G., Ward, M., Gibson, W.T., Dudding-Byth, T. and Scott, R.J. (2018) A clinical review of generalized overgrowth syndromes in the era of massively parallel sequencing. Molecular Syndromology, 9 (2). pp. 70-82.

Kermode, A. (2018) The Microbiota and MS. Multiple Sclerosis Journal, 24 (3). p. 368.

Kermode, A.G., Hart, P.H., Fabis-Pedrini, M.J., Lucas, R.M., Booth, D.R., Carroll, W.M., Nolan, D., Cole, J.M., Jones, A.P. and Trend, S. (2018) Narrowband UVB Phototherapy for Clinically Isolated Syndrome: Delivering the Benefits of All UVB-Induced Molecules. Multiple Sclerosis Journal, 24 (3). pp. 376-377.

Kermode, A.G. and Triplett, J.D. (2018) Chronic HPV associated lesions associated with Fingolimod use. Multiple Sclerosis Journal, 25 (3). pp. 460-461.

Kermode, A.G., Triplett, J.D., Vijayan, S. and Prince, R. (2018) Transient bone marrow oedema syndrome following Dimethyl Fumarate use. Multiple Sclerosis Journal, 25 (3). p. 458.

Kim, W.B., Worley, B., Holmes, J., Phillips, E.J. and Beecker, J. (2018) Minimal clinically important differences for measures of treatment efficacy in Stevens-Johnson syndrome and toxic epidermal necrolysis. Journal of the American Academy of Dermatology, 79 (6). pp. 1150-1152.

Köhler, S., Carmody, L., Vasilevsky, N., Jacobsen, J.O.B, Danis, D., Gourdine, J-P, Gargano, M., Harris, N.L, Matentzoglu, N., McMurry, J.A., Osumi-Sutherland, D., Cipriani, V., Balhoff, J.P., Conlin, T., Blau, H., Baynam, G., Palmer, R., Gratian, D., Dawkins, H., Segal, M., Jansen, A.C., Muaz, A., Chang, W.H., Bergerson, J., Laulederkind, S.J.F., Yüksel, Z., Beltran, S., Freeman, A.F., Sergouniotis, P.I., Durkin, D., Storm, A.L., Hanauer, M., Brudno, M., Bello, S.M., Sincan, M., Rageth, K., Wheeler, M.T., Oegema, R., Lourghi, H., Della Rocca, M.G., Thompson, R., Castellanos, F., Priest, J., Cunningham-Rundles, C., Hegde, A., Lovering, R.C., Hajek, C., Olry, A., Notarangelo, L., Similuk, M., Zhang, X.A., Gómez-Andrés, D., Lochmüller, H., Dollfus, H., Rosenzweig, S., Marwaha, S., Rath, A., Sullivan, K., Smith, C., Milner, J.D., Leroux, D., Boerkoel, C.F., Klion, A., Carter, M.C., Groza, T., Smedley, D., Haendel, M.A, Mungall, C. and Robinson, P.N. (2018) Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources. Nucleic Acids Research, 47 (D1). D1018-D1027.

Li, R., Sun, X., Shu, Y., Wang, Y., Xiao, L., Wang, Z., Hu, X., Kermode, A.G. and Qui, W. (2018) Serum CCL20 and Its Association with SIRT1 Activity in Multiple Sclerosis Patients. Multiple Sclerosis Journal, 24 (3). p. 390.

Lu, T., Shu, Y., Dai, Y., Liu, X., Chang, Y., Huang, Q., Kermode, A.G. and Qiu, W. (2018) B cell depleting therapy for multiple sclerosis overlapping with neuromyelitis optica spectrum disorder. Multiple Sclerosis and Related Disorders, 22 . pp. 83-85.

Lu, T.T., Shu, Y.Q., Dai, Y.Q., Liu, X., Chang, Y.Y., Huang, Q., Kermode, A. and Qui, W. (2018) B Cell Depleting Therapy for Multiple Sclerosis Overlapping with Neuromyelitis Optica Spectrum Disorder. Multiple Sclerosis Journal, 24 (3). p. 420.

Lucas, M., Arnold, A., Sommerfield, A., Trevenen, M., Braconnier, L., Schilling, A., Abass, F., Slevin, L., Knezevic, B., Blyth, C., Murray, K., von Ungern-Sternberg, B. and Rueter, K. (2018) Antibiotic allergy labels in children are associated with adverse clinical outcomes. The Journal of Allergy and Clinical Immunology: In Practice, 7 (3). pp. 975-982.

Lucas, M., Deshpande, P., James, I., Rauch, A., Pfafferott, K., Gaylard, E., Merani, S., Plauzolles, A., Lucas, A., McDonnell, W., Kalams, S., Pilkinton, M., Chastain, C., Barnett, L., Prosser, A., Mallal, S., Fitzmaurice, K., Drummer, H., Ansari, M.A., Pedergnana, V., Barnes, E., John, M., Kelleher, D., Klenerman, P. and Gaudieri, S. (2018) Evidence of CD4+ T cell-mediated immune pressure on the Hepatitis C virus genome. Scientific Reports, 8 . Article number: 7224.

MacLennan, A.H, Kruer, M.C, Baynam, G., Moreno-De-Luca, A., Wilson, Y.A., Zhu, C., Wintle, R.F. and Gecz, J. (2018) Cerebral palsy and genomics: an international consortium. Developmental Medicine & Child Neurology, 60 (2). pp. 209-210.

Martinez, K.A., Romano-Keeler, J., Zackular, J.P., Moore, D.J., Brucker, R.M., Hooper, C., Meng, S., Brown, N., Mallal, S., Reese, J., Aronoff, D.M., Shin, H., Dominguez-Bello, M.G. and Weitkamp, J-H (2018) Bacterial DNA is present in the fetal intestine and overlaps with that in the placenta in mice. PLoS ONE, 13 (5).

McDonnell, W.J., Koethe, J.R., Mallal, S.A., Pilkinton, M.A., Kirabo, A., Ameka, M.K., Cottam, M.A., Hasty, A.H. and Kennedy, A.J. (2018) High CD8 T-cell receptor clonality and altered CDR3 properties are associated with elevated isolevuglandins in adipose tissue during diet-induced obesity. Diabetes, 67 (11). pp. 2361-2376.

Mitchell, T., McKinnon, E., Ayonrinde, O.T., Adams, L.A., Trinder, D., Chua, A., Newton, R., Strakers, L. and Olynyk, J.K. (2018) Decreased physical working capacity in adolescents with Non-Alcoholic fatty liver disease reflects reduced iron bioavailability. Hepatology, 68 . 1317A-1318A.

Moore, E., Grifoni, A., Weiskopf, D., Schulten, V., Arlehamn, C.S.L., Angelo, M., Pham, J., Leary, S., Sidney, J., Broide, D., Frazier, A., Phillips, E., Mallal, S., Mack, S.J. and Sette, A. (2018) Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 496 adults from San Diego, California, USA. Human Immunology, 79 (12). pp. 821-822.

Morabito, K.M., Ruckwardt, T.J., Bar-Haim, E., Nair, D., Moin, S.M., Redwood, A.J., Price, D.A. and Graham, B.S. (2018) Memory Inflation Drives Tissue-Resident Memory CD8+ T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus. Frontiers in Immunology, 9 .

Norton, A.E., Konvinse, K., Phillips, E.J. and Broyles, A.D. (2018) Antibiotic allergy in pediatrics. Pediatrics, 141 (5).

Nowak, K.J., Bauskis, A., Dawkins, H.J. and Baynam, G. (2018) Incidental inequity. European Journal of Human Genetics, 26 . pp. 616-617.

Pavlos, R., Karnes, J., Trubiano, J., Peters, J. and Phillips, E. (2018) Pharmacogenomics of Drug Allergy. In: Khan, D.A. and Banerji, A., (eds.) Drug Allergy Testing. Elsevier Inc., pp. 39-51.

Philip, M., Pilkinton, M., Ramesh, R., McDonnell, W.J., Gangula, R.D., Camara, S., Chopra, A., Schietinger, A. and Mallal, S.A. (2018) Population dynamics of tumor-specific CD8 T cell differentiation from plastic to fixed dysfunctional states. Journal of immunology, 200 (Supp. 1).

Phillips, E.J. and Mallal, S.A. (2018) Active suppression rather than ignorance: Tolerance to abacavir-induced HLA-B*57:01 peptide repertoire alteration. Journal of Clinical Investigation, 128 (7). pp. 2746-2749.

Phillips, E.J., Sukasem, C., Whirl-Carrillo, M., Müller, D.J., Dunnenberger, H.M., Chantratita, W., Goldspiel, B., Chen, Y-T, Carleton, B.C., George, A.L., Mushiroda, T., Klein, T., Gammal, R.S. and Pirmohamed, M. (2018) Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update. Clinical Pharmacology & Therapeutics, 103 (4). pp. 574-581.

Redwood, A., Trubiano, J. and Phillips, E. (2018) Prevention and diagnosis of severe T-Cell-Mediated adverse drug reactions: Are we there yet? Journal of Allergy and Clinical Immunology: In Practice, 7 (1). pp. 228-230.

Riley, M., Bakeberg, M., Byrnes, M., Jefferson, A., Ghosh, S., Stell, R., Mastaglia, F.L., Hince, D. and Anderton, R.S. (2018) Demographic and clinical predictors of trait impulsivity in Parkinson’s disease patients. Parkinson's Disease, 2018 . pp. 1-7.

Rueter, K., Ta, B., Bear, N., Lucas, M., Borland, M.L. and Prescott, S.L. (2018) Increased Use of Adrenaline in the Management of Childhood Anaphylaxis Over the Last Decade. The Journal of Allergy and Clinical Immunology: In Practice, 6 (5). pp. 1545-1552.

Rueter, K., Ta, B., Bear, N., Lucas, M., Borland, M.L. and Prescott, S.L. (2018) More adrenaline for anaphylaxis over the last decade? Internal Medicine Journal, 48 (S6). p. 15.

Salman, S., James, T., Stevenson, B., Bundell, C., Kelly, G., Nolan, D. and John, M. (2018) P68: The pathogenic role of autoreactive IGE in bullous pemphigoid: A unique case supporting conclusions from experimental data. Internal Medicine Journal, 48 (S6). pp. 24-25.

Setliff, Ian, McDonnell, W.J., Raju, N., Bombardi, R.G., Murji, A.A., Scheepers, C., Ziki, R., Mynhardt, C., Shepherd, B.E., Mamchak, A.A., Garrett, N., Karim, S.A., Mallal, S.A., Crowe, J.E., Morris, L. and Georgiev, I.S. (2018) Multi-Donor longitudinal antibody repertoire sequencing reveals the existence of public antibody clonotypes in HIV-1 infection. Cell Host & Microbe, 23 (6). pp. 845-854.

Sommerfield, D.L., Sommerfield, A., Schilling, A., Slevin, L., Lucas, M., von Ungern-Sternberg, B.S. and Thomas, M. (2018) Allergy alerts - The incidence of parentally reported allergies in children presenting for general anesthesia. Pediatric Anesthesia, 29 (2). pp. 153-160.

Sooben, S., Thin, L., Picardo, S., Mckinnon, B., Ryan, J. and Wallace, M.H. (2018) A high CRP before surgery and early medical prophylaxis predict postoperative endoscopic Crohn’s disease recurrence. Journal of Crohn's and Colitis, 12 (Supp. 1). S465-S466.

Stone, C.A., Commins, S.P., Choudhary, S., Vethody, C., Heavrin, J.L., Wingerter, J., Hemler, J.A., Babe, K., Phillips, E.J. and Norton, A.E. (2018) Anaphylaxis after vaccination in a pediatric patient: further implicating Alpha-Gal allergy. The Journal of Allergy and Clinical Immunology: In Practice, 7 (1). pp. 322-324.

Stone, C.A., Hemler, J.A., Commins, S.P., Schuyler, A.J., Phillips, E.J., Peebles, R.S. and Fahrenholz, J.M. (2018) Reply. Journal of Allergy and Clinical Immunology, 141 (5). pp. 1957-1958.

Tan, E., Chan, J. and Lucas, M. (2018) Biologic therapy-induced psoriasis: An illustrative case. Internal Medicine Journal, 48 (S6). p. 25.

Tan, E., Thompson, G., Ekstrom, C. and Lucas, M. (2018) Non-immediate heparin and heparinoid cutaneous allergic reactions: a role for fondaparinux. Internal Medicine Journal, 48 (1). pp. 73-77.

Thompson, G., Boan, P., Baumwol, J., Chakera, A., MacQuillan, G., Swaminathan, S., Lavender, M., Flexman, J., James, I. and John, M. (2018) Analysis of the QuantiFERON-CMV assay, CMV viraemia and antiviral treatment following solid organ transplantation in Western Australia. Pathology, 50 (5). pp. 554-561.

Triplett, J., Hee, G., McLean-Tooke, A. and Lucas, M. (2018) Long-term control of laryngeal plasma cell mucositis with systemic immunosuppression. BMJ Case Reports, 2018 .

Triplett, J., Kermode, A.G., Corbett, A. and Reddel, S.W. (2018) Warts and all: Fingolimod and unusual HPV-associated lesions. Multiple Sclerosis Journal . Online First.

Trubiano, J.A, Grayson, M.L., Phillips, E.J., Stewardson, A.J., Thursky, K.A. and Slavin, M.A. (2018) Antibiotic allergy testing improves antibiotic appropriateness in patients with cancer. Journal of Antimicrobial Chemotherapy, 73 . pp. 3209-3211.

Trubiano, J.A., Douglas, A.P., Goh, M., Slavin, M.A. and Phillips, E.J. (2018) The safety of antibiotic skin testing in severe T-cell-mediated hypersensitivity of immunocompetent and immunocompromised hosts. The Journal of Allergy and Clinical Immunology: In Practice, 7 (4). pp. 1341-1343.

Trubiano, J.A., Grayson, M.L., Thursky, K.A., Phillips, E.J. and Slavin, M.A. (2018) How antibiotic allergy labels may be harming our most vulnerable patients. The Medical Journal of Australia, 208 (11). pp. 469-470.

Trubiano, J.A., Strautins, K., Redwood, A.J., Pavlos, R., Konvinse, K.C., Aung, A.K., Slavin, M.A., Thursky, K.A., Grayson, M.L. and Phillips, E.J. (2018) The combined utility of Ex Vivo IFN-γ release Enzyme-Linked ImmunoSpot assay and In Vivo skin testing in patients with Antibiotic-Associated severe cutaneous adverse reactions. The Journal of Allergy and Clinical Immunology: In Practice, 6 (4). pp. 1287-1296.

Vyles, D., Chiu, A., Routes, J., Castells, M., Phillips, E.J., Kibicho, J. and Brousseau, D.C. (2018) Antibiotic use after removal of penicillin allergy label. Pediatrics, 141 (5).

Weiskopf, D., Grifoni, A., Arlehamn, C.S.L., Angelo, M., Leary, S., Sidney, J., Frazier, A., Mack, S.J., Phillips, E., Mallal, S., Cerpas, C., Balmaseda, A., Harris, E. and Sette, A. (2018) Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 339 adults from Managua, Nicaragua. Human Immunology, 79 (1). pp. 1-2.

White, K.D., Abe, R., Ardern-Jones, M., Beachkofsky, T., Bouchard, C., Carleton, B., Chodosh, J., Cibotti, R., Davis, R., Denny, J.C., Dodiuk-Gad, R.P., Ergen, E.N., Goldman, J.L., Holmes, J.H., Hung, S-L, Lacouture, M.E., Lehloenya, R.J., Mallal, S., Manolio, T.A., Micheletti, R.G., Mitchell, C.M., Mockenhaupt, M., Ostrov, D.A., Pavlos, R., Pirmohamed, M., Pope, E., Redwood, A., Rosenbach, M., Rosenblum, M.D., Roujeau, J-C, Saavedra, A.P., Saeed, H.N., Struewing, J.P., Sueki, H., Sukasem, C., Sung, C., Trubiano, J.A., Weintraub, J., Wheatley, L.M., Williams, K.B., Worley, B., Chung, W-H, Shear, N.H. and Phillips, E.J. (2018) SJS/TEN 2017: Building multidisciplinary networks to drive science and translation. The Journal of Allergy and Clinical Immunology: In Practice, 6 (1). pp. 38-69.

White, K.D., Konvinse, K.C., Pilkinton, M.A., Redwood, A., Trubiano, J.A., Peter, J.G., Lehloenya, R., Chung, W-H, Hung, S-L, Pan, R-Y, Chopra, A., Barnett, L., Gangula, R., Mallal, S.A. and Phillips, E.J. (2018) Single cell approaches to define the pathogenic immune cells that mediate drug hypersensitivity. Journal of Allergy and Clinical Immunology, 141 (2). AB88.

Zahedi, A.ORCID: 0000-0002-0165-3797, Gofton, A., Greay, T., Monis, P., Oskam, C., Ball, A., Bath, A., Watkinson, A., Robertson, I.ORCID: 0000-0002-4255-4752 and Ryan, U.ORCID: 0000-0003-2710-9324 (2018) Metagenomic analysis of Cryptosporidium species and genotypes in wastewater treatment plants. In: 14th International Congress of Parasitology (ICOPA) 2018, 19 - 24 August 2018, Daegu, South Korea

Zahedi, A.ORCID: 0000-0002-0165-3797, Gofton, A., Greay, T., Monis, P., Oskam, C., Ball, A., Bath, A., Watkinson, A., Robertson, I.ORCID: 0000-0002-4255-4752 and Ryan, U.ORCID: 0000-0003-2710-9324 (2018) Profiling the diversity of Cryptosporidium species and genotypes in wastewater treatment plants in Australia using next generation sequencing. In: The West Coast Microbiome Network (WCMN). Annual Symposium - Global Microbiome 2018, 17th August 2018, Harry Perkins Institute, Nedlands, Western Australia.

Zhong, X., Chang, Y., Tan, S., Wang, J., Sun, X., Wu, A., Peng, L., Lau, A.Y., Kermode, A.G. and Qiu, W. (2018) Relapsing optic neuritis and meningoencephalitis in a Child-Delayed diagnosis of MOG-IgG syndrome. Multiple Sclerosis Journal, 25 (3). p. 490.

Zhou, Y., Jia, X., Yang, H., Chen, C., Sun, X., Peng, L., Kermode, A.G. and Qiu, W. (2018) Myelin oligodendrocyte glycoprotein antibody-associated demyelination: comparison between onset phenotypes. European Journal of Neurology, 26 (1). pp. 175-183.

da Silva Antunes, R., Pham, J., McMurtrey, C., Hildebrand, W.H., Phillips, E., Mallal, S., Sidney, J., Busse, P., Peters, B., Schulten, V. and Sette, A. (2018) Urinary peptides as a novel source of T Cell allergen epitopes. Frontiers in Immunology, 9 .

2017

Abana, C.O., Pilkinton, M.A., Gaudieri, S., Chopra, A., McDonnell, W.J., Wanjalla, C., Barnett, L., Gangula, R., Hager, C., Jung, D.K., Engelhardt, B.G., Jagasia, M.H., Klenerman, P., Phillips, E.J., Koelle, D.M., Kalams, S.A. and Mallal, S.A. (2017) Cytomegalovirus (CMV) Epitope–Specific CD4 + T Cells Are Inflated in HIV + CMV + Subjects. The Journal of Immunology, 199 (9). pp. 3187-3201.

Adland, E., Hill, M., Lavandier, N., Csala, A., Edwards, A., Chen, F., Radkowski, M., Kowalska, J.D., Paraskevis, D., Hatzakis, A., Valenzuela-Ponce, H., Pfafferott, K., Williams, I., Pellegrino, P., Borrow, P., Mori, M., Rockstroh, J., Prado, J.G., Mothe, B., Dalmau, J., Martinez-Picado, J., Tudor-Williams, G., Frater, J., Stryhn, A., Buus, S., Reyes Teran, G., Mallal, S., John, M., Buchbinder, S., Kirk, G., Martin, J., Michael, N., Fellay, J., Deeks, S., Walker, B.ORCID: 0000-0002-8506-6740, Avila-Rios, S., Cole, D., Brander, C., Carrington, M. and Goulder, P. (2017) Differential immunodominance hierarchy OF CD8+ T cell responses in HLA-B*27:05 AND B*27:02-mediated control of HIV-1 infection. Journal of Virology, 82 (4). e01685-e016817.

Adler, N.R., Aung, A.K., Ergen, E.N., Trubiano, J., Goh, M.S.Y. and Phillips, E.J. (2017) Recent advances in the understanding of severe cutaneous adverse reactions. British Journal of Dermatology, 177 (5). pp. 1234-1247.

Almeida, C., van Miert, P., O'Driscoll, K., Zoet, Y.M., Chopra, A., Watson, M.ORCID: 0000-0002-6438-9225, de Santis, D., Witt, C., John, M., Claas, F.H.J. and D'Orsogna, L.J. (2017) Stimulation of HIV-specific T cell clonotypes using allogeneic HLA. Cellular Immunology, 316 . pp. 32-40.

Altmüller, F., Lissewski, C., Bertola, D., Flex, E., Stark, Z., Spranger, S., Baynam, G., Buscarilli, M., Dyack, S., Gillis, J., Yntema, H.G., Pantaleoni, F., van Loon, R.L.E., MacKay, S., Mina, K., Schanze, I., Tan, T.Y., Walsh, M., White, S.M., Niewisch, M.R., García-Miñaúr, S., Plaza, D., Ahmadian, M.R., Cavé, H., Tartaglia, M. and Zenker, M. (2017) Genotype and phenotype spectrum of NRAS germline variants. European Journal of Human Genetics, 25 (7). pp. 823-831.

Anderton, R.S., Hill, L.R., Morris, R., Mastaglia, F.L., Greene, W. and Boulos, S. (2017) Lack of evidence for decreased protein stability in the 2397 (Met) haplotype of the leucine rich repeat kinase 2 protein implicated in Parkinson’s disease. Advances in Parkinson's Disease, 06 (04). pp. 113-123.

Arlehamn, C.S.L., Copin, R., Leary, S., Mack, S.J., Phillips, E., Mallal, S., Sette, A., Blatner, G., Siefers, H. and Ernst, J.D. (2017) Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 100 Luo infants from the Boro area of Nyanza Province, Kenya. Human Immunology, 78 (4). pp. 325-326.

Au, P.Y.B., Huang, L., Broley, S., Gallagher, L., Creede, E., Lahey, D., Ordorica, S., Mina, K., Boycott, K.M., Baynam, G. and Dyment, D.A. (2017) Two females with mutations in USP9X highlight the variable expressivity of the intellectual disability syndrome. European Journal of Medical Genetics, 60 (7). pp. 359-364.

Baynam, G., Broley, S., Bauskis, A., Pachter, N., McKenzie, F., Townshend, S., Slee, J., Kiraly-Borri, C., Vasudevan, A., Hawkins, A., Schofield, L., Helmholz, P., Palmer, R., Kung, S., Walker, C.E., Molster, C., Lewis, B., Mina, K., Beilby, J., Pathak, G., Poulton, C., Groza, T., Zankl, A., Roscioli, T., Dinger, M.E., Mattick, J.S., Gahl, W., Groft, S., Tifft, C., Taruscio, D., Lasko, P., Kosaki, K., Wilhelm, H., Melegh, B., Carapetis, J., Jana, S., Chaney, G., Johns, A., Owen, P.W., Daly, F., Weeramanthri, T., Dawkins, H. and Goldblatt, J. (2017) Initiating an undiagnosed diseases program in the Western Australian public health system. Orphanet Journal of Rare Diseases, 12 (1).

Carroll, G.J., Makin, K., Garnsey, M., Bulsara, M., Carroll, B.V., Curtin, S.M., Allan, E.M., McLean-Tooke, A., Bundell, C., Kemp, M.L., Deshpande, P., Ihdayhid, D., Coleman, S., Easter, T., Triplett, J., Disteldorf, T., Marsden, C.H. and Lucas, M. (2017) Undetectable mannose binding lectin and corticosteroids increase serious infection risk in rheumatoid arthritis. The Journal of Allergy and Clinical Immunology: In Practice, 5 (6). pp. 1609-1616.

Coutinho, C.M.L.M., Coutinho-Silva, R., Zinkevich, V., Pearce, C.B., Ojcius, D.M. and Beech, I. (2017) Sulphate-reducing bacteria from ulcerative colitis patients induce apoptosis of gastrointestinal epithelial cells. Microbial Pathogenesis, 112 . pp. 126-134.

Cull, G., Hall, D., Fabis-Pedrini, M.J., Carroll, W.M., Forster, L., Robins, F., Ghassemifar, R., Crosbie, C., Walters, S., James, I., Augustson, B. and Kermode, A.G. (2017) Lymphocyte reconstitution following autologous stem cell transplantation for progressive MS. Multiple Sclerosis Journal – Experimental, Translational and Clinical, 3 (1). pp. 1-9.

Delpoux, A., Michelini, R.H., Verma, S., Lai, C.-Y., Omilusik, K.D., Utzschneider, D.T., Redwood, A.J., Goldrath, A.W., Benedict, C.A. and Hedrick, S.M. (2017) Continuous activity of Foxo1 is required to prevent anergy and maintain the memory state of CD8+T cells. The Journal of Experimental Medicine, 215 (2). pp. 575-594.

Evans, T., Jefferson, A., Byrnes, M., Walters, S., Ghosh, S., Mastaglia, F.L., Power, B. and Anderton, R.S. (2017) Extended “Timed Up and Go” assessment as a clinical indicator of cognitive state in Parkinson's disease. Journal of the Neurological Sciences, 375 . pp. 86-91.

Fewings, N., Gatt, P.N., McKay, F.C., Parnell, G.P., Schibeci, S.D., Edwards, J., Basuki, M.A., Goldinger, A., Fabis-Pedrini, M.J., Kermode, A.G., Manrique, C.P., McCauley, J.L., Nickles, D., Baranzini, S.E., Burke, T., Vucic, S., Stewart, G.J. and Booth, D.R. (2017) Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis. Data in Brief, 11 . pp. 364-370.

Fewings, N.L., Gatt, P.N., McKay, F.C., Parnell, G.P., Schibeci, S.D., Edwards, J., Basuki, M.A., Goldinger, A., Fabis-Pedrini, M.J., Kermode, A.G., Manrique, C.P., McCauley, J.L., Nickles, D., Baranzini, S.E., Burke, T., Vucic, S., Stewart, G.J. and Booth, D.R. (2017) The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis. Journal of Autoimmunity, 78 . pp. 57-69.

Fonceca, A.M., Chopra, A., Levy, A., Noakes, P.S., Poh, M.W.-P., Bear, N.L., Prescott, S. and Everard, M.L. (2017) Infective respiratory syncytial virus is present in human cord blood samples and most prevalent during winter months. PLOS ONE, 12 (4). e0173738.

Garon, S.L., Pavlos, R.K., White, K.D., Brown, N.J., Stone, C.A. and Phillips, E.J. (2017) Pharmacogenomics of off-target adverse drug reactions. British Journal of Clinical Pharmacology, 83 (9). pp. 1896-1911.

Gatanaga, H., Brumme, Z.L., Adland, E., Reyes-Teran, G., Avila-Rios, S., Mejía-Villatoro, C.R., Hayashida, T., Chikata, T., Van Tran, G., Van Nguyen, K., Meza, R.I., Palou, E.Y., Valenzuela-Ponce, H., Pascale, J.M., Porras-Cortés, G., Manzanero, M., Lee, G.Q., Martin, J.N., Carrington, M.N., John, M., Mallal, S., Poon, A.F.Y., Goulder, P., Takiguchi, M. and Oka, S. (2017) Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infection. AIDS, 31 (14). pp. 1935-1943.

Gaudieri, S. and John, M. (2017) Evolution of the Human Leukocyte Antigen System. In: Tibayrenc, M. and Ayala, F.J., (eds.) On Human Nature. Elsevier Inc., pp. 211-219.

Gaudieri, S. and Lucas, M. (2017) Innate and adaptive immunity shape circulating HCV strains. Nature Genetics, 49 (5). pp. 657-658.

Goozee, K., Chatterjee, P., James, I., Shen, K., Sohrabi, H.R.ORCID: 0000-0001-8017-8682, Asih, P.R., Dave, P., Ball, B., ManYan, C., Taddei, K., Chung, R., Garg, M.L. and Martins, R.N. (2017) Alterations in erythrocyte fatty acid composition in preclinical Alzheimer’s disease. Scientific Reports, 7 . Article number: 676.

Grifoni, A., Angelo, M., Sidney, J., Paul, S., Peters, Bjoern, de Silva, A.D., Phillips, E., Mallal, S., Diehl, S.A., Botten, J., Boyson, J., Kirkpatrick, B.D., Whitehead, S.S., Durbin, A.P., Sette, A., Weiskopf, D. and García-Sastre, A. (2017) Patterns of Cellular Immunity Associated with Experimental Infection with rDEN2Δ30 (Tonga/74) Support Its Suitability as a Human Dengue Virus Challenge Strain. Journal of Virology, 91 (8).

Grifoni, A., Angelo, M.A., Lopez, B., O’Rourke, P.H., Sidney, J., Cerpas, C., Balmaseda, A., Silveira, C.G.T., Maestri, A., Costa, P.R., Durbin, A.P., Diehl, S.A., Phillips, E., Mallal, S., De Silva, A.D., Nchinda, G., Nkenfou, C., Collins, M.H., de Silva, A.M., Lim, M.Q., Macary, P.A., Tatullo, F., Solomon, T., Satchidanandam, V., Desai, A., Ravi, V., Coloma, J., Turtle, L., Rivino, L., Kallas, E.G., Peters, B., Harris, E., Sette, A. and Weiskopf, D. (2017) Global assessment of dengue Virus-Specific CD4+ T cell responses in Dengue-Endemic areas. Frontiers in Immunology, 8 .

Grifoni, A., Pham, J., Sidney, J., O'Rourke, P.H., Paul, S., Peters, B., Martini, S.R., de Silva, A.D., Ricciardi, M.J., Magnani, D.M., Silveira, C.G.T., Maestri, A., Costa, P.R., de-Oliveira-Pinto, L.M., de Azeredo, E.L., Damasco, P.V., Phillips, E., Mallal, S., de Silva, A.M., Collins, M., Durbin, A., Diehl, S.A., Cerpas, C., Balmaseda, A., Kuan, G., Coloma, J., Harris, E., Crowe, J.E., Stone, M., Norris, P.J., Busch, M., Vivanco-Cid, H., Cox, J., Graham, B.S., Ledgerwood, J.E., Turtle, L., Solomon, T., Kallas, E.G., Watkins, D.I., Weiskopf, D., Sette, A. and Dermody, T.S. (2017) Prior dengue virus exposure shapes T Cell immunity to Zika Virus in humans. Journal of Virology, 91 (24).

Grifoni, A., Weiskopf, D., Lindestam Arlehamn, C.S., Angelo, M., Leary, S., Sidney, J., Frazier, A., Phillips, E., Mallal, S., Mack, S.J., Tippalagama, R., Goonewardana, S., Premawansa, S., Premawansa, G., Wijewickrama, A., De Silva, A.D. and Sette, A. (2017) Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 714 adults from Colombo, Sri Lanka. Human Immunology, 79 (2). pp. 87-88.

Gupta, V.B., Hone, E., Pedrini, S., Doecke, J., O'Bryant, S., James, I., Bush, A.I., Rowe, C.C., Villemagne, V.L., Ames, D, Masters, C.L. and Martins, R.N. (2017) Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 8 . pp. 60-72.

Gutteridge, D.H. and Mastaglia, F.L. (2017) Recognition of giant cell arteritis in patients with polymyalgia rheumatica who have a stroke: A cautionary tale. Internal Medicine Journal, 47 (10). pp. 1199-1201.

Hart, P.H., Lucas, R.M., Booth, D.R., Carroll, W.M., Nolan, D., Cole, J.M., Jones, A.P. and Kermode, A.G. (2017) Narrowband UVB phototherapy for clinically isolated syndrome: A trial to deliver the benefits of Vitamin D and other UVB-Induced molecules. Frontiers in Immunology, 8 .

Huang, Y., Wang, Y., Zhou, Y., Huang, Q., Sun, X., Chen, C., Fang, L., Long, Y., Yang, H., Wang, H., Li, C., Lu, Z., Hu, X., Kermode, A.G. and Qiu, W. (2017) Pregnancy in neuromyelitis optica spectrum disorder: A multicenter study from South China. Journal of the Neurological Sciences, 372 . pp. 152-156.

John, M., Gaudieri, S. and Mallal, S. (2017) Immunogenetics and vaccination. In: Modjarrad, K. and Koff, W.C., (eds.) Human Vaccines: Emerging Technologies in Design and Development. Academic Press.

Jones, A.P., Trend, S., Byrne, S.N., Fabis-Pedrini, M.J., Geldenhuys, S., Nolan, D., Booth, D.R., Carroll, W.M., Lucas, R.M., Kermode, A.G. and Hart, P.H. (2017) Altered regulatory T-cell fractions and Helios expression in clinically isolated syndrome: Clues to the development of multiple sclerosis. Clinical & Translational Immunology, 6 (5).

Kalincik, T., Jokubaitis, V., Spelman, T., Horakova, D., Havrdova, E., Trojano, M., Lechner-Scott, J., Lugaresi, A., Prat, A., Girard, M., Duquette, P., Grammond, P., Solaro, C., Grand’Maison, F., Hupperts, R., Prevost, J., Sola, P., Ferraro, D., Terzi, M., Butler, E., Slee, M., Kermode, A., Fabis-Pedrini, M., McCombe, P., Barnett, M., Shaw, C., Hodgkinson, S. and Butzkueven, H. (2017) Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis. Multiple Sclerosis Journal, 24 (12). pp. 1617-1626.

Karnes, J.H., Bastarache, L., Shaffer, C.M., Gaudieri, S., Xu, Y., Glazer, A.M., Mosley, J.D., Zhao, S., Raychaudhuri, S., Mallal, S., Ye, Z., Mayer, J.G., Brilliant, M.H., Hebbring, S.J., Roden, D.M., Phillips, E.J. and Denny, J.C. (2017) Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants. Science Translational Medicine, 9 (389). eaai8708.

Karnes, J.H., Shaffer, C.M., Bastarache, L., Gaudieri, S., Glazer, A.M., Steiner, H.E., Mosley, J.D., Mallal, S., Denny, J.C., Phillips, E.J. and Roden, D.M. (2017) Comparison of HLA allelic imputation programs. PLoS ONE, 12 (2).

Karnes, J.H., Shaffer, C.M., Cronin, R., Bastarache, L., Gaudieri, S., James, I., Pavlos, R., Steiner, H., Mosley, J.D., Mallal, S., Denny, J.C., Phillips, E.J. and Roden, D.M. (2017) Influence of human leukocyte antigen (HLA) alleles and killer cell immunoglobulin-like receptors (KIR) types on heparin-induced thrombocytopenia (HIT). Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 37 (9). pp. 1164-1171.

Kermode, A.G., Hart, P., Lucas, R., Booth, D., Carroll, W., Nolan, D., Cole, J., Jones, A. and Trend, S. (2017) Narrowband UVB phototherapy for clinically isolated syndrome: Delivering the benefits of all UVB-induced molecules. Journal of the Neurological Sciences, 381 (Supp.). p. 446.

Koethe, J.R., McDonnell, W., Kennedy, A., Abana, C.O., Pilkinton, M., Setliff, I., Georgiev, I., Barnett, L., Hager, C.C., Smith, R., Kalams, S.A., Hasty, A. and Mallal, S. (2017) Adipose tissue is enriched for activated and Late-differentiated CD8+ T cells, and shows distinct CD8+ receptor usage, compared to blood in HIV-infected persons. JAIDS Journal of Acquired Immune Deficiency Syndromes, 77 (2). e14-e21.

Li, R., Sun, X., Shu, Y., Wang, Yuge, Xiao, Li, Wang, Z., Hu, X., Kermode, A.G. and Qiu, W. (2017) Serum CCL20 and its association with SIRT1 activity in multiple sclerosis patients. Journal of Neuroimmunology, 313 . pp. 56-60.

Lucas, M., Kallies, A. and Klenerman, P. (2017) The immune system of the liver: 50 years of strangeness. Clinical & Translational Immunology, 6 (12). e164.

Mahurkar, S., Moldovan, M., Suppiah, V., Sorosina, M., Clarelli, F., Liberatore, G., Malhotra, S., Montalban, X., Antigüedad, A., Krupa, M., Jokubaitis, V.G., McKay, F.C., Gatt, P.N., Fabis-Pedrini, M.J., Martinelli, V., Comi, G., Lechner-Scott, J., Kermode, A.G., Slee, M., Taylor, B.V., Vandenbroeck, K., Comabella, M., Boneschi, F.M. and King, C. (2017) Response to interferon-beta treatment in multiple sclerosis patients: A genome-wide association study. The Pharmacogenomics Journal, 17 (4). pp. 312-318.

Mallal, S. (2017) What HIV has taught about the interactions between biology, culture, and other evolving systems. In: Tibayrenc, M. and Ayala, F.J., (eds.) On Human Nature. Elsevier Inc., pp. 771-776.

Manolio, T.A., Hutter, C.M., Avigan, M., Cibotti, R., Davis, R.L., Denny, J.C., Grenade, L.L., Wheatley, L.M., Carrington, M.N., Chantratita, W., Chung, W.H., Dalton, A.D., Hung, S.I., Lee, M.T.M., Leeder, J.S., Lertora, J.J.L., Mahasirimongkol, S., McLeod, H.L., Mockenhaupt, M., Pacanowski, Michael, Phillips, E.J., Pinheiro, S., Pirmohamed, M., Sung, C., Suwankesawong, W., Trepanier, L.A., Tumminia, S.J., Veenstra, D., Yuliwulandari, R. and Shear, N.H. (2017) Research directions in genetic predispositions to Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis. Clinical Pharmacology & Therapeutics, 103 (3). pp. 390-394.

McGovern, A.M., Androga, G.O., Knight, D.R.ORCID: 0000-0002-9480-4733, Watson, M.W.ORCID: 0000-0002-6438-9225, Elliott, B., Foster, N.F., Chang, B.J. and Riley, T.V. (2017) Prevalence of binary toxin positive Clostridium difficile in diarrhoeal humans in the absence of epidemic ribotype 027. PLoS ONE, 12 (11). e0187658.

Merani, S., Lucas, M., Deshpande, P., Pfafferott, K., Chopra, A., Cooper, D., Leary, S., Luciani, F. and Gaudieri, S. (2017) Influence of transmitted virus on the host's immune response: A case study. Viral Immunology, 30 (7).

Molster, C.M., Lister, K., Metternick-Jones, S., Baynam, G., Clarke, A.J., Straub, V., Dawkins, H.J.S. and Laing, N. (2017) Outcomes of an International Workshop on Preconception Expanded Carrier Screening: Some Considerations for Governments. Frontiers in Public Health, 5 . Article 25.

Needham, M. and Mastaglia, F.L. (2017) Advances in inclusion body myositis: genetics, pathogenesis and clinical aspects. Expert Opinion on Orphan Drugs, 5 (5). pp. 431-443.

Noto, J.M., Chopra, A., Loh, J., Romero-Gallo, J., Piazuelo, M.B., Watson, M.W.ORCID: 0000-0002-6438-9225, Leary, S., Beckett, A., Cover, T., Mallal, S., Israel, D. and Peek, R.M. (2017) Carcinogenic host microenvironments target and modify key pathogenic loci within helicobacter pylori. Gastroenterology, 152 (5). S666.

Noto, J.M., Chopra, A., Loh, J.T., Romero-Gallo, J., Piazuelo, M.B., Watson, M.ORCID: 0000-0002-6438-9225, Leary, S., Beckett, A.C., Wilson, K.T., Cover, T.L., Mallal, S., Israel, D.A. and Peek, R.M. (2017) Pan-genomic analyses identify key Helicobacter pylori pathogenic loci modified by carcinogenic host microenvironments. Gut, 67 (10). pp. 1793-1804.

Pavlos, R., McKinnon, E.J., Ostrov, D.A., Peters, B., Buus, S., Koelle, D., Chopra, A., Schutte, R., Rive, C., Redwood, A., Restrepo, S., Bracey, A., Kaever, T., Myers, P., Speers, E., Malaker, S.A., Shabanowitz, J., Jing, Y., Gaudieri, S., Hunt, D.F., Carrington, M., Haas, D.W., Mallal, S. and Phillips, E.J. (2017) Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles. Scientific Reports, 7 (1).

Pavlos, R., Redwood, A. and Phillips, E. (2017) AdDRESSing T-cell responses to antituberculous drugs. British Journal of Dermatology, 176 (2). pp. 292-293.

Pedrini, S., Gupta, V.B., Hone, E., Doecke, J., O’Bryant, S., James, I., Bush, A.I., Rowe, C.C., Villemagne, V.L., Ames, D., Masters, C.L. and Martins, R.N. (2017) A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort. Scientific Reports, 7 (1).

Peter, J.G., Lehloenya, R., Dlamini, S., Risma, K., White, K.D., Konvinse, K.C. and Phillips, E.J. (2017) Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice. The Journal of Allergy and Clinical Immunology: In Practice, 5 (3). pp. 547-563.

Pina-Salazar, E-Z, Urita, K., Hayashi, T., Futamura, R., Vallejos-Burgos, F., Włoch, J., Kowalczyk, P., Wiśniewski, M., Sakai, T., Moriguchi, I., Terzyk, A.P., Osawa, E. and Kaneko, K. (2017) Water adsorption property of hierarchically nanoporous detonation nanodiamonds. Langmuir, 33 (42). pp. 11180-11188.

Poulton, C., Baynam, G., Yates, C., Alinejad-Rokny, H., Williams, S., Wright, H., Woodward, K.J., Sivamoorthy, S., Peverall, J., Shipman, P., Ravine, D., Beilby, J. and Heng, J.I-T (2017) A review of structural brain abnormalities in Pallister-Killian syndrome. Molecular Genetics & Genomic Medicine, 6 (1). pp. 92-98.

Redwood, A.J., Pavlos, R.K., White, K.D. and Phillips, E.J. (2017) HLAs: Key regulators of T-cell-mediated drug hypersensitivity. HLA, 91 (1). pp. 3-16.

Secombe, C.J., Tan, R.H.H., Perera, D.I., Byrne, D.P.ORCID: 0000-0003-2910-9133, Watts, S.P. and Wearn, J.G. (2017) The effect of geographic location on circannual adrenocorticotropic hormone plasma concentrations in horses in Australia. Journal of Veterinary Internal Medicine, 31 (5). pp. 1533-1540.

Sheahan, Jordana (2017) Defining latent EBV load in B lymphocytes: Application to multiple sclerosis. Honours thesis, Murdoch University.

Shu, Y., Li, R., Qiu, W., Chang, Y., Sun, X., Fang, L., Chen, C., Yang, Y., Lu, Z., Hu, X. and Kermode, A.G. (2017) Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis. Multiple Sclerosis and Related Disorders, 18 . pp. 65-70.

Somogyi, A.A. and Phillips, E. (2017) Genomic testing as a tool to optimise drug therapy. Australian Prescriber, 40 (3). pp. 101-104.

Soto-Nava, M., Avila-Rios, S., Valenzuela-Ponce, H., Garcia-Morales, C., Carlson, J.M., Tapia-Trejo, D., Garrido-Rodriguez, D., Alva-Hernández, S.N., García-Tellez, T.A., Murakami-Ogasawara, A., Mallal, S.A., John, M., Brockman, M.A., Brumme, C.J., Brumme, Z.L., Reyes-Teran, G. and Silvestri, G. (2017) Weaker HLA footprints on HIV in the unique and highly genetically admixed host population of Mexico. Journal of Virology, 92 (2).

Stewart, T., Spelman, T., Havrdova, E., Horakova, D., Trojano, M., Izquierdo, G., Duquette, P., Girard, M., Prat, A., Lugaresi, A., Grand’Maison, F., Grammond, P., Sola, P., Shaygannejad, V., Hupperts, R., Alroughani, R., Oreja-Guevara, C., Pucci, E., Boz, C., Lechner-Scott, J., Bergamaschi, R., van Pesch, V., Iuliano, G., Ramo, C., Taylor, B., Slee, M., Spitaleri, D., Granella, F., Verheul, F., McCombe, P., Hodgkinson, S., Amato, M.P., Vucic, S., Gray, O., Cristiano, E., Barnett, M., Sanchez Menoyo, J.L., van Munster, E., Saladino, M.L., Olascoaga, J., Prevost, J., Deri, N., Shaw, C., Singhal, B., Moore, F., Rózsa, C., Shuey, N., Skibina, O., Kister, I., Petkovska-Boskova, T., Ampapa, R., Kermode, A., Butzkueven, H., Jokubaitis, V. and Kalincik, T. (2017) Contribution of different relapse phenotypes to disability in multiple sclerosis. Multiple Sclerosis Journal, 23 (2). pp. 266-276.

Styles, C.E., Seed, C.R., Hoad, V.C., Gaudieri, S. and Keller, A.J. (2017) Reconsideration of blood donation testing strategy for human T-cell lymphotropic virus in Australia. Vox Sanguinis, 112 (8). pp. 723-732.

Sulzer, D., Alcalay, R.N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W.H., Mao, X., Dawson, V.L., Dawson, T.M., Oseroff, C., Pham, J., Sidney, J., Dillon, M.B., Carpenter, C., Weiskopf, D., Phillips, E., Mallal, S., Peters, B., Frazier, A., Lindestam Arlehamn, C.S. and Sette, A. (2017) T cells from patients with Parkinson’s disease recognize α-synuclein peptides. Nature, 546 (7660). pp. 656-661.

Symons, J., Chopra, A., Malantinkova, E., De Spiegelaere, W., Leary, S., Cooper, D., Abana, C.O., Rhodes, A., Rezaei, S.D., Vandekerckhove, L., Mallal, S., Lewin, S.R. and Cameron, P.U. (2017) HIV integration sites in latently infected cell lines: evidence of ongoing replication. Retrovirology, 14 (1).

Symons, J., Chopra, A., Malatinkova, E., De Spiegelaere, W., Leary, S., Cooper, D., Abana, C.O., Rhodes, A., Rezaei, S.D., Vandekerckhove, L., Mallal, S., Lewin, S.R. and Cameron, P.U. (2017) Erratum to: HIV integration sites in latently infected cell lines: evidence of ongoing replication. Retrovirology, 14 (1).

Tay, J., Lui, W., Tian, J.ORCID: 0000-0001-9887-7211, Hughes, Q., Tiao, J. and Baker, R. (2017) Evidence for direct and indirect modulation of haemostatic factors by miR-494. In: International Society on Thrombosis and Haemostasis 2017, 8-13 July 2017, Berlin, Germany.

Tay, J.W., James, I., Hughes, Q.W., Tiao, J.Y. and Baker, R.I. (2017) Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy. BMC Research Notes, 10 (1).

Thomas, M., Hopkins, C., Duffy, E., Lee, D., Loulergue, P., Ripamonti, D., Ostrov, D.A. and Phillips, E. (2017) Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir. Clinical Infectious Diseases, 64 (9). pp. 1198-1203.

Trend, S., Jones, A., Geldenhuys, S., Byrne, S., Fabis-Pedrini, M., Nolan, D., Booth, D., Carroll, W., Lucas, R., Kermode, A.G. and Hart, P. (2017) Evolving Identification of Blood Cells Associated with Clinically Isolated Syndrome: Importance of Time since Clinical Presentation and Diagnostic MRI. International Journal of Molecular Sciences, 18 (6). p. 1277.

Trubiano, J.A., Adkinson, N.F. and Phillips, E.J. (2017) Penicillin allergy is not necessarily forever. JAMA, 318 (1). p. 82.

Trubiano, J.A., Stone, C.A., Grayson, M.L., Urbancic, K., Slavin, M.A., Thursky, K.A. and Phillips, E.J. (2017) The 3 Cs of antibiotic allergy—classification, cross-reactivity, and collaboration. The Journal of Allergy and Clinical Immunology: In Practice, 5 (6). pp. 1532-1542.

Trubiano, J.A., Thursky, K.A., Stewardson, A.J., Urbancic, K., Worth, L.J., Jackson, C., Stevenson, W., Sutherland, M., Slavin, M.A., Grayson, M.L. and Phillips, E.J. (2017) Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation. Clinical Infectious Diseases, 65 (1). pp. 166-174.

Tseng, A., Hughes, C.A., Wu, J., Seet, J. and Phillips, E.J. (2017) Cobicistat Versus Ritonavir: Similar pharmacokinetic enhancers but some important differences. Annals of Pharmacotherapy, 51 (11). pp. 1008-1022.

Urbancic, K.F., Ierino, F., Phillips, E., Mount, P.F., Mahony, A. and Trubiano, J.A. (2017) Taking the challenge: A protocolized approach to optimize Pneumocystis pneumonia prophylaxis in renal transplant recipients. American Journal of Transplantation, 18 (2). pp. 462-466.

Walker, C.E., Mahede, T., Davis, G., Miller, L.J., Girschik, J., Brameld, K., Sun, W., Rathod, A., Ayme, S., Zubrick, S.R., Baynam, G.S., Molster, C., Dawkins, H.J.S. and Weeramanthri, T.S. (2017) The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort. Genetics in Medicine, 19 (5). pp. 546-552.

Young, A., Ngiow, S.F., Gao, Y., Patch, A-M, Barkauskas, D.S., Messaoudene, M., Lin, G., Coudert, J.D., Stannard, K.A., Zitvogel, L., Degli-Esposti, M.A., Vivier, E., Waddell, N., Linden, J., Huntington, N.D., Souza-Fonseca-Guimaraes, F. and Smyth, M.J. (2017) A2AR adenosine signaling suppresses natural killer cell maturation in the tumor microenvironment. Cancer Research, 78 (4). pp. 1003-1016.

Zahedi, A.ORCID: 0000-0002-0165-3797, Gofton, A., Jian, F., Paparini, A.ORCID: 0000-0002-1105-5184, Oskam, C., Ball, A., Robertson, I.ORCID: 0000-0002-4255-4752 and Ryan, U.ORCID: 0000-0003-2710-9324 (2017) Next generation sequencing uncovers within-host differences in the genetic diversity of Cryptosporidium gp60 subtypes. In: Australian Society for Parasitology Annual Conference 2017, 26 - 29 June 2017, Blue Mountains, NSW, Australia

Zhong, X., Zhou, Y., Lu, T., Wang, Z., Fang, L., Peng, L., Kermode, A.G. and Qiu, W. (2017) Infections in neuromyelitis optica spectrum disorder. Journal of Clinical Neuroscience, 47 . pp. 14-19.

Zhou, Y., Huang, Q., Lu, T., Sun, X., Fang, L., Lu, Z., Hu, X., Kermode, A. and Qiu, W. (2017) Azathioprine therapy in a case of pediatric multiple sclerosis that was seropositive for MOG-IgG. Journal of Clinical Neuroscience, 38 . pp. 71-73.

da Silva Antunes, R., Paul, S., Sidney, J., Weiskopf, D., Dan, J.M., Phillips, E., Mallal, S., Crotty, S., Sette, A. and Lindestam Arlehamn, C.S. (2017) Definition of human epitopes recognized in tetanus toxoid and development of an assay strategy to detect Ex Vivo tetanus CD4+ T cell responses. PLoS ONE, 12 (1).

2016

Angelo, M.A., Grifoni, A., O'Rourke, P.H., Sidney, J., Paul, S., Peters, B., De Silva, A.D., Phillips, E., Mallal, S., Diehl, S.A., Kirkpatrick, B.D., Whitehead, S.S., Durbin, A.P., Sette, A., Weiskopf, D. and Frueh, K. (2016) Human CD4 + T Cell Responses to an Attenuated Tetravalent Dengue Vaccine Parallel Those Induced by Natural Infection in Magnitude, HLA Restriction, and Antigen Specificity. Journal of Virology, 91 (5).

Armstrong, A.R., Herrmann, S.E., Chassany, O., Lalanne, C., Da Silva, M.H., Galano, E., Carrieri, P.M., Estellon, V., Sogni, P. and Duracinsky, M. (2016) The International development of PROQOL-HCV: An instrument to assess the health-related quality of life of patients treated for Hepatitis C virus. BMC Infectious Diseases, 16 (1).

Barnard, R., Chopra, A., James, I., Blinco, J., Watson, M.W.ORCID: 0000-0002-6438-9225, Jabara, C.B., Hazuda, D., Lemon, S.M., Mallal, S. and Gaudieri, S. (2016) Primer ID ultra-deep sequencing reveals dynamics of drug resistance-associated variants in breakthrough hepatitis C viruses: Relevance to treatment outcome and resistance screening. Antiviral Therapy, 21 . pp. 567-577.

Bates, K.A., Sohrabi, H.R.ORCID: 0000-0001-8017-8682, Rainey-Smith, S.R., Weinborn, M., Bucks, R.S., Rodrigues, M., Beilby, J., Howard, M., Taddei, K., Martins, G., Paton, A., Shah, T., Dhaliwal, S.S., Foster, J.K., Martins, I.J., Lautenschlager, N.T., Mastaglia, F.L., Gandy, S.E. and Martins, R.N. (2016) Serum high-density lipoprotein is associated with better cognitive function in a cross-sectional study of aging women. International Journal of Neuroscience, 127 (3). pp. 243-252.

Baynam, G., Pachter, N., McKenzie, F., Townshend, S., Slee, J., Kiraly-Borri, C., Vasudevan, A., Hawkins, A., Broley, S., Schofield, L., Verhoef, H., Walker, C.E., Molster, C., Blackwell, J.M., Jamieson, S., Tang, D., Lassmann, T., Mina, K., Beilby, J., Davis, M., Laing, N., Murphy, L., Weeramanthri, T., Dawkins, H. and Goldblatt, J. (2016) The rare and undiagnosed diseases diagnostic service – Application of massively parallel sequencing in a state-wide clinical service. Orphanet Journal of Rare Diseases, 11 (1).

Bundell, C., Rojana-udomsart, A., Mastaglia, F., Hollingsworth, P. and McLean-Tooke, A. (2016) Diagnostic performance of a commercial immunoblot assay for myositis antibody testing. Pathology, 48 (4). pp. 363-366.

Carlson, J.M., Du, V.Y., Pfeifer, N., Bansal, A., Tan, V.Y.F., Power, K., Brumme, C.J., Kreimer, A., DeZiel, C.E, Fusi, N., Schaefer, M., Brockman, M.A., Gilmour, J., Price, M.A., Kilembe, W., Haubrich, R., John, M., Mallal, S., Shapiro, R., Frater, J., Harrigan, P.R., Ndung'u, T., Allen, S., Heckerman, D., Sidney, J., Allen, T.M., Goulder, P.J.R., Brumme, Z.L., Hunter, E. and Goepfert, P.A. (2016) Impact of pre-adapted HIV transmission. Nature Medicine, 22 (6). pp. 606-613.

Castley, A., Williams, L., James, I., Guelfi, G., Berry, C. and Nolan, D. (2016) Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors. PloS one, 11 (6). e0158169.

Castley, A.S.L., Gaudieri, S., James, I., Gizzarelli, L.S., Guelfi, G., John, M. and Nolan, D. (2016) Longitudinal Trends in Western Australian HIV-1 Sequence Diversity and Viral Transmission Networks and Their Influence on Clinical Parameters: 2000–2014. AIDS Research and Human Retroviruses, 32 (3). pp. 211-219.

Chan, B., Mitrovic, M., Masters, L., Jonjic, S., Shellam, G., Smith, L. and Redwood, A. (2016) The m15 locus of murine cytomegalovirus modulates natural killer cell responses and promotes dissemination to the salivary glands. In: International Congress of Immunology, 21 - 26 August 2016, Melbourne, VIC.

Chatterjee, P., Lim, W.L.F., Shui, G., Gupta, V.B., James, I., Fagan, A.M., Xiong, C., Sohrabi, H.R.ORCID: 0000-0001-8017-8682, Taddei, K., Brown, B.M.ORCID: 0000-0001-7927-2540, Benzinger, T., Masters, C., Snowden, S.G., Wenk, M.R., Bateman, R.J., Morris, J.C. and Martins, R.N. (2016) Plasma phospholipid and sphingolipid alterations in presenilin1 mutation carriers: A pilot study. Journal of Alzheimer's Disease, 50 (3). pp. 887-894.

Chopra, A. (2016) Analysis and visualization tools for NGS sequence data. In: Science on the Swan 2016, 2 - 5 May 2016, Perth, Western Australia

Chopra, A. (2016) Core Laboratory Activity at IIID. In: Immunology Seminar. Fiona Stanley Hospital, Murdoch, W.A.

Chopra, A., Gaudieri, S., Pilkington, M., Blinco, J., Leary, S., Cooper, D., Abana, C., Watson, M.ORCID: 0000-0002-6438-9225, Kalams, S. and Mallal, S. (2016) Cutting edge tools for phenotyping and characterising T-Cell subsets. In: Science on the Swan 2016, 2 - 5 May 2016, Perth, Western Australia.

Cromer, D., Schlub, T., Smyth, R., Grimm, A., Chopra, A., Mallal, S., Davenport, M. and Mak, J. (2016) HIV-1 Mutation and recombination rates are different in Macrophages and T-cells. Viruses, 8 (4). p. 118.

D'Orsogna, L.J. (2016) Stimulation of HIV-specific T cell responses using allogeneic HLA. In: Science on the Swan Post Conference Workshop: Cutting Edge tools: from populations to signal cell., 6 May 2016, Perth, WA.

Dai, Y., Lu, T., Wang, Y., Fang, L., Li, R., Kermode, A.G. and Qiu, W. (2016) Rapid exacerbation of neuromyelitis optica after rituximab treatment. Journal of Clinical Neuroscience, 26 . pp. 168-170.

Deshpande, P., Lucas, M., Brunt, S., Lucas, A., Hollingsworth, P. and Bundell, C. (2016) Low level autoantibodies can be frequently detected in the general Australian population. Pathology, 48 (5). pp. 483-490.

Duracinsky, M., Armstrong, A., Herrmann, S., Lalanne, C., Fofana, D.A., Galano, E., Da Silva, M.H., Carrieri, P.M. and Chassany, O. (2016) Validation of health-related quality of life (HRQL) of a new questionnaire specific to Viral hepatitis C: PROQOL-HCV. In: 51st European Association of the Study of Liver Disease Annual Meeting (EASL), 13 - 17 April 2016, Barcelona, Spain.

Elera, J.D., Boteanu, C., Blanco, M.A.J., Gonzalez-Mendiola, R., García, I.C., Alvarez, A., Martinez, J.J.L., Garrido, J.M., Barona, C.T., Chorda, C.P., Salgueiro, R.L., Palacios, M.D., De Rojas, D.H.F., Acar, E.A., Aktas, A., Ermertcan, A.T., Temiz, C., Lin, C-Y, Hui, C-Y.R., Chang, Y-C, Yang, C-H, Chung, W-H, Carolino, F., Silva, D., De Castro, E.D., Cernadas, J.R., Ensina, L.F., Aranda, C., Nunes, I.C., Lacerda, A., Martins, A.M., Goudouris, E., Ribeiro, M., Da Silva Franco, J.F., Queiroz, L., Solé, D., Dalgiç, C.T., Sin, A.Z., Günsen, F.D., Bulut, G., Ardeniz, F.Ö., Gülbahar, O., Gökmen, E.N.M., Kokuludag, A., De Francisco, A.M.M., De Vicente Jiménez, T.M., Mendoza Parra, A.M., Burgos Pimentel, A.M., Luque, A.G., Amaral, L., Leão, L.C., Pinto, N., Belo, J., Marques, J., Carreiro-Martins, P., Leiria-Pinto, P., Chaabane, A., Romdhane, H.B., Fredj, N.B., Chadly, Z., Boughattas, N.A., Aouam, K., Uyttebroek, A.P., Bridts, C.H., Romano, A., Ebo, D.G., Sabato, V., Lopes, A., Cosme, J., Aguiar, R., Lourenço, T., Paes, M-J, Spínola-Santos, A., Pereira-Barbosa, M., Cruz, C.R., Dos Reis, R.P., Tomaz, E., Pires, A.P., Inácio, F., Benito-Garcia, F., Mota, I., Correia, M., Gaspar, Â., Chambel, M., Piedade, S., Morais-Almeida, M., Nakonechna, A., Antipkin, Y., Umanets, T., Pineda, F., Arribas, F., Lapshyn, V., Miranda, P.A., De La Cruz Hoyos, B., Blanco, A.J., Del Pozo, M., Vultaggio, A., Nencini, F., Pratesi, S., Matucci, A., Maggi, E., Cegec, I., Nahal, D.J., Turk, V.E., Aumiler, M.R., Ausperger, K.M., Kraljickovic, I., Simic, I., Yamaguchi, Y., Watanabe, T., Satoh, M., Tanegashima, T., Oda, K., Wada, H., Aihara, M., Lee, J.J., Choi, J.C., Lee, H.Y., Fernandes, R-A.R., Faria, E., Pita, J., Sousa, N., Ribeiro, C., Carrapatoso, I., Bom, A.T., Rodolfo, A., Dias-Castro, E., Voronova, M., Valle, D.K., Coronel, V.P., Chordá, C.P., Madamba, R.C.Y., Ferrer, M., Goikoetxea, M.J., D’Amelio, C., Bernad, A., Vega, O., Gastaminza, G., Bibián, B.L., Salazar, M.L., Vilà-Nadal, G., Roman, A.M.F., Ortega, J.D., Muñoz, M.G., Gancedo, S.Q., Moreno, M.R.C., Hofmeier, K.S., Barzylovych, V., Pola, B., Lluncor, M., Fiandor, A., Bellón, T., Domínguez, J., Quirce, S., Yang, M-S, Kim, S-S, Kim, S-H, Kang, H-R, Park, H-W, Cho, S-H, Min, K-U, Chang, Y-S, Delahaye, C., Flabbee, J., Waton, J., Bauvin, O., Barbaud, A., Fadhel, N.B., Gulin, S.J., Chiriac, A., Cardoso, B.K., Viseu, R., Moreira, A., Cadinha, S., Neves, A.C., Barreira, P., Malheiro, D., Da Silva, J.P., Jurakic-Toncic, R., Ljubojevic, S., Turcic, P., Gilissen, L., Huygens, S., Goossens, A., Andreu, I., Romero, A.M., Cabezas, P.G., Parejo, P.A., Del Carmen Plaza-Serón, M., Doña, I., Blanca-López, N., Flores, C., Galindo, M.L., Molina, A., Perkins, J.R., Cornejo-García, J.A., García-Agúndez, J.A., García-Martín, E., Campo, P., Canto, M.G., Blanca, M., Guéant-Rodríguez, R.M., Jurado-Escobar, R., Barrionuevo, E., Salas, M., Canto, G., Guéant, J-L, Usui, T., Tailor, A., Faulkner, L., Farrell, J., Alfirevic, A., Kevin Park, B., Naisbitt, D.J., Trelles, O., Guerrero, M.A., Upton, A., Ueta, M., Sawai, H., Sotozono, C., Tokunaga, K., Kinoshita, S., Sukasem, C., Satapornpong, P., Tempark, T., Rerknimitr, P., Pairayayutakul, K., Klaewsongkram, J., Koomdee, N., Jantararoungtong, T., Santon, S., Puangpetch, A., Intusoma, U., Tassaneeyakul, W., Theeramoke, V., Ramirez, E., Borobia, A.M., Tong, H., Castañer, J.L., De Abajo, F.J., Galvao, V.R., Pavlos, R., McKinnon, E., Williams, K., Beeghly-Fadiel, A., Phillips, E., Castells, M., Boni, E., Russello, M., Mauro, M., Ue, K.L., Rutkowski, K., Gomis, V.S., Ferre, J.F., Rodriguez, A.E., Reig, V.C., Sanchez, J.F., Breynaert, C., Van Hoeyveld, E., Schrijvers, R., Blanco, A.J., Irigoyen, R.F., Collado, D., Vida, Y., Najera, F., Perez-Inestrosa, E., Mesa-Antunez, P., Mayorga, C., Torres, M.J., Tannert, L.K., Mortz, C.G., Skov, P.S., Bindslev-Jensen, C., Pfützner, W., Dörnbach, H., Visse, J., Rauber, M., Möbs, C., Elzagallaai, A.A., Chow, L., Abuzgaia, A.M., Rieder, M.J., Trubiano, J., Woolnough, E., Cheng, C., Kato, K., Azukizawa, H., Hanafusa, T., Katayama, I., Fujiyama, T., Hashizume, H., Umayahara, T., Ito, T., Tokura, Y., Silar, M., Zidarn, M., Rupnik, H., Korosec, P., Redwood, A.J., Strautins, K., White, K., Chopra, A., Konvinse, K., Leary, S., Mallal, S., Cabañas, R., Fiandor, A.M., Sullivan, A., Whitaker, P., Peckham, D., Haw, W.Y., Polak, M.E., Mcguire, C., Ardern-Jones, M.R., Aoyama, Y., Shiohara, T., Correia, S., Gelincik, A., Demir, S., Sen, F., Bozbey, H.U., Olgac, M., Unal, D., Coskun, R., Colakoglu, B., Buyuozturk, S., Çatin-Aktas, E., Deniz, G., Laguna, J.J., Dionicio, J., Fernandez, T., Olazabal, I., Ruiz, M.D., Torres, M.J., Lafuente, A., Núñez, J., Fernández, T.D., Palomares, F., Fernández, R., Sanchez, M.I., Fernandez, T., Ruiz, A., Ariza, A., Alonso, A.B., Garófalo, C.D., Matute, O.V., Puga, M.F., Lapresa, M.J.G., Lasarte, G.G., Thinnes, A., Merk, H.F., Baron, J.M., Leverkus, M., Balakirski, G., Gibson, A., Ogese, M., Al-Attar, Z., Yaseen, F., Meng, X., Jenkins, R., Farrel, J., Alhilali, K., Xue, Y., Illing, P., Mifsud, N., Fettke, H., Lai, J., Ho, R., Kwan, P., Purcell, A., Ogese, M.O., Betts, C., Thomson, P., Alhaidari, M., Berry, N., O’Neill, P.M., Alzahrani, A., Azoury, M.E., Fili, L., Bechara, R., Scornet, N., Nhim, C., Weaver, R., Claude, N., Joseph, D., Maillere, B., Parronchi, P., Pallardy, M., Villani, A.P., Rozières, A., Bensaïd, B., Tardieu, M., Albert, F., Mutez, V., Baysal, T., Maryanski, J., Nicolas, J-F, Kanagawa, O., Vocanson, M., Hung, S-L, Harrison, C.J., Jenkins, R.E., French, N.S., Montañez, M.I., Fernandez, T.D., Martin-Serrano, A., Torres, M.J., Molina, N., Wood, S., Pirmohamed, M., Montañez, M.I., Martín-Serrano, Á., Pérez-Inestrosa, E., Pérez-Sala, D., Guzmán, A.E., Ko, T-M, Chen, Y-T, Wu, J-Y, Sánchez-Gómez, F.J., González-Morena, J.M., Torres, M.J., Arreola, A.M., Corona, J.A.B., Flores, S.M., Cherit, J.D., Figueroa, N.V.D., Flores, J.L.C., Perkins, J., Pérez-Alzate, D., Bogas, G., Torres, M.J., Marti, L.M.T., De La Losa, F.P., Poves, F.A., Lopez, J.T. and Santiago, T.L. (2016) 7th Drug hypersensitivity meeting: part two. Clinical and Translational Allergy, 6 (S3).

Fabis-Pedrini, M.J., Xu, W., Burton, J., Carroll, W.M. and Kermode, A.G. (2016) Asymptomatic progressive multifocal leukoencephalopathy during natalizumab therapy with treatment. Journal of Clinical Neuroscience, 25 . pp. 145-147.

Fiches, G.N., Eyre, N.S., Aloia, A.L., Van Der Hoek, K., Betz-Stablein, B., Luciani, F., Chopra, A. and Beard, M.R. (2016) HCV RNA traffic and association with NS5A in living cells. Virology, 493 . pp. 60-74.

Fritzius, T., Turecek, R., Seddik, R., Kobayashi, H., Tiao, J., Rem, P.D., Metz, M., Kralikova, M., Bouvier, M., Gassmann, M. and Bettler, B. (2016) KCTD Hetero-oligomers confer unique kinetic properties on Hippocampal GABA B Receptor-Induced K + Currents. The Journal of Neuroscience, 37 (5). pp. 1162-1175.

Gaido, C.M., Stone, S., Chopra, A., Thomas, W.R., Le Souëf, P.N., Hales, B.J. and Williams, B. (2016) Immunodominant T-Cell Epitopes in the VP1 Capsid Protein of Rhinovirus Species A and C. Journal of Virology, 90 (23). pp. 10459-10471.

Galvão, V.R., Pavlos, R., McKinnon, E. and Guitart, M.C.C. (2016) Overrepresentation of a Class II HLA haplotype in severe hypersensitivity Type I reactions To carboplatin. In: 7th Drug Hypersensitivity Meeting (DHM) 2016, 21 - 23 April 2016, Malaga, Spain.

Galvão, V.R., Phillips, E., Giavina-Bianchi, P. and Castells, M.C. (2016) Carboplatin-allergic patients undergoing desensitization: prevalence and impact of the BRCA 1/2 mutation. The Journal of Allergy and Clinical Immunology: In Practice, 5 (3). pp. 816-818.

Gaudieri, S. (2016) T cells: TCR sequencing, transcriptomics and transfectomas. In: Science on the Swan Post Conference Workshop: Cutting Edge tools: from populations to signal cell., 6 May 2016, Perth, WA.

Gaudieri, S., Chopra, A., Leary, S., Clark, H., Mallal, S., Baraki, B., Brockman, M., Brumme, Z.L. and John, M. (2016) Identifying sites of “Deep Conservation" in HIV-1 for vaccine immunogen design. In: Science on the Swan 2016, 2 - 5 May 2016, Perth, Western Australia.

Gimeno Brias, S., Stack, G., Stacey, M.A., Redwood, A.J. and Humphreys, I.R. (2016) The role of IL-22 in viral infections: Paradigms and paradoxes. Frontiers in Immunology, 7 .

Gitschlag, B.L., Kirby, C.S., Samuels, D.C., Gangula, R.D., Mallal, S.A. and Patel, M.R. (2016) Homeostatic Responses Regulate Selfish Mitochondrial Genome Dynamics in C. elegans. Cell Metabolism, 24 (1). pp. 91-103.

Harutyunyan, A.S., Giambruno, R., Krendl, C., Stukalov, A., Klampfl, T., Berg, T., Chen, D., Milosevic Feenstra, J.D., Jager, R., Gisslinger, B., Gisslinger, H., Rumi, E., Passamonti, F., Pietra, D., Muller, A.C., Parapatics, K., Breitwieser, F.P., Herrmann, R., Colinge, J., Bennett, K.L., Superti-Furga, G., Cazzola, M., Hammond, E. and Kralovics, R. (2016) Germline RBBP6 mutations in familial myeloproliferative neoplasm. Blood, 127 (3). pp. 362-365.

Herrmann, S., McKinnon, E., Grace, A., Locke, V., Correia, H.ORCID: 0000-0003-2717-2294, Byrnes, M., Chaney, R., Mastaglia, F. and Mallal, S. (2016) A snapshot of neuropsychological health in a “50-Something Aged” cohort of people living with chronic HIV infection. In: Australasian Sexual Health Conference (ASHM) 2016, 14 - 16 November 2016, Adelaide, Australia.

Herrmann, S. and Skinner, M. (2016) HIV and ageing. In: Baker, D. and Bloch, M., (eds.) ASHM HIV management in Australasia. ASHM.

Herrmann, S.E., Grace, A., McKinnon, E., Skinner, M.J., Locke, V., Correia, H.ORCID: 0000-0003-2717-2294, Byrnes, M., Chaney, R. and Mastaglia, F.L. (2016) Moving into the 50+ age demographic: A snapshot of neuropsychological health in a cohort of people living with chronic HIV infection. In: Australasian HIV AIDS Conference 2016, 16 - 18 November 2016, Adelaide, South Australia.

Hu, H., Haas, S.A., Chelly, J., Van Esch, H., Raynaud, M., de Brouwer, A.P.M., Weinert, S., Froyen, G., Frints, S.G M, Laumonnier, F., Zemojtel, T., Love, M.I., Richard, H., Emde, A-K, Bienek, M., Jensen, C., Hambrock, M., Fischer, U., Langnick, C., Feldkamp, M., Wissink-Lindhout, W., Lebrun, N., Castelnau, L., Rucci, J., Montjean, R., Dorseuil, O., Billuart, P., Stuhlmann, T., Shaw, M., Corbett, M.A., Gardner, A., Willis-Owen, S., Tan, C., Friend, K.L., Belet, S., van Roozendaal, K.E.P., Jimenez-Pocquet, M., Moizard, M-P, Ronce, N., Sun, R., O'Keeffe, S., Chenna, R., van Bömmel, A., Göke, J., Hackett, A., Field, M., Christie, L., Boyle, J., Haan, E., Nelson, J., Turner, G., Baynam, G., Gillessen-Kaesbach, G., Müller, U., Steinberger, D., Budny, B., Badura-Stronka, M., Latos-Bieleńska, A., Ousager, L.B., Wieacker, P., Rodríguez Criado, G., Bondeson, M-L, Annerén, G., Dufke, A., Cohen, M., Van Maldergem, L., Vincent-Delorme, C., Echenne, B., Simon-Bouy, B., Kleefstra, T., Willemsen, M., Fryns, J-P, Devriendt, K., Ullmann, R., Vingron, M., Wrogemann, K., Wienker, T.F., Tzschach, A., van Bokhoven, H., Gecz, J., Jentsch, T.J., Chen, W., Ropers, H-H and Kalscheuer, V.M. (2016) X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes. Molecular Psychiatry, 21 (1). pp. 133-148.

Jing, L., Laing, K.J., Dong, L., Russell, R.M., Barlow, R.S., Haas, J.G., Ramchandani, M.S., Johnston, C., Buus, S., Redwood, A.J., White, K.D., Mallal, S.A., Phillips, E.J., Posavad, C.M., Wald, A. and Koelle, D.M. (2016) Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses. The Journal of Immunology, 196 (5). pp. 2205-2218.

John, M. (2016) Allergen-specific IgE. Medical Forum (WA), August .

John, M. (2016) Host-pathogen adaptation and evolutionary analyses. In: Science on the Swan Post Conference Workshop: Cutting Edge tools: from populations to signal cell., 6 May 2016, Perth, WA.

John, M., Gaudieri, S., Chopra, A., Leary, S., Jorritsma, J., Mallal, S., Baraki, B., Brockman, M.A. and Brumme, Z.L. (2016) HIV-1 residues under strong functional constraint are predicted by measures of evolutionary rather than population-level genetic conservation. In: 25th Conference of the Canadian Association for HIV Research (CAHR) 2016, 12-15 May 2016, Winnipeg, Manitoba, Canada.

Jones, A.P., Kermode, A.G., Lucas, R.M., Carroll, W.M., Nolan, D. and Hart, P.H. (2016) Circulating immune cells in multiple sclerosis. Clinical & Experimental Immunology, 187 (2). pp. 193-203.

Jorgensen, A., O’Leary, P., James, I., Skeaff, S. and Sherriff, J. (2016) Assessment of breast milk iodine concentrations in lactating women in Western Australia. Nutrients, 8 (11). p. 699.

Kermode, A. (2016) Early treatment of MS. In: 15th Asian and Oceanian Congress of Neurology (AOCN), 18 - 21 August 2016, Kuala Lumpur, Malaysia.

Kermode, A. (2016) Is there such a thing as benign MS? In: Australian and New Zealand Association of Neurologists (ANZAN) Annual Scientific Meeting, 24 - 27 May 2016, Perth, WA.

Knezevic, B., Sprigg, D., Seet, J., Trevenen, M., Trubiano, J., Smith, W., Jeelall, Y., Vale, S., Loh, R., McLean-Tooke, A. and Lucas, M. (2016) The revolving door: Antibiotic allergy labelling in a tertiary care centre. Internal Medicine Journal, 46 (11). pp. 1276-1283.

Konvinse, K.C., Phillips, E.J., White, K.D. and Trubiano, J.A. (2016) Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity. Current Opinion in Infectious Diseases, 29 (6). pp. 561-576.

Konvinse, K.C., White, K., Pavlos, R., Redwood, A., Trubiano, J., Ergen, E., Mallal, S.A. and Phillips, E.J. (2016) Allergic Mechanisms: Characterizing immune responses in severe T-cell mediated adverse drug reaction. In: American Association of Immunologists Conference, (AAI) 2016, 13 - 17 May 2016, Seattle, USA.

Konvinse, K.C., White, K., Pavlos, R., Redwood, A., Trubiano, J., Ergen, E., Mallal, S.A. and Phillips, E.J. (2016) Characterizing immune responses in severe T-cell mediated adverse drug reaction. The Journal of Immunology, 196 (Supp. 1).

Leary, S., Cooper, D., Chopra, A., Watson, M.ORCID: 0000-0002-6438-9225 and Mallal, S. (2016) Analysis and visualisation tools for NGS sequence data. In: Science on the Swan 2016, 2 - 5 May 2016, Perth, Western Australia.

Lu, T.T., Dai, Y.Q., Wang, Y.G., Fang, L., Li, R., Kermode, A.G. and Qju, W. (2016) Rapid exacerbation of neuromyelitis optica after rituximab treatment. Multiple Sclerosis Journal, 22 (3). p. 440.

Lucas, M., Jeelall, Y., Kavanagh, S., Bundell, C., Hew, M., Wood, B.A., Joske, D. and McLean-Tooke, A. (2016) B-cell small lymphocytic lymphoma associated with extremely high total IgE and cutaneous vasculitis. The Journal of Allergy and Clinical Immunology: In Practice, 4 (3). pp. 552-554.

Magaret, A., Dong, L., John, M., Mallal, S.A., James, I., Warren, T., Gaudieri, S., Koelle, D.M. and Wald, A. (2016) HLA Class I and II alleles, heterozygosity and HLA-KIR interactions are associated with rates of genital HSV shedding and lesions. Genes and Immunity, 17 (7). pp. 412-418.

Mallal, S. (2016) Putting together core technologies for your AdVANTAGE. In: PMI Research Retreat, 30 January 2016, Student Life Center, Vanderbuilt University, Nashville.

Mallal, S. (2016) Role of heterologous immunity in transplant rejection and other experiments of man. In: Division of Hematology/Oncology Hematology Grand Rounds, 30 March 2016, Vanderbilt University, Nashville.

Mallal, S. (2016) T Cells behaving badly: Evolution to population to single cells. In: ID Grand Rounds, 10 March 2016, Vanderbilt University, Nashville.

Maxwell, S., James, I., Dickinson, J.E. and O'Leary, P. (2016) First trimester screening cut-offs for noninvasive prenatal testing as a contingent screen: Balancing detection and screen-positive rates for trisomy 21. Australian and New Zealand Journal of Obstetrics and Gynaecology, 56 (1). pp. 29-35.

Mbae, C., Mulinge, E., Guleid, F., Wainaina, J., Waruru, A., Njiru, Z.K. and Kariuki, S. (2016) Molecular characterization of Giardia duodenalis in children in Kenya. BMC Infectious Diseases, 16 (1).

McKay, F.C., Gatt, P.N., Fewings, N., Parnell, G.P., Schibeci, S.D., Basuki, M.A.I., Powell, J.E., Goldinger, A., Fabis-Pedrini, M.J., Kermode, A.G., Burke, T., Vucic, S., Stewart, G.J. and Booth, D.R. (2016) The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies. Clinical Immunology, 163 . pp. 96-107.

McKinnon, E., Castley, A., Payne, L., Pummer, S. and Nolan, D. (2016) Determinants of residual viraemia during combination HIV treatment: Impacts of baseline HIV RNA levels and treatment choice. HIV Medicine, 17 (7). pp. 495-504.

Morabito, K.M., Ruckwardt, T.R., Redwood, A.J., Moin, S.M., Price, D.A. and Graham, B.S. (2016) Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung. Mucosal Immunology, 10 . pp. 545-554.

Murphy, A.A., Redwood, A.J. and Jarvis, M.A. (2016) Self-disseminating vaccines for emerging infectious disease. Expert Review of Vaccines, 15 (1). pp. 31-39.

Murphy, N.M., Burton, M., Powell, D.R., Rossello, F.J., Cooper, D., Chopra, A., Hsieh, M.J., Sayer, D.C., Gordon, L., Pertile, M.D., Tait, B.D., Irving, H.R. and Pouton, C.W. (2016) Haplotyping the human leukocyte antigen system from single chromosomes. Scientific Reports, 6 . p. 30381.

Needham, M. and Mastaglia, F.L. (2016) Sporadic inclusion body myositis: A review of recent clinical advances and current approaches to diagnosis and treatment. Clinical Neurophysiology, 127 (5). pp. 1764-1773.

Nolan, D. (2016) New tools to investigate Multiple Sclerosis. In: Science on the Swan Post Conference Workshop: Cutting Edge tools: from populations to signal cell., 6 May 2016, Perth, WA.

O'Grady, G.L., Ma, A., Sival, D., Wong, M.T.Y., Peduto, T., Menezes, M.P., Young, H., Waddell, L., Ghaoui, R., Needham, M., Lek, M., North, K.N., MacArthur, D.G., van Ravenswaaij-Arts, C.M.A. and Clarke, N.F. (2016) Prominent scapulae mimicking an inherited myopathy expands the phenotype of CHD7-related disease. European Journal of Human Genetics, 24 (8). pp. 1216-1219.

Pasi, K.J., Fischer, K., Ragni, M., Nolan, B., Perry, D.J., Kulkarni, R., Ozelo, M., Mahlangu, J., Shapiro, A.D., Baker, R.I., Bennett, C.M., Barnes, C., Oldenburg, J., Matsushita, T., Yuan, H., Ramirez-Santiago, A., Pierce, G.F., Allen, G. and Mei, B. (2016) Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia B. Thrombosis and Haemostasis, 117 (3). pp. 508-518.

Pavlos, R., McKinnon, E., Ostrov, D., Peters, B., Buus, S., Koelle, D., Chopra, A., Rive, C., Redwood, A., Restrepo, S., Bracey, A., Yuan, J., Gaudieri, S., Carrington, M., Haas, D., Mallal, S. and Phillips, E. (2016) Specific binding characteristics Of HLA Alleles associated with nevirapine hypersensitivity. In: 7th Drug Hypersensitivity Meeting (DHM) 2016, 21 - 23 April 2016, Malaga, Spain.

Pavlos, R., Strautins, K., James, I., Mallal, S., Redwood, A.J. and Phillips, E. (2016) Variation in EraP Influencees Risk for HLA-B*57:01 positive abacavir hypersensitivity. In: 23rd Conference on Retroviruses and Opportunistic Infections (CROI) 2016, 22 - 25 February 2016, Boston, MA.

Pham, J., Oseroff, C., Hinz, D., Sidney, J., Paul, S., Greenbaum, J., Vita, R., Phillips, E., Mallal, S., Peters, B. and Sette, A. (2016) Sequence conservation predicts T cell reactivity against ragweed allergens. Clinical & Experimental Allergy, 46 (9). pp. 1194-1205.

Phillips, E. (2016) Improving phenotypic precision & using pharmacogenomics to understand mechanisms of drug hypersensitivity reactions. In: Science on the Swan Post Conference Workshop: Cutting Edge tools: from populations to signal cell., 6 May 2016, Perth, WA.

Phillips, E. (2016) Improving the prediction of drug action. In: ASCPT, 8 - 12 March 2016, San Diego, USA.

Phillips, E. (2016) Pharmacogenomics in drug hypersensitivity practice. In: 7th Drug Hypersensitivity Meeting (DHM) 2016, 21 - 23 April 2016, Malaga, Spain.

Phillips, E. (2016) TPS 10 Anaphylaxis in drug hypersensitivity and LB TPS 9 Drug Allergy II. In: European Academy of Allergy and Clinical Immunology Congress (EAACI), 11 - 15 June 2016, Vienna, Austria.

Phillips, E. (2016) Translational drug safety: Predicting and preventing severe immunologically-mediated drug reactions. In: Drug Safety Gordon Research Conference 2016, 26 June - 1 July 2016, Stonehill College, Easton, Massachussetts.

Phillips, E. (2016) Utility of HLA in Pharmacogenomic testing. In: IGNITE Meeting, 27 January 2016, Nashville, Tennessee.

Phillips, E.J. (2016) Classifying ADRs - Does dose matter? British Journal of Clinical Pharmacology, 81 (1). pp. 10-12.

Redwood, A., White, K., Strautins, K., Chopra, A., Konvinse, K., Leary, S., Pavlos, R., Mallal, S. and Phillips, E. (2016) Single cell analysis of drug responsive T cells; identification of candidate drug reactive T cell receptors in abacavir and carbamazepine hypersensitivity. In: 7th Drug Hypersensitivity Meeting (DHM) 2016, 21 - 23 April 2016, Malaga, Spain.

Redwood, A.J., Trubiano, J.A., Pavlos, R., Woolnough, E., Strautins, K., Chang, C. and Phillips, E. (2016) Enzyme linked Immunospot assay used in the diagnosis of severe cutaneous adverse reactions to antimicrobials. In: 7th Drug Hypersensitivity Meeting (DHM) 2016, 21 - 23 April 2016, Malaga, Spain.

Rive, Craig (2016) The immunopathogenesis of drug hypersensitivity. PhD thesis, Murdoch University.

Rueter, K., Ta, B., Bear, N., Lucas, M. and Prescott, S. (2016) Physician training programs significantly improve diagnosis in cases coded as anaphylaxis over time: A major factor compounding time-trend data? The Journal of Allergy and Clinical Immunology: In Practice . In Press.

Schulte, B.M., Gielen, P.R., Kers-Rebel, E.D., Prosser, A.C., Lind, K., Flodström-Tullberg, M., Tack, C.J., Elving, L.D. and Adema, G.J. (2016) Enterovirus exposure uniquely discriminates type 1 diabetes patients with a homozygous from a heterozygous melanoma differentiation-associated protein 5/interferon induced with helicase C domain 1A946T genotype. Viral Immunology, 29 (7). pp. 389-397.

Simeoni, I., Stephens, J.C., Hu, F., Deevi, S.V.V., Megy, K., Bariana, T.K., Lentaigne, C., Schulman, S., Sivapalaratnam, S., Vries, M.J.A., Westbury, S.K., Greene, D., Papadia, S., Alessi, M-C, Attwood, A.P., Ballmaier, M., Baynam, G., Bermejo, E., Bertoli, M., Bray, P.F., Bury, L., Cattaneo, M., Collins, P., Daugherty, L.C., Favier, R., French, D.L., Furie, B., Gattens, M., Germeshausen, M., Ghevaert, C., Goodeve, A.C., Guerrero, J.A., Hampshire, D.J., Hart, D.P., Heemskerk, J.W.M., Henskens, Y.M.C., Hill, M., Hogg, N., Jolley, J.D., Kahr, W.H., Kelly, A.M., Kerr, R., Kostadima, M., Kunishima, S., Lambert, M.P., Liesner, R., Lopez, J.A., Mapeta, R.P., Mathias, M., Millar, C.M., Nathwani, A., Neerman-Arbez, M., Nurden, A.T., Nurden, P., Othman, M., Peerlinck, K., Perry, D.J., Poudel, P., Reitsma, P., Rondina, M.T., Smethurst, P.A., Stevenson, W., Szkotak, A., Tuna, S., van Geet, C., Whitehorn, D., Wilcox, D.A., Zhang, B., Revel-Vilk, S., Gresele, P., Bellissimo, D.B., Penkett, C.J., Laffan, M.A., Mumford, A.D., Rendon, A., Gomez, K., Freson, K., Ouwehand, W.H. and Turro, E. (2016) A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders. Blood, 127 (23). pp. 2791-2803.

St Pierre, T.G., House, M.J., Bangma, S.J., Pang, W., Bathgate, A., Gan, E.K., Ayonrinde, O.T., Bhathal, P.S., Clouston, A., Olynyk, J.K. and Adams, L.A. (2016) Stereological analysis of liver biopsy histology sections as a reference standard for validating Non-Invasive liver fat fraction measurements by MRI. PLoS ONE, 11 (8). e0160789.

Stone, C.A., Hemler, J.A., Commins, S.P., Schuyler, A.J., Phillips, E.J., Peebles, R.S. and Fahrenholz, J.M. (2016) Anaphylaxis after zoster vaccine: Implicating alpha-gal allergy as a possible mechanism. Journal of Allergy and Clinical Immunology, 139 (5). pp. 1710-1713.

Symons, J., Chopra, A., Malantinkova, E., De Spiegelaere, W. and Leary, S. (2016) Integration analysis of latently infected cell lines: Evidence of ongoing replication. In: 23rd Conference on Retroviruses and Opportunistic Infections (CROI), 20-25 February 2016, Boston, MA.

Symons, J., Lewin, S.R., Chopra, A., Malantinkova, E., De Spiegelaere, W., Leary, S., Cooper, D., Vandekerckhove, L., Mallal, S. and Cameron, P. (2016) Integration site analysis of latently infected cell lines: evidence of ongoing replication. In: Science on the Swan 2016, 2 - 5 May 2016, Perth, Western Australia.

Thompson, G., John, M. and Chopra, A. (2016) Triple threats: Tracking antigen-specific T cells in a case of concurrent autoimmunity, infectious disease and possible malignancy. Pathology, 48 (Supp. 1). S44.

Trubiano, J.A., Beekmann, S.E., Polgren, P.M., Worth, L.J., Grayson, M.L. and Phillips, E.J. (2016) Antibiotic allergy De-Labeling: Teaching an old dog new tricks. Journal of Allergy and Clinical Immunology, 137 (2). AB398.

Trubiano, J.A., Beekmann, S.E., Worth, L.J., Polgreen, P.M., Thursky, K.A., Slavin, M.A., Grayson, M.L. and Phillips, E.J. (2016) Improving antimicrobial stewardship by antibiotic allergy delabeling: Evaluation of knowledge, attitude, and practices throughout the emerging infections network. Open Forum Infectious Diseases, 3 (3).

Trubiano, J.A., Redwood, A., Strautins, K., Pavlos, R., Woolnough, E., Chang, C.C. and Phillips, E. (2016) Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis. The Journal of Allergy and Clinical Immunology: In Practice, 5 (3). pp. 823-826.

Trubiano, J.A., Worth, L.J., Urbancic, K., Brown, T.M., Paterson, D.L., Lucas, M. and Phillips, E. (2016) Return to Sender: The need to re-address patient antibiotic allergy labels in Australia and New Zealand. Internal Medicine Journal, 46 (11). pp. 1311-1317.

Tschochner, M., Leary, S., Cooper, D., Strautins, K., Chopra, A., Clark, H., Choo, L., Dunn, D., James, I., Carroll, W.M., Kermode, A.G. and Nolan, D. (2016) Identifying Patient-Specific Epstein-Barr nuclear antigen-1 genetic variation and potential autoreactive targets relevant to multiple sclerosis pathogenesis. PloS one, 11 (2).

Tschochner, M., Strautins, K., James, I., Leary, S., Choo, L., Clark, H., Dunn, D., Chopra, A., Cooper, D., Kermode, A., Carroll, W. and Nolan, D. (2016) Contribution of EBV infection to Multiple Sclerosis Pathogenesis: Human leukocyte antigen restricted, EBV epitope-specific T cell responses in Multiple Sclerosis. In: Science on the Swan 2016, 2 - 5 May 2016, Perth, Western Australia.

Watson, M.ORCID: 0000-0002-6438-9225 (2016) Development and challenges of HLA typing using NGS in a research and clinical setting. In: 6th NGS Asia Congress, 4th Single Cell Analysis Asia Congress and 3rd Microbiology Asia Congress, 11 - 12 October 2016, Concorde Hotel, Singapore.

Weiskopf, D., Angelo, M.A., Grifoni, A., O'Rourke, P.H., Sidney, J., Paul, S., De Silva, A.D., Phillips, E., Mallal, S., Premawansa, S., Premawansa, G., Wijewickrama, A., Peters, B. and Sette, A. (2016) HLA-DRB1 alleles are associated with different magnitudes of dengue Virus–Specific CD4+T-Cell responses. Journal of Infectious Diseases, 214 (7). pp. 1117-1124.

White, K., Redwood, A., Jing, L., Konvinse, K., Pavlos, R., Koelle, D., Mallal, S. and Phillips, E. (2016) Isolation of activated CD8+ T cells following drug stimulation: A first step toward evaluating the heterologous immunity model for pure T-cell mediated adverse drug reactions. In: American Society for Clinical Investigation (ASCI) Meeting, 15 - 17 April 2016, Chicago, IL.

White, K.D., Konvinse, K., Pilkington, M., Barnett, L., Gangula, R., Redwood, A., Pavlos, R., Chopra, A., Mallal, S. and Phillips, E. (2016) Characterization of TCR repertoire diversity and tissue distribution of drug-specific T cells in DRESS. In: 16th Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS) 2016, 22 - 26 June 2016, Boston, MA.

von Delft, A., Humphreys, I.S., Brown, A., Pfafferott, K., Lucas, M., Klenerman, P., Lauer, G.M., Cox, A.L., Gaudieri, S. and Barnes, E. (2016) The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design. Gut, 65 (1). pp. 112-123.

2015

Abraham, M.B., Carpenter, K., Baynam, G.S., Mackay, D.J.G., Price, G. and Choong, C.S. (2015) Report and review of described associations of Mayer-Rokitansky-Küster-Hauser syndrome and Silver-Russell syndrome. Journal of Paediatrics and Child Health, 51 (5). pp. 555-560.

Adams, L.A., Crawford, D.H., St Pierre, T.G. and Olynyk, J.K. (2015) Reply: Does the Death Knell Toll for Phlebotomy in NAFLD? Hepatology, 62 (6). pp. 1921-1922.

Adams, L.A., Crawford, D.H., Stuart, K., House, M.J., St Pierre, T.G., Webb, M., Ching, H.L.I., Kava, J., Bynevelt, M., MacQuillan, G.C., Garas, G., Ayonrinde, O.T., Mori, T.A., Croft, K.D., Niu, X., Jeffrey, G.P. and Olynyk, J.K. (2015) The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial. Hepatology, 61 (5). pp. 1555-1564.

Affandi, J.S., Montgomery, J., Brunt, S.J., Nolan, D. and Price, P. (2015) The immunological footprint of CMV in HIV-1 patients stable on long-term ART. Immunity & Ageing, 12 (1).

Alvarez Palomo, A.B., McLenachan, S., Chen, F.K., Da Cruz, L., Dilley, R.J., Requena, J., Lucas, M., Lucas, A., Drukker, M. and Edel, M.J. (2015) Prospects for clinical use of reprogrammed cells for autologous treatment of macular degeneration. Fibrogenesis & Tissue Repair, 8 (1).

Anderton, R.S. and Mastaglia, F.L. (2015) Advances and challenges in developing a therapy for spinal muscular atrophy. Expert Review of Neurotherapeutics, 15 (8). pp. 895-908.

Bartlett, J., Mocroft, A., Lundgren, J.D., Ross, M., Law, M., Reiss, P., Kirk, O., Smith, C., Wentworth, D., Neuhaus, J., Fux, C.A., Moranne, O., Morlat, P., Johnson, M.A., Ryom, L. and Nolan, D. (2015) Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study. PLoS Medicine, 12 (3). e1001809.

Baynam, G., Walters, M., Claes, P., Kung, S., LeSouef, P., Dawkins, H., Bellgard, M., Girdea, M., Brudno, M., Robinson, P., Zanki, A., Groza, T., Gillet, D. and Goldblatt, J. (2015) Phenotyping: Targeting genotype's rich cousin for diagnosis. Journal of Paediatrics and Child Health, 51 (4). pp. 381-386.

Bernard, R., Chopra, A., James, I., Cooper, D., Blinco, J., Watson, M.ORCID: 0000-0002-6438-9225, Jabara, C., Lemon, S., Mallal, S. and Gaudieri, S. (2015) Ultra-deep sequencing reveals dynamics of drug Resistance-Associated variants in Hepatitis C viruses: Relevance to treatment outcome and resistance screening. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Bourke, J., Pavlos, R., James, I. and Phillips, E. (2015) Improving the effectiveness of penicillin allergy De-labeling. The Journal of Allergy and Clinical Immunology: In Practice, 3 (3). pp. 365-374.

Broadley, S.A., Barnett, M.H., Boggild, M., Brew, B.J., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A.G., Lechner-Scott, J., Macdonell, R.A.L., Marriott, M., Mason, D.F., Parratt, J., Reddel, S.W., Shaw, C.P., Slee, M., Spies, J.M., Taylor, B.V., Carroll, W.M., Kilpatrick, T.J., King, J., McCombe, P.A., Pollard, J.D. and Willoughby, E. (2015) A new era in the treatment of multiple sclerosis. The Medical Journal of Australia, 203 (3). pp. 139-141.

Bruyand, M., Ryom, L., Shepherd, L., Fatkenheuer, G., Grulich, A., Reiss, P., De Wit, S., d´Arminio Monforte, A., Furrer, H., Pradier, C., Lundgren, J., Sabin, C. and Nolan, D. (2015) Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor–based combination antiretroviral therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes, 68 (5). pp. 568-577.

Bull, R.A., Leung, P., Gaudieri, S., Deshpande, P., Cameron, B., Walker, M., Chopra, A., Lloyd, A.R. and Luciani, F. (2015) Transmitted/founder viruses rapidly escape from CD8+T cell responses in acute hepatitis C virus infection. Journal of Virology, 89 (10). pp. 5478-5490.

Carey, D., Puls, R., Amin, J., Losso, M., Phanupak, P., Foulkes, S., Mohapi, L., Crabtree-Ramirez, B., Jessen, H., Kumar, S., Winston, A., Lee, M.P., Belloso, W., Cooper, D.A., Emery, S. and Nolan, D. (2015) Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study. The Lancet Infectious Diseases, 15 (7). pp. 793-802.

Chan, B., Masters, L., Mitrovic, M., Jonijic, S., Rwandamuriye, F., Shellam, G., Smith, L. and Redwood, A.J. (2015) Acute interactions between the MCMV m15 locus and asialo-GM1+ cells determines viral dissemination to and replication in the salivary glands. In: 8th Australasian Virology Meeting (AVS) 2015, 6 - 9 December 2015, Hunter Valley, NSW.

Chopra, A., Clark, H., Blinco, J., John, M., Watson, M.ORCID: 0000-0002-6438-9225 and Mallal, S. (2015) Identification of clonal TCR expansion using Next Generation Sequencing. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Chopra, A., Gaudieri, S., Clark, H., Blinco, J., Cooper, D., Leary, S., Watson, M.ORCID: 0000-0002-6438-9225 and Mallal, S. (2015) Cutting edge tools for Phenotyping and characterising T-Cell subsets. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Chopra, A., Mpunga, T. and Gaudieri, S. (2015) Differential gene expression profiling of NK cells. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Cooper, D., Chopra, A., Blinco, J., Leary, S., Watson, M.ORCID: 0000-0002-6438-9225 and Mallal, S. (2015) Hybridization based enrichment for genotyping HLA and KIR genes using Next Generation Sequencing. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Cooper, Don (2015) High resolution HLA typing from second generation sequencing data. PhD thesis, Murdoch University.

Creaney, J., Ma, S., Sneddon, S.A., Tourigny, M.R., Dick, I.M., Leon, J.S., Khong, A., Fisher, S.A., Lake, R.A., Lesterhuis, W.J., Nowak, A.K., Leary, S., Watson, M.W.ORCID: 0000-0002-6438-9225 and Robinson, B.W. (2015) Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen. OncoImmunology, 4 (7). e1011492.

Delatycki, M.B., Gurrin, L.C., Ong, S.Y., Ramm, G.A., Anderson, G.J., Olynyk, J.K., Allen, K.J., Nicoll, A.J. and Powell, L.W. (2015) Reduced mortality due to phlebotomy in moderately iron-loaded HFE haemochromatosis? The need for clinical trials. Journal of Hepatology, 63 (1). pp. 282-283.

Duracinsky, M., Armstrong, A., Herrmann, S., Lalanne, C., Galano, E., Da Silva, M.H., Carrieri, P.M. and Chassany, O. (2015) Psychometric Validation of the New International Questionnaire to Assess Health-Related Quality of Life (Hrql) Specific to Viral Hepatitis C: Proqol-Hcv. Value in Health, 18 (7). A591-A592.

Elsegood, C.L., Chan, C.W., Degli-Esposti, M.A., Wikstrom, M.E., Domenichini, A., Lazarus, K., van Rooijen, N., Ganss, R., Olynyk, J.K. and Yeoh, G.C.T. (2015) Kupffer cell-monocyte communication is essential for initiating murine liver progenitor cell-mediated liver regeneration. Hepatology, 62 (4). pp. 1272-1284.

Gang, Q., Bettencourt, C., Machado, P.M., Fox, Z., Brady, S., Healy, E., Parton, M., Holton, J.L., Hilton-Jones, D., Shieh, P.B., Zanoteli, E., De Paepe, B., De Bleecker, J., Shaibani, A., Ripolone, M., Violano, R., Moggio, M., Barohn, R.J., Dimachkie, M.M., Mora, M., Mantegazza, R., Zanotti, S., Hanna, M.G., Houlden, H., Needham, M. and Mastaglia, F. (2015) The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis. Neurobiology of Aging, 36 (4). 1766.e1-1766.e3.

Gerace, K.S., Karlin, E., McKinnon, E. and Phillips, E. (2015) Varying penicillin allergy testing practices in the United States: A time for consensus. The Journal of Allergy and Clinical Immunology: In Practice, 3 (5). pp. 791-793.

Goris, A., Pauwels, I., Gustavsen, M.W., van Son, B., Hilven, K., Bos, S.D., Celius, E.G., Berg-Hansen, P., Aarseth, J., Myhr, K-M, D'Alfonso, S., Barizzone, N., Leone, M.A., Martinelli Boneschi, F., Sorosina, M., Liberatore, G., Kockum, I., Olsson, T., Hillert, J., Alfredsson, L., Bedri, S.K., Hemmer, B., Buck, D., Berthele, A., Knier, B., Biberacher, V., van Pesch, V., Sindic, C., Bang Oturai, A., Sondergaard, H.B., Sellebjerg, F., Jensen, P.E.H., Comabella, M., Montalban, X., Perez-Boza, J., Malhotra, S., Lechner-Scott, J., Broadley, S., Slee, M., Taylor, B., Kermode, A.G., Gourraud, P-A, Sawcer, S.J., Andreassen, B.K., Dubois, B. and Harbo, H.F. (2015) Genetic variants are major determinants of CSF antibody levels in multiple sclerosis. Brain, 138 (3). pp. 632-643.

Groza, T., Kohler, S., Doelken, S., Collier, N., Oellrich, A., Smedley, D., Couto, F.M., Baynam, G., Zankl, A. and Robinson, P.N. (2015) Automatic concept recognition using the Human Phenotype Ontology reference and test suite corpora. Database, 2015 . pp. 1-13.

Hemler, J.A., Phillips, E.J., Mallal, S.A. and Kendall, P.L. (2015) The evolving story of human leukocyte antigen and the immunogenetics of peanut allergy. Annals of Allergy, Asthma & Immunology, 115 (6). pp. 471-476.

Hew, M., McKinnon, E.J., Kirwin, B., Martinez, O.P. and Lucas, M. (2015) Systemic lupus erythematosus patients and tertiary specialist care - simple considerations dropping through the cracks: Osteoporosis monitoring as an example. Internal Medicine Journal, 45 (5). p. 596.

Hew, M., O'Connor, K., Edel, M. and Lucas, M. (2015) The possible future roles for iPSC-Derived therapy for autoimmune diseases. Journal of Clinical Medicine, 4 (6). pp. 1193-1206.

House, M.J., Bangma, S.J., Thomas, M., Gan, E.K., Ayonrinde, O.T., Adams, L.A., Olynyk, J.K. and St Pierre, T.G. (2015) Texture-based classification of liver fibrosis using MRI. Journal of Magnetic Resonance Imaging, 41 (2). pp. 322-328.

Huang, Y., Wang, G., Rowe, D., Wang, Y., Kwok, J.B.J., Xiao, Q., Mastaglia, F., Liu, J., Chen, S-D and Halliday, G. (2015) SNCA Gene, but not MAPT, influences onset age of Parkinson’s Disease in Chinese and Australians. BioMed Research International, 2015 . pp. 1-6.

John, M. (2015) ANA and immune periodicity. In: WA ASCIA Research day, 20 June 2015, The Zoo, South Perth, WA.

John, M. (2015) Antinuclear antibodies. In: Diagnostic Solutions Autoimmunity user group meeting, 5 November 2015, Kogarah, Sydney.

John, M. (2015) CMV quantiferon and antigen-specific monitoring. In: Fiona Stanley Hospital Seminars, 27 October 2010, Haematology Department, Fiona Stanley Hospital, Murdoch.

John, M. (2015) Celiac Disease: New food for thought, Celiac disease and advances in T cell diagnostics. In: ASCIA Educational Seminars, 13 October 2015, Perth, WA.

John, M. (2015) Drug hypersensitivity and abacavir. In: The art of ART meeting, 11 April 2015, Brisbane, Australia.

John, M. (2015) Immune deficiency and autoimmunity updates. In: Rural Health West WEBCAST, 16 October 2015, Perth, WA.

John, M., Gaudieri, S., Chopra, A., Leary, S., Jorritsma, J., Mallal, S., Baraki, B., Brockman, M. and Brumme, Z. (2015) Strong functional constraint at residues in HIV-1 Gag are predicted by measures of evolutionary rather than population-level genetic conservation. In: 8th AIS Conference on HIV Pathogenesis, Treatment & Prevention, 19 - 22 July 2015, Vancouver, Canada.

Johnson, L., Rodrigues, J., Teo, W-P, Walters, S., Stell, R., Thickbroom, G. and Mastaglia, F. (2015) Interactive effects of GPI stimulation and levodopa on postural control in Parkinson's disease. Gait & Posture, 41 (4). pp. 929-934.

Jorritsma, J., Tay, J., Hughes, Q. and Baker, R. (2015) In silico prediction of microRNA binding sites in haemostatic factors. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Keane, N.M., Ma, M.X., Jorritsma, J., Forbes, G. and John, M. (2015) Development of a Novel T cell based assay to aid diagnoses of coeliac disease. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Kongmaroeng, C., Romphruk, A., Puapairoj, C., Leelayuwat, C., Kulski, J.K., Inoko, H., Dunn, D.S. and Romphruk, A.V. (2015) HLA alleles and haplotypes in Burmese (Myanmarese) and Karen in Thailand. Tissue Antigens, 86 (3). pp. 199-204.

Kung, S., Walters, M., Claes, P., LeSouef, P., Goldblatt, J., Martin, A., Balasubramaniam, S. and Baynam, G. (2015) Monitoring of therapy for mucopolysaccharidosis Type I Using dysmorphometric facial phenotypic signatures. JMID Reports, 22 . pp. 99-106.

Köhn-Gaone, J., Gogoi-Tiwari, J., Ramm, G.A., Olynyk, J.K. and Tirnitz-Parker, J.E.E. (2015) The role of liver progenitor cells during liver regeneration, fibrogenesis and carcinogenesis. American Journal of Physiology: Gastrointestinal and Liver Physiology, 310 (3). G143-G154.

Loh, J.T., Gaddy, J.A., Algood, H.M.S., Gaudieri, S., Mallal, S. and Cover, T.L. (2015) Helicobacter pylori adaptation in vivoin response to a high salt diet. Infection and Immunity .

Lui, W., Tay, J., Hughes, Q., Tiao, J. and Baker, R. (2015) MicroRNA-494 promotes thrombosis by targeting multiple coagulation factors. In: 1st International Symposium on Functional Nucleic Acids: From Laboratory to Targeted Molecular Therapy, 26 - 27 November 2015, Murdoch University, Perth.

Luo, Y-B and Mastaglia, F.L. (2015) Dermatomyositis, polymyositis and immune-mediated necrotising myopathies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1852 (4). pp. 622-632.

Mallal, S. and Phillips, E. (2015) Personalizing immunology: The immunopathogenesis of severe T-cell mediated drug hypersensitivity. In: Advances in Personalized Medicine Workshop, 20 April 2015, Institute for Immunology & Infectious Diseases, Murdoch.

Martin, J.H., Phillips, E., Thomas, D. and Somogyi, A.A. (2015) Adding the ‘medicines’ back into personalized medicine to improve cancer treatment outcomes. British Journal of Clinical Pharmacology, 80 (5). pp. 929-931.

Mastaglia, F.L. and Needham, M. (2015) Inclusion body myositis: A review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches. Journal of Clinical Neuroscience, 22 (1). pp. 6-13.

McKay, F., Gatt, P.N., Fewings, N., Schibeci, S.D., Parnell, G., Basuki, M.A.I., Powell, J.E., Goldinger, A., Fabis-Pedrini, M.J., Kermode, A.G., Burke, T., Vucic, S., Stewart, G.J. and Booth, D.R. (2015) Characterising the Molecular Phenotypes of MS: heredity, gene expression modules, dysregulated immune cell subsets and response to therapy. Multiple Sclerosis Journal, 21 (14). NP1-NP32.

McWhorter, A.R., Smith, L.M., Shellam, G.R. and Redwood, A.J. (2015) Murine cytomegalovirus strains co-replicate at multiple tissue sites and establish co-persistence in salivary glands in the absence of Ly49H-mediated competition. Journal of General Virology, 96 (Pt.5). pp. 1127-1137.

Metharom, P., Berndt, M.C., Baker, R.I. and Andrews, R.K. (2015) Current state and novel approaches of antiplatelet therapy. Arteriosclerosis, Thrombosis, and Vascular Biology, 35 (6). pp. 1327-1338.

Metushi, I.G., Wriston, A., Banerjee, P., Gohlke, B.O., English, A.M., Lucas, A., Moore, C., Sidney, J., Buus, S., Ostrov, D.A., Mallal, S., Phillips, E., Shabanowitz, J., Hunt, D.F., Preissner, R. and Peters, B. (2015) Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity. PloS one, 10 (5). e0124878.

Needham, M. and Mastaglia, F.L. (2015) Immunotherapies for Immune-Mediated myopathies: A current perspective. Neurotherapeutics, 13 (1). pp. 132-146.

Nolan, D. (2015) HIV Treatment revision: As simple as old versus new. In: Australasian HIV & AIDS (ASHM) Conference 2015, 16 - 18 September 2015, Brisbane, QLD.

Pavlos, R., Rive, C., McKinnon, E., Ostrov, D., Plascensia, P.C., Peters, B., Yuan, J., Gaudieri, S., Haas, D., Mallal, S. and Phillips, E.J. (2015) Specific binding characteristics of HLA alleles associate with nevirapine hypersensitivity. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Pedrini, M.J., Cull, G., Augustson, B.M., Walters, S., Crosbie, C., Carroll, W.M. and Kermode, A.G. (2015) Autologous stem cell transplantation in multiple sclerosis: Results from a single centre. Multiple Sclerosis Journal, 21 (6). p. 806.

Pedrini, M.J.F., Seewann, A., Bennett, K.A., Wood, A.J.T., James, I., Burton, J., Marshall, B.J., Carroll, W.M. and Kermode, A.G. (2015) Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females. Journal of Neurology, Neurosurgery & Psychiatry, 86 (6). pp. 603-607.

Phillips, E. (2015) Current science and translational opportunities in the prediction and prevention of immunologically-mediated adverse drug reactions. In: 54th Annual Meeting Society of Toxicology (SOT) and ToxExpo, 22 - 26 March 2015, San Diego, CA.

Phillips, E. (2015) Defining and prioritizing unmet research needs for a deadly disease. In: Research Directions in Genetically-mediated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN), 3 - 4 March 2015, Rockville, Maryland.

Phillips, E. (2015) HLA and SCARs: What’s new and What’s next? In: 9th International Congress on Cutaneous Adverse Drug Reactions, 8 June 2015, Vancouver, BC, Canada.

Phillips, E. (2015) Personalized approaches to severe immunologically mediated drug reactions: Abacavir hypersensitivity and HLA-B*57:01 as a roadmap for science and translation. In: Advances in Personalized Medicine Workshop, 20 April 2015, Institute for Immunology & Infectious Diseases, Murdoch.

Phillips, E. (2015) Personalized approaches to severe immunologically-mediated drug reactions. In: Future Directions in Personalized Medicine, 5 February 2015, Vanderbilt University, Nashville, Tennessee.

Phillips, E. (2015) Pharmacogenomics of severe adverse reactions to antituberculous medications. In: NIAID Host Response to TB-HIV Infections, 13 - 14 January 2015, Rockville, Maryland.

Phillips, E. (2015) Translational opportunities in the prediction and prevention of drug hypersensitivity. In: Telethon Kids Research Retreat, 29 - 30 October 2015, Rottnest Island, Perth.

Phillips, E. (2015) Understanding and preventing HLA-associated drug reactions. In: PGRN Retreat, 3 - 4 November 2015, San Francisco, USA.

Prosser, A., Pfafferott, K., Deshpande, P., Eule, U., McKinnon, E., Chopra, A., Lucas, A., Gaudieri, S. and Lucas, M. (2015) Using a population based reverse genomics approach to predict HCV vaccine T cell responses. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Qiu, W., Kermode, A.G., Li, R., Dai, Y., Wang, Y., Wang, J., Zhong, X., Li, C., Lu, Z. and Hu, X. (2015) Azathioprine plus corticosteroid treatment in Chinese patients with neuromyelitis optica. Journal of Clinical Neuroscience, 22 (7). pp. 1178-1182.

Redwood, A. (2015) In search of a virotope: Identification of herpesvirus specific CD8 T cells. In: 11th Annual Scientific Workshop, 9 - 11 December 2015, Hunter Valley, NSW.

Redwood, A., Jing, L., Tran, T., White, K., Mallal, S., Koelle, D. and Phillips, E. (2015) In search of a virotope: Identification of herpesvirus specific CD8T cells. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Redwood, A., Lloyd, M., Allan, J. and Scalzo, T. (2015) Obituary: Geoff Shellam (1942–2015). Immunology and Cell Biology, 93 (9). pp. 765-766.

Saito, Y., Stamp, L.K., Caudle, K.E., Hershfield, M.S., McDonagh, E.M., Callaghan, J.T., Tassaneeyakul, W., Mushiroda, T., Kamatani, N., Goldspiel, B.R., Phillips, E.J., Klein, T.E. and Lee, M.T.M. (2015) Clinical pharmacogenetics implementation consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update. Clinical Pharmacology & Therapeutics, 99 (1). pp. 36-37.

Shin, E-C, Pfafferott, K., Deshpande, P., McKinnon, E., Merani, S., Lucas, A., Heckerman, D., Mallal, S., John, M., Gaudieri, S. and Lucas, M. (2015) Anti-Hepatitis C virus T-Cell immunity in the context of multiple exposures to the virus. PloS one, 10 (6). e0130420.

Shoukry, N.H., Lucas, A., Lucas, M., Strhyn, A., Keane, N.M., McKinnon, E., Pavlos, R., Moran, E.M., Meyer-Pannwitt, V., Gaudieri, S., D’Orsogna, L., Kalams, S., Ostrov, D.A., Buus, S., Peters, B., Mallal, S. and Phillips, E. (2015) Abacavir-Reactive memory T Cells are present in drug naïve individuals. PLoS ONE, 10 (2). e0117160.

Silbert, B.I., Heaton, A.E., Cash, R.F.H., James, I., Dunne, J.W., Lawn, N.D., Silbert, P.L., Mastaglia, F.L. and Thickbroom, G.W. (2015) Evidence for an excitatory GABAA response in human motor cortex in idiopathic generalised epilepsy. Seizure, 26 . pp. 36-42.

Smith, R.C., Smith, S.F., Wilson, J., Pearce, C., Wray, N., Vo, R., Chen, J., Ooi, C.Y., Oliver, M., Katz, T., Turner, R., Nikfarjam, M., Rayner, C., Horowitz, M., Holtmann, G., Talley, N., Windsor, J., Pirola, R. and Neale, R. (2015) Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology . In Press.

Sohrabi, H.R.ORCID: 0000-0001-8017-8682, Bates, K.A., Weinborn, M., Bucks, R.S., Rainey-Smith, S.R., Rodrigues, M.A., Bird, S.M., Brown, B.M.ORCID: 0000-0001-7927-2540, Beilby, J., Howard, M., Criddle, A., Wraith, M., Taddei, K., Martins, G., Paton, A., Shah, T., Dhaliwal, S.S., Mehta, P.D., Foster, J.K., Martins, I.J., Lautenschlager, N.T., Mastaglia, F., Laws, S.M. and Martins, R.N. (2015) Bone mineral density, adiposity, and cognitive functions. Frontiers in Aging Neuroscience, 7 . Article 16.

Sterling, T.R., Moro, R.N., Borisov, A.S., Phillips, E., Shepherd, G., Adkinson, N.F., Weis, S., Ho, C. and Villarino, M.E. (2015) Flu-like and other systemic drug reactions among persons receiving weekly rifapentine plus isoniazid or daily isoniazid for treatment of latent tuberculosis infection in the PREVENT tuberculosis study. Clinical Infectious Diseases, 61 (4). pp. 527-535.

Strautins, K., Tschochner, M., James, I., Leary, S., Choo, L., Walters, S., Pedrini, M., Dunn, D., Berry, C., Clark, H., Cooper, D., Kermode, A., Carroll, W. and Nolan, D. (2015) Investigating the role of EBV infection in multiple sclerosis pathogenesis. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Strock, S.B., Gaudieri, S., Mallal, S., Yu, C., Mitchell, D., Cogan, J., Mason, W., Crowe, D. and Loyd, J.E. (2015) Fibrosing mediastinitis complicating prior histoplasmosis is associated with human leukocyte antigen DQB1*04:02 − a case control study. BMC Infectious Diseases, 15 (1).

Symons, J., Lewin, S., Chopra, A., Malatinkova, E., De Spiegelaere, W., Leary, S., Cooper, D., Vandekerckhove, L., Mallal, S. and Cameron, P. (2015) Integration site analysis of latently infected cell lines: evidence of ongoing replication. In: 7th International workshop on HIV Persistence during Therapy, 8 - 11 December 2015, Miami, FL.

Taruscio, D., Groft, S.C., Cederroth, H., Melegh, B., Lasko, P., Kosaki, K., Baynam, G., McCray, A. and Gahl, W.A. (2015) Undiagnosed Diseases Network International (UDNI): White paper for global actions to meet patient needs. Molecular Genetics and Metabolism, 116 (4). pp. 223-225.

Tay, J., James, I., Hughes, Q. and Baker, R.I. (2015) Identification of oestrogen responsive miRNAs associated with regulating coagulation and increased thrombotic risk in pregnant women. In: International Society on Thrombosis and Haemostasis (ISTH) 2015, 20-25 June 2015, Toronto, Canada.

Tay, J., Jorritsma, J., Hughes, Q. and Baker, R. (2015) Probing miR-494 function in coagulation. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Tay, J., Jorritsma, J., Hughes, Q. and Baker, R.I. (2015) In silico Prediction of microRNA Binding Sites in Haemostatic factors. In: International Society on Thrombosis and Haemostasis (ISTH) 2015, 20 - 25 June 2015, Toronto, Canada.

Tay, J., Jorritsma, J., Hughes, Q., Tiao, J. and Baker, R.I. (2015) Platelet activation releases mature miR-494 in microparticles. In: 1st International Symposium on Functional Nucleic Acids: From Laboratory to Targeted Molecular Therapy, 26 - 27 November 2015, Murdoch University, Perth.

Tian, J.ORCID: 0000-0001-9887-7211, Tay, J., Hughes, Q., Tiao, J. and Baker, R.I. (2015) Oestrogen sensitive miR-365a-3p, a new player in regulating tissue factor expression during pregnancy. In: 1st International Symposium on Functional Nucleic Acids: From Laboratory to Targeted Molecular Therapy, 26-27 November 2015, Murdoch University, Perth.

Tiao, J. and Baker, R. (2015) APMAT, A Multi-Centre observational study of patients with microangiopathic thrombocytopenia. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Tseng, A., Seet, J. and Phillips, E.J. (2015) The evolution of three decades of antiretroviral therapy: Challenges, triumphs and the promise of the future. British Journal of Clinical Pharmacology, 79 (2). pp. 182-194.

Vaezeslami, S., Tao, J., Blinco, J., Yu, F., Sinha, R., Heo, S-J, Miller, D.ORCID: 0000-0002-4634-5819, Watson, M.ORCID: 0000-0002-6438-9225, Pitcher, D., Boffelli, D., Quake, S., Weissman, I. and Jenkins, J. (2015) Methods for reduced cost and lower sample prep volumes for genetic analysis applications. In: American Society of Human Genetics (ASHG) 2015 Annual Meeting, 6 - 10 October 2015, Baltimore, MD.

Waugh, C., Cromer, D., Grimm, A., Chopra, A., Mallal, S., Davenport, M. and Mak, J. (2015) A general method to eliminate laboratory induced recombinants during massive, parallel sequencing of cDNA library. Virology Journal, 12 (1).

Wheatley, L.M., Plaut, M., Schwaninger, J.M., Banerji, A., Castells, M., Finkelman, F.D., Gleich, G.J., Guttman-Yassky, E., Mallal, S.A.K., Naisbitt, D.J., Ostrov, D.A., Phillips, E.J., Pichler, W.J., Platts-Mills, T.A.E., Roujeau, J-C, Schwartz, L.B. and Trepanier, L.A. (2015) Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy. Journal of Allergy and Clinical Immunology, 136 (2). 262-271.e2.

White, K.D., Chung, W-H, Hung, S-L, Mallal, S. and Phillips, E.J. (2015) Evolving models of the immunopathogenesis of T cell–mediated drug allergy: The role of host, pathogens, and drug response. Journal of Allergy and Clinical Immunology, 136 (2). pp. 219-234.

Zahedi, A.ORCID: 0000-0002-0165-3797, Paparini, A.ORCID: 0000-0002-1105-5184, Jian, F., King, B., Monis, P., Ball, A., Robertson, I.ORCID: 0000-0002-4255-4752 and Ryan, U.ORCID: 0000-0003-2710-9324 (2015) Identification of Cryptosporidium hominisin Eastern Grey Kangaroo populations in Sydney catchments. In: World Association for the Advancement of Veterinary Parasitology (WAAVP) 2015, 16 - 20 August 2016, Liverpool, England

2014

Anderton, R., Meloni, B., Mastaglia, F. and Boulos, S. (2014) Investigation of a recombinant SMN protein delivery system to treat spinal muscular atrophy. Translational Neuroscience, 5 (1). pp. 8-16.

Apetrei, C., Borges, Á.H., O’Connor, J.L., Phillips, A.N., Baker, J.V., Vjecha, M.J., Losso, M.H., Klinker, H., Lopardo, G., Williams, I., Lundgren, J.D. and John, M. (2014) Factors associated with D-Dimer levels in HIV-Infected individuals. PLoS ONE, 9 (3).

Applegate, T.L., Gaudieri, S., Plauzolles, A., Chopra, A., Grebely, J., Lucas, M., Hellard, M., Luciani, F., Dore, G.J. and Matthews, G.V. (2014) Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C. Antiviral Therapy, 20 (2). pp. 199-208.

Aung, A.K., Haas, D.W., Hulgan, T. and Phillips, E.J. (2014) Pharmacogenomics of antimicrobial agents. Pharmacogenomics, 15 (15). pp. 1903-1930.

Ayonrinde, O.T., Olynyk, J.K., Marsh, J.A., Beilin, Lawrence J., Mori, Trevor A., Oddy, Wendy H. and Adams, Leon A. (2014) Childhood adiposity trajectories and risk of nonalcoholic fatty liver disease in adolescents. Journal of Gastroenterology and Hepatology, 30 (1). pp. 163-171.

Ayonrinde, O.T., Subramaniam, K., Latchmiah, F., Helenius, J.P., Ng, K., Kan, M, Spilsbury, K., Semmens, J., Mukhtar, A., Leahy, M.F. and Olynyk, J.K. (2014) Patterns of aspirin use in the Australian community. Journal of Gastroenterology and Hepatology, 29 (Supp. 2). p. 57.

Baker, R. (2014) Global haemostatic assay assessment of the direct oral anticoagulants. In: HAA (HSANZ, ANZSBT, ASTH), Perth Convention Centre, 19 - 22 October 2014, Perth Convention Centre, WA.

Baker, R. (2014) Interim analysis of the ASTH Anticoagulant Reversal and Events Study (ARES) Collaborative. In: HAA (HSANZ, ANZSBT, ASTH), Perth Convention Centre, 19 - 22 October 2014, Perth Convention Centre, WA.

Baker, R. (2014) Update on Microangiopathic thrombocytopenia - diagnosis and treatment. In: Asian Pacific Society Thrombosis and Haemostasis Scientific Meeting, 9 - 11 October 2014, Hanoi, Vietnam.

Baker, R. and McGregor, S.R. (2014) Does preoperative laboratory monitoring of antithrombotic therapy avoid adverse outcomes in patients undergoing surgery or regional anaesthesia? Anaesthesia and Intensive Care, 42 (5). pp. 555-557.

Bellgard, M., Beroud, C., Parkinson, K., Harris, T., Ayme, S., Baynam, G., Weeramanthri, T., Dawkins, H. and Hunter, A. (2014) Correction: Dispelling myths about rare disease registry system development. Source Code for Biology and Medicine, 9 (1).

Bellgard, M.I., Sleeman, M.W., Guerrero, F.D., Fletcher, S., Baynam, G., Goldblatt, J., Rubinstein, Y., Bell, C., Groft, S., Barrero, R., Bittles, A.H., Wilton, S.D., Mason, C.E. and Weeramanthri, T. (2014) Rare disease research roadmap: Navigating the bioinformatics and translational challenges for improved patient health outcomes. Health Policy and Technology, 3 (4). pp. 325-335.

Black, L.J., Jacoby, P., She Ping-Delfos, W.C., Mori, T.A., Beilin, L.J., Olynyk, J.K., Ayonrinde, O.T., Huang, R.C., Holt, P.G., Hart, P.H., Oddy, W.H. and Adams, L.A. (2014) Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity. Journal of Gastroenterology and Hepatology, 29 (6). pp. 1215-1222.

Broadley, S.A., Barnett, M.H., Boggild, M., Brew, B.J., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A.G., Lechner-Scott, J., Macdonell, R.A.L., Marriott, M., Mason, D.F., Parratt, J., Reddel, S.W., Shaw, C.P., Slee, M., Spies, J., Taylor, B.V., Carroll, W.M., Kilpatrick, T.J., King, J., McCombe, P.A., Pollard, J.D. and Willoughby, E. (2014) Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies. Journal of Clinical Neuroscience, 21 (11). pp. 1835-1846.

Broadley, S.A., Barnett, M.H., Boggild, M., Brew, B.J., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A.G., Lechner-Scott, J., Macdonell, R.A.L., Marriott, M., Mason, D.F., Parratt, J., Reddel, S.W., Shaw, C.P., Slee, M., Spies, J., Taylor, B.V., Carroll, W.M., Kilpatrick, T.J., King, J., McCombe, P.A., Pollard, J.D. and Willoughby, E. (2014) Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy. Journal of Clinical Neuroscience, 21 (11). pp. 1847-1856.

Brusch, A.M., Clarke, R.C., Platt, P.R. and Phillips, E.J. (2014) Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis. British Journal of Clinical Pharmacology, 78 (7). pp. 14-23.

Carlson, J.M., Schaefer, M., Brumme, C., Pfeifer, N., Shapiro, R., Ndung'u, T., Frater, J., Mallal, S., John, M., Heckerman, D., Goulder, P., Brumme, Z. and Hunter, E. (2014) Transmitted escape mutations lead to accelerated HIV-1 disease progression and largely define the relative contribution of HLA Alleles to control. AIDS Research and Human Retroviruses, 30 (S1). A40.

Castley, A., Berry, C.M., French, M., Fernandez, S., Krueger, R. and Nolan, D. (2014) Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: A changing paradigm for routine HIV laboratory monitoring? PLoS ONE, 9 (12). e115226.

Castley, A., Gizzarelli, L., John, M. and Nolan, D. (2014) Monitoring HIV-1 drug resistance mutations among newly diagnosed Western Australian HIV patients. In: 10th Annual Scientific Workshop Australian Centre for HIV and Hepatitis Virology Research (ACH²), 4 - 6 June 2014, Lorne, NSW.

Chikata, T., Carlson, J.M., Tamura, Y., Borghan, M.A., Naruto, T., Hashimoto, M., Murakoshi, H., Le, A.Q., Mallal, S., John, M., Gatanaga, H., Oka, S., Brumme, Z.L. and Takiguchi, M. (2014) Host-Specific adaptation of HIV-1 Subtype B in the Japanese population. Journal of Virology, 88 (9). pp. 4764-4775.

Chua, A.C.G., Divitini, M.L., Trinder, D., Knuiman, M.W. and Olynyk, J.K. (2014) High iron and transferrin saturation levels are associated with increased risks of non-skin cancers in women. Journal of Gastroenterology and Hepatology, 29 (Supp. 2). p. 147.

Cooper, D., Chopra, A., Blinco, J., Sharma, L., Dunn, D., Watson, M.ORCID: 0000-0002-6438-9225 and Mallal, S. (2014) HLA typing from second generation sequencing data – where are we headed? In: Asia Pacific Histocompatibility & Immunogenetics Association Conference, 15 - 19 November 2014, Peter Doherty Institute, Melbourne

Duracinsky, M., Lalanne, C., Goujard, C., Herrmann, S., Cheung-Lung, C., Brosseau, J -P, Schwartz, Y. and Chassany, O. (2014) Electronic versus paper-based assessment of health-related quality of life specific to HIV disease: Reliability study of the PROQOL-HIV questionnaire. Journal of Medical Internet Research, 16 (4).

Duracinsky, M., Leclercq, P., Herrmann, S., Christen, M-O, Dolivo, M., Goujard, C. and Chassany, O. (2014) Safety of poly-L-lactic acid (New-Fill®) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patients. BMC Infectious Diseases, 14 (1). p. 474.

Dwyer, B.J., Olynyk, J.K., Ramm, G.A. and Tirnitz-Parker, J.E.E. (2014) TWEAK and LTβ signaling during chronic liver disease. Frontiers in Immunology, 5 .

Edwards, D.J., Dipietro, L., Demirtas-Tatlidede, A., Medeiros, A.H., Thickbroom, G.W., Mastaglia, F.L., Krebs, H.I. and Pascual-Leone, A. (2014) Movement-generated afference paired with transcranial magnetic stimulation: An associative stimulation paradigm. Journal of NeuroEngineering and Rehabilitation, 11 (1).

Gaudieri, S. (2014) Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C. In: 9th Australasian Viral Hepatitis Conference 2014, 17 - 19 September 2014, Alice Springs, Australia.

Gaylard, E., Lucas, A., Deshpande, P., Lucas, M. and Gaudieri, S. (2014) Identification of new CD4+ T Cell Hepatitis C virus targets: Relevance to infection outcome. In: 24th Annual Combined Biological Sciences Meeting 2014, 29 August 2014, University of Western Australia, Perth.

Gratte, F.D., Olynyk, J.K., Yeoh, G.C.T., Tosh, D., Coombe, D.R. and Tirnitz-Parker, J.E.E. (2014) Serum-free hepatocytic transdifferentiation of pancreatic progenitor cells facilitated by extracellular matrix proteins. Journal of Gastroenterology and Hepatology, 29 (Supp. 2). pp. 6-7.

Holm, M. (2014) Interview administered versus self-administered PROQOL-HIV scale in India. Quality of Life Research, 23 (Supp. 1). pp. 84-85.

James, I. (2014) Assessment of positivity in ELISPOT assays based on FDR-type and mixture procedures. In: 35th Annual Conference of the International Society for Clinical Biostatistics (ISCB 2014), 24 - 28 August 2014, Vienna, Austria.

John, M. (2014) CHIV and the traveller. In: Travel Medicine Alliance National Clinical Meeting, 26 July 2014, Perth, WA.

John, M. (2014) Coeliac disease and immunogenetics. In: GUT School Meeting, 30 January 2014, Perth, WA.

John, M. and Gaudieri, S. (2014) Influence of HIV and HCV on T cell antigen presentation and challenges in the development of vaccines. Frontiers in Microbiology, 5 (art. 514). pp. 1-6.

Kamara, D.A., Ryom, L., Ross, M., Kirk, O., Reiss, P., Morlat, P., Moranne, O., Fux, C.A., Mocroft, A., Sabin, C., Lundgren, J.D., Smith, C.J. and Nolan, D. (2014) Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study. BMC Nephrology, 15 (1).

Kanyenda, L.J., Verdile, G., Martins, R., Meloni, B.P., Chieng, J., Mastaglia, F., Laws, S.M., Anderton, R.S. and Boulos, S. (2014) Is cholesterol and Amyloid-β stress induced CD147 expression a protective response? Evidence that extracellular cyclophilin a mediated neuroprotection is Reliant on CD147. Journal of Alzheimer's disease : JAD, 39 (3). pp. 545-556.

Karlin, E. and Phillips, E. (2014) Genotyping for severe drug hypersensitivity. Current Allergy and Asthma Reports, 14 (3).

Keane, N.M., Almeida, C., Chopra, A., Leary, S., McKinnon, E., Cooper, D., Mallal, S. and John, M. (2014) Viral adaptation in autologous viral sequences of patients with acute and early HIV infection prior to full seroconversion. In: Australian Centre for HIV & Hepatitis Virology Research (ACH2) 5th National Workshop, 3 - 5 June, Terrigal, NSW, Australia

Keane, N.M., Pavlos, R.K., McKinnon, E., Lucas, A., Rive, C., Blyth, C.C., Dunn, D., Lucas, M., Mallal, S. and Phillips, E. (2014) HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity. AIDS, 28 (13). pp. 1891-1901.

Kermode, A.G. (2014) Controversies in NMO. In: 55th Annual Meeting of the Japanese Society of Neurology, 21 - 24 May 2014, Fukuoka, Japan.

Kermode, A.G. (2014) Grey matter and MS: 50 Shades of Grey. In: Novartis Clinical Neurology Symposium, 8 - 9 March 2014, Sydney, NSW.

Kermode, A.G. (2014) Moving beyond conventional markers of Disease Activity to Evaluate MS Progression. In: 7th Annual Meeting PACTRIMS, 6 - 8 November 2014, Taipei, Taiwan.

Kermode, A.G. (2014) Multiple Sclerosis Update. In: RACGP Update. St John of God Hospital, 15 July 2014, Subiaco, WA.

Kermode, A.G. (2014) Natalizumab in real clinical practice. In: 55th Annual Meeting of the Japanese Society of Neurology, 21 - 24 May 2014, Fukuoka, Japan.

Kermode, A.G. (2014) What is new in Multiple Sclerosis. In: An Eye on Inflammation Inaugural Annual Grand Round, 30 July 2014, Harry Perkins Institute, Nedlands.

Lalanne, C., Armstrong, A.R., Herrmann, S., Le Coeur, S., Carrieri, P., Chassany, O. and Duracinsky, M. (2014) Psychometric assessment of health-related quality of life and symptom experience in HIV patients treated with antiretroviral therapy. Quality of Life Research, 24 (6). pp. 1407-1418.

Lalanne, C., Goujard, C., Herrmann, S., Cheung-Lung, C., Schwartz, Y., Armstrong, A., Chassany, O. and Duracinsky, M. (2014) Analysis of response .me in electronic PRO instrument: How could it be used to refine the analysis of health-­‐related quality of life data? In: Medicine 2.0 Conference, 9 - 10 October 2014, Malaga, Spain

Lalanne, C., Herrmann, S., Armstrong, A., Lecoeur, S., Goujard, C., Chassany, O. and Duracinsky, M. (2014) Joint analysis of reported symptoms and health-related quality of life endpoints in HIV patients: A way to improve health care. In: IXème Congrès de Physiologie, Pharmacologie et de Thérapeutique (P2T) 2014, 22 - 24 April 2014, Poitiers, France.

Luo, Y-B, Mastaglia, F.L. and Wilton, S.D. (2014) Normal and aberrant splicing of LMNA. Journal of Medical Genetics, 51 (4). pp. 215-223.

Luo, Y-B, Mitrpant, C., Adams, A.M., Johnsen, R.D., Fletcher, S., Mastaglia, F.L. and Wilton, S.D. (2014) Antisense oligonucleotide induction of progerin in human myogenic cells. PLoS ONE, 9 (6).

Luquetti, D., Claes, P., Liberton, D.K., Daniels, K., Rosana, K.M., Quillen, E.E., Pearson, L.N., McEvoy, B., Bauchet, M., Zaidi, A.A., Yao, W., Tang, H, Barsh, G.S., Absher, D.M., Puts, D.A., Rocha, J., Beleza, S., Pereira, R.W., Baynam, G., Suetens, P., Vandermeulen, D., Wagner, J.K., Boster, J.S. and Shriver, M.D. (2014) Modeling 3D Facial Shape from DNA. PLoS Genetics, 10 (3). e1004224.

Mallal, S. (2014) Experiments of man that shine light on enigmatic immune disease. In: Immunology Seminar. Royal Perth Hospital, 7 July 2014, Perth, WA.

Mallal, S. (2014) Heterologous immune responses and drug hypersensitivity. In: 6th Drug Hypersensitivity Meeting (DHM6), 11 April 2014, Bern, Switzerland.

Mallal, S. (2014) Heterologous immunity: Parallels between transplant rejection and drug hypersensitivitiy. In: Renal Medicine Seminar, 12 December 2014, Vanderbilt University, Nashville.

Mallal, S. (2014) Impact of herpes control on the immune system. In: European Academy of Allergy and Clinical Immunology (EAACI) Congress 2014, 7 - 11 June 2014, Copenhagen, Denmark.

Mallal, S. (2014) Mechanisms of drug hypersensitivity. In: 17th World Congress of Basic & Clinical Pharmacology, 13 - 18 July 2014, Cape Town, South Africa.

Mastaglia, F.L. (2014) Immune-mediated inflammatory myopathies. In: ANZAN 2014 Neurology Conference, 18 - 22 May 2014, Adelaide, SA.

McKinnon, E.J., Chua, A.C.G., Oddy, W., Adams, L.A., Ayonrinde, O.T. and Olynyk, J.K. (2014) Evaluation of serum ferritin as a marker of iron status in young Australian adults. Journal of Gastroenterology and Hepatology, 29 (Supp. 2). p. 146.

McKinnon, E.J., Rossi, E., Beilby, J.P., Trinder, D. and Olynyk, J.K. (2014) Factors that affect serum levels of ferritin in Australian adults and implications for Follow-up. Clinical Gastroenterology and Hepatology, 12 (1). pp. 101-108.

Milpied-Homsi, B., Moran, E.M. and Phillips, E.J. (2014) Antiviral Drug Allergy. Immunology and Allergy Clinics of North America, 34 (3). pp. 645-662.

Moran, E.M. and Mastaglia, F.L. (2014) Cytokines in immune-mediated inflammatory myopathies: Cellular sources, multiple actions and therapeutic implications. Clinical & Experimental Immunology, 178 (3). pp. 405-415.

Moran, E.M. and Mastaglia, F.L. (2014) The role of interleukin-17 in immune-mediated inflammatory myopathies and possible therapeutic implications. Neuromuscular Disorders, 24 (11). pp. 943-952.

Needham, M. and Mastaglia, F.L. (2014) Statin myotoxicity: A review of genetic susceptibility factors. Neuromuscular Disorders, 24 (1). pp. 4-15.

Oh, D., Huh, J.Y., Chong, S.Y., Kim, I-H, Bang, S-M, Jung, C-W, Lee, J-W, Lee, H.G., Lee, S.M., Kim, Y-K, Park, Y., Jang, S.J., Kim, J-S, Jo, D-Y, Zang, D.Y., Yoon, H-J, Yhim, H-Y, Sohn, S.K., Hong, J., Lee, W-S and Baker, R.I. (2014) Similar levels of complement activation in both patients with thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome: The report from the Korean TTP registry. Blood, 124 (21).

O’Connor, K.D.J. and Mastaglia, F.L. (2014) Drug-Induced disorders of the nervous system. In: Aminoff, M.J. and Josephson, S.A., (eds.) Aminoff's Neurology and General Medicine. Academic Press, pp. 685-711.

Palomo, A., Lucas, M., Dilley, R., McLenachan, S., Chen, F., Requena, J., Sal, M., Lucas, A., Alvarez, I., Jaraquemada, D. and Edel, M. (2014) The Power and the Promise of Cell Reprogramming: Personalized Autologous Body Organ and Cell Transplantation. Journal of Clinical Medicine, 3 (2). pp. 373-387.

Pavlos, R. (2014) Mechanistic basis of Antiretroviral HLA - Associated drug hypersensitivities: Nevirapine. In: 10th Annual Scientific Workshop Australian Centre for HIV and Hepatitis Virology Research (ACH²), 4 - 6 June 2014, Lorne, NSW.

Pavlos, R., Mallal, S., Ostrov, D., Pompeu, Y. and Phillips, E. (2014) Fever, rash, and systemic symptoms: Understanding the role of virus and HLA in severe cutaneous drug allergy. The Journal of Allergy and Clinical Immunology: In Practice, 2 (1). pp. 21-33.

Pavlos, R., Rive, C., McKinnon, E., Ostrov, D., Peters, B., Yuan, J., Gaudieri, S., Haas, D., Mallal, S. and Phillips, E. (2014) Specific binding characteristics of HLA alleles associate with Nevirapine hypersensitivity. In: Conference on Retroviruses and Opportunistic Infections (CROI) 2014, 3 - 6 March 2014, Boston, MA.

Payne, R.P., Branch, S., Kloverpris, H., Matthews, P.C., Koofhethile, C.K., Strong, T., Adland, E., Leitman, E., Frater, J., Ndung'u, T., Hunter, E., Haubrich, R., Mothe, B., Edwards, A., Riddell, L., Chen, F., Harrigan, P.R., Brumme, Z.L., Mallal, S., John, M., Jooste, J.P., Shapiro, R., Deeks, S.G., Walker, B.D., Brander, C., Landis, C., Carlson, J.M., Prado, J.G. and Goulder, P.J.R. (2014) Differential escape patterns within the dominant HLA-B*57:03-restricted HIV gag epitope reflect distinct Clade-Specific functional constraints. Journal of Virology, 88 (9). pp. 4668-4678.

Pendyala, G., McManus, H., Petoumenos, K., Franic, T., Kelly, M.D., Watson, J., O’Connor, C.C., Jeanes, M., Hoy, J., Cooper, D.A., Law, M.G. and Nolan, D. (2014) Determinants of suicide and accidental or violent death in the Australian HIV Observational Database. PLoS ONE, 9 (2). e89089.

Phillips, E. (2014) Advances in antibiotic allergy. In: Infectious Diseases Grand Rounds, 24 July 2014, University of Melbourne (Austin Health).

Phillips, E. (2014) Models for prevention of drug hypersensitivity. In: 6th Drug Hypersensitivity Meeting (DHM6), 11 April 2014, Bern, Switzerland.

Phillips, E. (2014) Models for prevention of drug hypersensitivity. In: La Jolla Institute for Allergy & Immunology, 3 September 2014, La Jolla, California.

Phillips, E. (2014) Strategy and policy cohesion: "The one health agenda: will it deliver". In: Anti-microbial resistance: addressing the one health security agenda, Centre on Global Health Security at Chatham House, 9 December 2014, Murdoch University, Perth.

Phillips, E.J. and Mallal, S. (2014) Abacavir pharmacogenomics. In: Murray, M.F., Babyatsky, M.W., Giovanni, M.A., Alkuraya, F.S. and Stewart, D.S., (eds.) Clinical Genomics: Practical Applications in Adult Patient Care. McGraw-Hill Professional.

Prakoso, E., Tirnitz-Parker, J.E.E., Clouston, A.D., Kayali, Z., Lee, A., Gan, E.K., Ramm, G.A., Kench, J.G., Bowen, D.G., Olynyk, J.K., McCaughan, G.W. and Shackel, N.A. (2014) Analysis Of The intrahepatic ductular reaction and progenitor cell responses in hepatitis C virus recurrence Post-Liver transplantation. Liver Transplantation, 20 (12). pp. 1508-1519.

Ranaweera, C.B., Ayonrinde, O.T., Mollison, L., Galhenage, S. and Olynyk, J.K. (2014) Liver ultrasound does not accurately predict transient elastography diagnosed cirrhosis. Journal of Gastroenterology and Hepatology, 29 (Supp. 2). p. 89.

Rath, S.R., Bartley, A., Charles, A., Powers, Neil, Baynam, G., Jones, T., Priest, J.R., Foulkes, W.D. and Choong, C.S.Y. (2014) Multinodular goiter in children: An important pointer to a germline DICER1 mutation. The Journal of Clinical Endocrinology & Metabolism, 99 (6). pp. 1947-1948.

Rive, C., Pavlos, R., Ostrov, D., Plasencia, P., Hung, S-L, Chung, W.H., Peters, B., Buus, S., Mallal, S. and Phillips, E. (2014) HLA class I-drug-T-cell receptor interactions in SJS/TEN. Clinical and Translational Allergy, 4 (Suppl. 3). P2.

Rodríguez Cruz, P.M., Luo, Y-B, Miller, J., Junckerstorff, R.C., Mastaglia, F.L. and Fabian, V. (2014) An analysis of the sensitivity and specificity of MHC-I and MHC-II immunohistochemical staining in muscle biopsies for the diagnosis of inflammatory myopathies. Neuromuscular Disorders, 24 (12). pp. 1025-1035.

Rodríguez Cruz, P.M., Needham, M., Hollingsworth, P., Mastaglia, F.L. and Hillman, D.R. (2014) Sleep disordered breathing and subclinical impairment of respiratory function are common in sporadic inclusion body myositis. Neuromuscular Disorders, 24 (12). pp. 1036-1041.

Schlub, T.E., Grimm, A.J., Smyth, R.P., Cromer, D., Chopra, A., Mallal, S., Venturi, V., Waugh, C., Mak, J. and Davenport, M.P. (2014) Fifteen to Twenty Percent of HIV substitution mutations are associated with recombination. Journal of Virology, 88 (7). pp. 3837-3849.

Shahid, A., Cotton, L., Jessen, H., Markowitz, M., Walker, B.D., Harrigan, P.R., Mallal, S. and John, M. (2014) Impact of HLA-B*13-associated polymorphisms in HIV-1 Gag and Pol on viral replication capacity. In: Keystone conference, 2014, Banff, Alberta.

Simes, John, Becattini, Cecilia, Agnelli, Giancarlo, Eikelboom, John W., Kirby, Adrienne C., Mister, Rebecca, Prandoni, Paolo, Brighton, Timothy A. and Baker, R.I. (2014) Aspirin for the prevention of recurrent venous thromboembolism: The INSPIRE Collaboration. Circulation, 130 (13). pp. 1062-1071.

Smyth, R.P., Schlub, T.E., Grimm, A.J., Waugh, C., Ellenberg, P., Chopra, A., Mallal, S., Cromer, D., Mak, J., Davenport, M.P. and Hahn, B.H. (2014) Identifying Recombination Hot Spots in the HIV-1 Genome. Journal of Virology, 88 (5). pp. 2891-2902.

Snowball, F., Watson, M.ORCID: 0000-0002-6438-9225 and Chopra, A. (2014) Methods for reducing sequence resampling and improving sample enrichment for Human Virome Sequencing. In: 24th Annual Combined Biological Sciences Meeting 2014, 29 August 2014, University of Western Australia, Perth.

Stone, S.F., Phillips, E.J., Wiese, M.D., Heddle, R.J. and Brown, S.G.A (2014) Immediate-type hypersensitivity drug reactions. British Journal of Clinical Pharmacology, 78 (1). pp. 1-13.

Strautins, K. (2014) Adaptive immune responses against Epstein-Barr Virus influencing Multiple Sclerosis risk. In: 24th Annual Combined Biological Sciences Meeting 2014, 29 August 2014, University of Western Australia, Perth.

Strautins, K., Tschochner, M., James, I., Choo, L., Dunn, D., Pedrini, M., Kermode, A., Carroll, W. and Nolan, D. (2014) Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risks. Multiple Sclerosis Journal, 20 (3). pp. 286-294.

Subramaniam, K., Spilsbury, K., Ayonrinde, O.T., Latchmiah, F., Mukhtar, A., Semmens, J., Leahy, M.F. and Olynyk, J.K. (2014) Blood transfusion is associated with increased mortality rate in upper gastrointestinal bleeding. Journal of Gastroenterology and Hepatology, 29 (Supp. 2). pp. 52-53.

Teo, W-P, Rodrigues, J.P., Mastaglia, F.L. and Thickbroom, G.W. (2014) Modulation of corticomotor excitability after maximal or sustainable-rate repetitive finger movement is impaired in Parkinson’s disease and is reversed by levodopa. Clinical Neurophysiology, 125 (3). pp. 562-568.

Thin, L.W.Y., Lawrance, I.C., Spilsbury, K., Kava, J. and Olynyk, J.K. (2014) Detection of liver injury in IBD using transient elastography. Journal of Crohn's and Colitis, 8 (7). pp. 671-677.

Tirnitz-Parker, J.E.E., Olynyk, J.K. and Ramm, G.A. (2014) Role of TWEAK in coregulating liver progenitor cell and fibrogenic responses. Hepatology, 59 (3). pp. 1198-1201.

White, K.D., Gaudieri, S. and Phillips, E.J. (2014) HLA and the Pharmacogenomics of Drug Hypersensitivity. In: Padmanabhan, S., (ed.) Handbook of Pharmacogenomics and Stratified Medicine. Elsevier, pp. 437-465.

Yeap, B.B., Divitini, M.L., Gunton, J.E., Olynyk, J.K., Beilby, J.P., McQuillan, B., Hung, J. and Knuiman, M.W. (2014) Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis. Clinical Endocrinology, 82 (4). pp. 525-532.

2013

Acikyol, B., Graham, R.M., Trinder, D., House, M.J., Olynyk, J.K., Scott, R.J., Milward, E.A. and Johnstone, D.M. (2013) Brain transcriptome perturbations in the transferrin receptor 2 mutant mouse support the case for brain changes in iron loading disorders, including effects relating to long-term depression and long-term potentiation. Neuroscience, 235 . pp. 119-128.

Adams, L.A., White, S.W., Marsh, J.A., Lye, S.J., Connor, K.L., Maganga, R., Ayonrinde, O.T., Olynyk, J.K., Mori, T.A., Beilin, L.J., Palmer, L.J., Hamdorf, J.M. and Pennell, C.E. (2013) Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease. Hepatology, 57 (2). pp. 590-600.

Allan, J., Qui, S., Clark, H., Hofmann, K., Watson, M.ORCID: 0000-0002-6438-9225 and Trinder, D. (2013) Does HCV alter the iron status of infected cells? In: 20th International Symposium on Hepatitis C Virus and Related Viruses, 6-10 October 2013, Melbourne, Australia.

Almeida, C.M., Olney, A., Claas, F., Witt, C., John, M. and D'Orsogna, L.J. (2013) Cross-reactive HIV Specific TCR Clonotypes identified from an HIV-1 infected patient expressing the Protective HLA-B*27:05 Allele: Implications for Protective HIV Immunity? In: Australian Society of Immunology (ASI) Conference, 2 - 4 December 2013, Wellington, NZ.

Apps, R., Qi, Y., Carlson, J.M., Chen, H., Gao, X., Thomas, R., Yuki, Y., Del Prete, G.Q., Goulder, P., Brumme, Z.L., Brumme, C.J., John, M., Mallal, S., Nelson, G. and Bosch, R. (2013) Opposing effects of HLA-C expression level in viral versus inflammatory disease. In: Keystone conference; Immune Activation in HIV Infection: Basic Mechanisms and Clinical Implications (D2), 3 - 8 April 2013, Breckenridge, Colorado.

Apps, R., Qi, Y., Carlson, J.M., Chen, H., Gao, X., Thomas, R., Yuki, Y., Del Prete, G.Q., Goulder, P., Brumme, Z.L., Brumme, C.J., John, M., Mallal, S., Nelson, G., Bosch, R., Heckerman, D., Stein, J.L., Soderberg, K.A., Moody, M.A., Denny, T.N., Zeng, X., Fang, J., Moffett, A., Lifson, J.D., Goedert, J.J., Buchbinder, S., Kirk, G.D., Fellay, J., McLaren, P., Deeks, S.G., Pereyra, F., Walker, B., Michael, N.L., Weintrob, A., Wolinsky, S., Liao, W. and Carrington, M. (2013) Influence of HLA-C expression level on HIV control. Science, 340 (6128). pp. 87-91.

Balloux, F., McLaren, P.J., Coulonges, C., Ripke, S., van den Berg, L., Buchbinder, S., Carrington, M., Cossarizza, A., Dalmau, J., Deeks, S.G., Delaneau, O., De Luca, A., Goedert, J.J., Haas, D., Herbeck, J.T., Kathiresan, S., Kirk, G.D., Lambotte, O., Luo, M., Mallal, S., van Manen, D., Martinez-Picado, J., Meyer, L., Miro, J.M., Mullins, J.I., Obel, N., O'Brien, S.J., Pereyra, F., Plummer, F.A., Poli, G., Qi, Y., Rucart, P., Sandhu, M.S., Shea, P.R., Schuitemaker, H., Theodorou, I., Vannberg, F., Veldink, J., Walker, B.D., Weintrob, A., Winkler, C.A., Wolinsky, S., Telenti, A., Goldstein, D.B., de Bakker, P.I.W., Zagury, J-F and Fellay, J. (2013) Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls. PLoS Pathogens, 9 (7). e1003515.

Bartha, I., Carlson, J.M., Brumme, C.J., McLaren, P.J., Brumme, Z.L., John, M., Haas, D.W., Martinez-Picado, J., Dalmau, J., Lopez-Galindez, C., Casado, C., Rauch, A., Günthard, H.F., Bernasconi, E., Vernazza, P., Klimkait, T., Yerly, S., O'Brien, S.J., Listgarten, J., Pfeifer, N., Lippert, C., Fusi, N., Kutalik, Z., Allen, T.M., Muller, V., Harrigan, P.R., Heckerman, D., Telenti, A. and Fellay, J. (2013) A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control. eLife, 2 . e01123-e01123.

Baynam, G.S., González, C. and Temtamy, S.A. (2013) A boy with hand anomalies similar to those documented with prenatal misoprostol exposure. Middle East Journal of Medical Genetics, 2 (2). pp. 58-62.

Beecham, A.H., Patsopoulos, N.A., Xifara, D.K., Davis, M.F., Kemppinen, A., Cotsapas, C., Shah, T.S., Spencer, C., Booth, D., Goris, A., Oturai, A., Saarela, J., Fontaine, B., Hemmer, B., Martin, C., Zipp, F., D'Alfonso, S., Martinelli-Boneschi, F., Taylor, B., Harbo, H.F., Kockum, I., Hillert, J., Olsson, T., Ban, M., Oksenberg, J.R., Hintzen, R., Barcellos, L.F., Agliardi, C., Alfredsson, L., Alizadeh, M., Anderson, C., Andrews, R., Søndergaard, H.B., Baker, A., Band, G., Baranzini, S.E., Barizzone, N., Barrett, J., Bellenguez, C., Bergamaschi, L., Bernardinelli, L., Berthele, A., Biberacher, V., Binder, T.M.C., Blackburn, H., Bomfim, I.L., Brambilla, P., Broadley, S., Brochet, B., Brundin, L., Buck, D., Butzkueven, H., Caillier, S.J., Camu, W., Carpentier, W., Cavalla, P., Celius, E.G., Coman, I., Comi, G., Corrado, L., Cosemans, L., Cournu-Rebeix, I., Cree, B.A.C., Cusi, D., Damotte, V., Defer, G., Delgado, S.R., Deloukas, P., di Sapio, A., Dilthey, A.T., Donnelly, P., Dubois, B., Duddy, M., Edkins, S., Elovaara, I., Esposito, F., Evangelou, N., Fiddes, B., Field, J., Franke, A., Freeman, C., Frohlich, I.Y., Galimberti, D., Gieger, C., Gourraud, P-A, Graetz, C., Graham, A., Grummel, V., Guaschino, C., Hadjixenofontos, A., Hakonarson, H., Halfpenny, C., Hall, G., Hall, P., Hamsten, A., Harley, J., Harrower, T., Hawkins, C., Hellenthal, G., Hillier, C., Hobart, J., Hoshi, M., Hunt, S.E., Jagodic, M., Jelčić, I., Jochim, A., Kendall, B., Kermode, A., Kilpatrick, T., Koivisto, K., Konidari, I., Korn, T., Kronsbein, H., Langford, C., Larsson, M., Lathrop, M., Lebrun-Frenay, C., Lechner-Scott, J., Lee, M.H., Leone, M.A., Leppä, V., Liberatore, G., Lie, B.A., Lill, C.M., Linden, M., Link, J., Luessi, F., Lycke, J., Macciardi, F., Männistö, S., Manrique, C.P., Martin, R., Martinelli, V., Mason, D., Mazibrada, G., McCabe, C., Mero, I-L, Mescheriakova, J., Moutsianas, L., Myhr, K-M, Nagels, G., Nicholas, R., Nilsson, P., Piehl, F., Pirinen, M., Price, S.E., Quach, H., Reunanen, M., Robberecht, W., Robertson, N.P., Rodegher, M., Rog, D., Salvetti, M., Schnetz-Boutaud, N.C., Sellebjerg, F., Selter, R.C., Schaefer, C., Shaunak, S., Shen, L., Shields, S., Siffrin, V., Slee, M., Sorensen, P.S., Sorosina, M., Sospedra, M., Spurkland, A., Strange, A., Sundqvist, E., Thijs, V., Thorpe, J., Ticca, A., Tienari, P., van Duijn, C., Visser, E.M., Vucic, S., Westerlind, H., Wiley, J.S., Wilkins, A., Wilson, J.F., Winkelmann, J., Zajicek, J., Zindler, E., Haines, J.L., Pericak-Vance, M.A., Ivinson, A.J., Stewart, G., Hafler, D., Hauser, S.L., Compston, A., McVean, G., De Jager, P., Sawcer, S.J. and McCauley, J.L. (2013) Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nature Genetics, 45 (11). pp. 1353-1360.

Bellgard, M., Beroud, C., Parkinson, K., Harris, T., Ayme, S., Baynam, G., Weeramanthri, T., Dawkins, H. and Hunter, A. (2013) Dispelling myths about rare disease registry system development. Source Code for Biology and Medicine, 8 (1). p. 21.

Bronke, C., Almeida, C.M., McKinnon, E., Roberts, S.G., Keane, N.M., Chopra, A., Carlson, J.M., Heckerman, D., Mallal, S. and John, M. (2013) HIV escape mutations occur preferentially at HLA-binding sites of CD8 T-cell epitopes. AIDS, 27 (6). pp. 899-905.

Carlson, J.M., Pfeifer, N., Schaefer, M., Brumme, C., Kreimer, A., DeZiel, C., Tan, V., John, M., Mallal, S., Ndung'u, T., Gilmour, J., Price, M., Lakhi, S., Harrigan, R., Miura, T., Goulder, P., Brumme, Z., Heckerman, D. and Hunter, E. (2013) Adaptation to HLA-I is a primary correlate of HIV-1 disease progression. In: AIDS Vaccine 2013, 7 - 10 October 2013, Barcelona, Spain.

Castley, A. (2013) Monitoring HIV-1 subtype diversity and mobility in the Western Australia HIV cohort - Where are HIV infections coming from and are there forward transmissions? In: Australian Centre for HIV and Hepatitis Virology Research (ACH2) 4th Annual Workshop, 4 - 6 June 2008, Novotel Barossa Valley Resort, South Australia.

Castley, A., Gaudieri, S., Gizzarelli, L., Guelfi, G., John, M. and Nolan, D. (2013) The changing face of HIV-1 diversity in Western Australia - a 12 year analysis. In: 25th Annual Conference of the Australasian Society for HIV Medicine (ASHM) 2013, 21 - 23 October 2013, Darwin, Australia.

Chikata, T., Carlson, J.M., Tamura, Y., Borghan, M.A., Naruto, T., Hashimoto, M., Murakoshi, H., Mallal, S., John, M., Gatanaga, H., Oka, S., Brumme, Z.L. and Takiguchi, M. (2013) HIV-1 polymorphisms associated with 4-Digit HLA alleles in Japanese individuals chronically infected with the Clade B virus. In: AIDS Vaccine 2013, 7 - 10 October 2013, Barcelona, Spain.

Chopra, A. (2013) High throughput HLA sequence-based typing using next generation sequencing. In: Australian Centre for HIV and Hepatitis Virology Research (ACH2) 4th Annual Workshop, 4 - 6 June 2008, Novotel Barossa Valley Resort, South Australia.

Chopra, A., Cooper, D., Sharma, L., Plauzolles, A., Watson, M.ORCID: 0000-0002-6438-9225, Rauch, A., Gaudieri, S. and Mallal, S. (2013) KIR Genotyping using a real time assay and FLX 454. In: 23rd Annual Combined Biological Sciences Meeting (CBSM) 2013, 30 August 2013, University of Western Australia, Perth

Chopra, A., Cooper, D., Sharma, L., Plauzolles, A., Watson, M.W.ORCID: 0000-0002-6438-9225, Rauch, A., Gaudieri, S. and Mallal, S. (2013) KIR genotyping using a real time assay and FLX454. In: 23rd Annual Combined Biological Sciences Meeting (CBSM) 2013, 30 August 2013, University of Western Australia, Perth.

Chopra, A. and Nanjundiah, V. (2013) The precision with which single cells of Dictyostelium discoideum can locate a source of cyclic AMP. Chaos, Solitons & Fractals, 50 . pp. 3-12.

Cooper, D., Chopra, A., Blinco, J., Jabara, C., Lemon, S., Barnard, R., Gaudieri, S., Watson, M.ORCID: 0000-0002-6438-9225 and Mallal, S. (2013) Accurate identification of HCV sequence variants using deep sequencing with a primer ID. In: 9th Annual Scientific Workshop Australian Centre for HIV and Hepatitis Virology Research (ACH2), 5 - 7 June 2013, Katoomba, NSW.

Cooper, D., Chopra, A., Blinco, J., Watson, M.ORCID: 0000-0002-6438-9225, Gaudieri, S. and Mallal, S. (2013) Forensic analysis of mitochondrial DNA mixtures by 454 FLX sequencing. In: 23rd Annual Combined Biological Sciences Meeting (CBSM) 2013, 30 August 2013, University of Western Australia, Perth.

D'Orsogna, L. (2013) Researcher bags HIV study award. Guardian Express, 10 September 2013 .

D'Orsogna, L.J., Nguyen, T.H.O., Claas, F.H.J., Witt, C. and Mifsud, N.A. (2013) Endogenous-peptide-dependent alloreactivity: new scientific insights and clinical implications. Tissue Antigens, 81 (6). pp. 399-407.

Deshpande, P., Lucas, M., Brunt, S., Goulding, M., Hollingsworth, P. and Bundell, C. (2013) Low level autoantibodies are common in a general Australian population. In: Australasian Society of Clinical Immunology and Allergy (ASCIA) 24th Annual Scientific Meeting, 11 - 13 September 2013, Perth, Australia.

Deshpande, P., Pfafferott, K., Lucas, M. and Gaudieri, S. (2013) Cross-genotype immunity in individuals with high-risk HCV exposure. In: 20th International Symposium on Hepatitis C Virus and Related Viruses, 6 - 10 October 2013, Melbourne, VIC.

Graham, R., Delima, R.D., Johnstone, D., Milward, E.A., Olynyk, J.K. and Trinder, D. (2013) Changes in gene expression of cholesterol metabolism pathways in mouse models of haemochromatosis. In: BioIron 2013, 14 - 18 April 2013, University College, London.

Greene, I.D., Mastaglia, F., Meloni, B.P., West, K.A.ORCID: 0000-0002-7036-5334, Chieng, J., Mitchell, C.J., Gai, W-P and Boulos, S. (2013) Evidence that the LRRK2 ROC domain Parkinson's disease-associated mutants A1442P and R1441C exhibit increased intracellular degradation. Journal of Neuroscience Research, 92 (4). pp. 506-516.

Ham, S., Meachem, S.J., Choong, C.S., Charles, A.K., Baynam, G.S., Jones, T.W., Samarajeewa, N.U., Simpson, E.R. and Brown, K.A. (2013) Overexpression of aromatase associated with loss of heterozygosity of the STK11 gene accounts for prepubertal gynecomastia in boys with Peutz-Jeghers Syndrome. Journal of Clinical Endocrinology & Metabolism, 98 (12). E1979-E1987.

Hazeldine, S., Trinder, D. and Olynyk, J.K. (2013) Non-Hfe iron overload: Is Phlebotomy the answer? Current Hepatitis Reports, 12 (1). pp. 20-27.

Herrmann, R., Thom, J., Wood, A., Phillips, M, Muhammad, S. and Baker, R. (2013) Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban. Thrombosis and Haemostasis, 111 (5). pp. 989-995.

Herrmann, S. (2013) Research shows HIV stigma strong. Medical Xpress, 9 October 2013 .

Herrmann, S., McKinnon, E., Hyland, N.B., Lalanne, C., Mallal, S., Nolan, D., Chassany, O. and Duracinsky, M. (2013) HIV-related stigma and physical symptoms have a persistent influence on health-related quality of life in Australians with HIV infection. Health and Quality of Life Outcomes, 11 (1).

Herrmann, S. and O'Leary, C. (2013) Living with HIV takes mental toll. West Australian, 9 October 2013 .

Herrmann, Susan (2013) By virtue of circumstance: HIV/AIDS in mobile and rural populations in Western Australia, an ethnographic study. PhD thesis, Murdoch University.

Hertz, T., Oshansky, C., Roddam, P., DeVincenzo, J., Caniza, M., Jojic, N., Mallal, S., Phillips, E., James, I., Thomas, P., Halloran, M. and Corey, L. (2013) HLA targeting efficiency correlates with human T cell response magnitude and with mortality from influenza A infection. The Journal of Immunology, 190 (Supp. 1). 49.21.

Hertz, T., Oshansky, C.M., Roddam, P.L., DeVincenzo, J.P., Caniza, M.A., Jojic, N., Mallal, S., Phillips, E., James, I., Halloran, M.E., Thomas, P.G. and Corey, L. (2013) HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection. Proceedings of the National Academy of Sciences, 110 (33). pp. 13492-13497.

House, M.J., Gan, E.K., Adams, L.A., Ayonrinde, O.T., Bangma, S.J., Bhathal, P.S., Olynyk, J.K. and St Pierre, T.G. (2013) Diagnostic performance of a rapid magnetic resonance imaging method of measuring hepatic steatosis. PLoS ONE, 8 (3). e59287.

Huang, R-C, Beilin, L.J., Ayonrinde, O., Mori, T.A., Olynyk, J.K., Burrows, S., Hands, B. and Adams, L.A. (2013) Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents. Hepatology, 58 (4). pp. 1306-1314.

James, I. (2013) Host-viral associations: Some statistical immunogenetics issues. In: Biometrics by the Canals: The International Biometric Society, Australasian Region Conference, 1 - 5 December 2013, The Sebel Hotel, Mandurah.

James, I. and McKinnon, E. (2013) Viral diversity attributable to host genotype. In: 34th Annual Conference of the International Society for Clinical Biostatistics (ISCB) 2013, 25 - 29 August 2013, Munich, Germany.

John, M. (2013) Cells could hold key to HIV fight. The Australian, 8 April 2013 .

John, M. (2013) HIV/SIV evolution and vaccine design. In: Perth Immunology Group Conference, 16 October 2013, Perth, WA.

John, M. (2013) HIV: Journey in Deep Time. In: Seminar series. Department of Pathology and Laboratory Medicine (PALM), 19 April 2013, University of Western Australia, Perth.

John, M. (2013) Immunogenetics and celiac disease. In: ASCIA Dinner Meeting, 18 August 2013, Perth, WA.

Johnson, L., James, I., Rodrigues, J., Stell, R., Thickbroom, G. and Mastaglia, F. (2013) Clinical and posturographic correlates of falling in Parkinson's disease. Movement Disorders, 28 (9). pp. 1250-1256.

Johnstone, D., Riveros, C., Heidari, M., Graham, R., Trinder, D., Berretta, R., Olynyk, J., Scott, R., Moscato, P. and Milward, E. (2013) Evaluation of different normalization and analysis procedures for illumina gene expression microarray data involving small changes. Microarrays, 2 (2). pp. 131-152.

Jorritsma, J., Keane, N., Ma, M., Forbes, G. and John, M. (2013) Optimisation of a Novel Assay to Detect Gliadin-Specific T-cells in Celiac Disease. In: 23rd Annual Combined Biological Sciences Meeting (CBSM) 2013, 30 August 2013, University of Western Australia, Perth.

Keane, N., Almeida, C., Chopra, A., Leary, S., Cooper, D., McKinnon, E., Mallal, S. and John, M. (2013) Analysis of HLA-restricted HIV-specific CD8 T cell responses and viral adaptation in patients with acute HIV infection prior to full seroconversion. In: 9th Annual Scientific Workshop Australian Centre for HIV and Hepatitis Virology Research, (ACH²), 5 - 7 June 2013, Katoomba, NSW.

Keane, N., Almeida, C.M., Chopra, A., Cooper, D., Mallal, S. and John, M. (2013) Analysis of HLA-restricted HIV-specific CD8 T cell responses and viral adaptation in patients with acute HIV infection prior to full seroconversion. In: Towards an HIV Cure Symposium IAS Conference, 30 June - 3 July 2013, Kuala Lumpur, Malaysia.

Kermode, A. (2013) Current understanding of pathogenic mechanisms for MS and a novel therapeutic approach. In: Multiple Sclerosis for Healthcare Professionals conference, 14 - 15 September 2013, Sydney, NSW.

Kermode, A., Pedrini, M., Seewann, A., Bennet, K., Marshall, B. and Carroll, W. (2013) Helicobacter pylori infection as a protective factor against multiple sclerosis development in Western Australians. In: European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS) 2013, 2 - 5 October 2013, Copenhagen, Denmark.

Kermode, A.G. (2013) How recently identified MS genes may affect clinical practice. In: Where MS Research and Clinical Practice Meet, 25 November 2013, University Club of Western Australia, Perth.

Kermode, A.G. (2013) Immunotherapy, sex and the whole damn thing. In: Multiple Sclerosis Nurses Association Annual Scientific Meeting, 6 September 2013, Perth, WA.

Kermode, A.G. (2013) Multiple Sclerosis Controversies. In: Australian Society of Immunology and Allergy, Annual Scientific Meeting, 13 September 2013, Perth, WA.

Kermode, A.G. (2013) Multiple Sclerosis: Fact and Fiction. In: RACGP Future Directions in Health Congress 2013, 27 May 2013, Perth, WA.

Kermode, A.G. (2013) Spasticity: A potentially disabling and frequent symptom in MS. In: PACTRIMS 2013, 6 - 8 November 2013, Kyoto, Japan.

Kermode, A.G. (2013) Treatment for the active MS patient: Benefits and risks of Natalizumab use. In: PACTRIMS 2013, 6 - 8 November 2013, Kyoto, Japan.

Lalanne, C., Herrmann, S., Armstrong, A.R., Cheung-Lung, C., Schwartz, Y., Chassany, O. and Duracinsky, M. (2013) Paper-based and electronic assessment of health-related quality of life specific to HIV disease: A reliability study with the Proqol-HIV questionnaire. In: International Society for Pharmacoeconomics and Outcomes Research, 16th Annual European Congress, 2 - 6 November, Dublin, Ireland.

Leary, C. and Baker, R. (2013) Travel boom sparks blood clot warning. West Australian, 7 September 2013 .

Leary, S., Cooper, D., Chopra, A., Watson, M.ORCID: 0000-0002-6438-9225 and Mallal, S. (2013) IIID VGAS - A visual genome analysis studio incorporating high performance next generation sequence analysis. In: 23rd Annual Combined Biological Sciences Meeting (CBSM) 2013, 30 August 2013, University of Western Australia, Perth.

Leary, S., Cooper, D., Chopra, A., Watson, M.ORCID: 0000-0002-6438-9225 and Mallal, S. (2013) IIID VGAS: A visual genome analysis studio incorporating high performance next generation sequence analysis. In: Great Lakes Bioinformatics Conference (GLBIO) 2013, 14 - 16 May 2013, Pittsburgh, PA.

Li, H., Blair, L., Chen, Y., Learn, G., Pfafferott, K., John, M., Bhattacharya, T., Hahn, B.H., Mallal, S., Shaw, G.M. and Bar, K.J. (2013) Molecular mechanisms of HIV Type 1 prophylaxis failure revealed by Single-genome sequencing. Journal of Infectious Diseases, 208 (10). pp. 1598-1603.

Lucas, A., Meyer-Pannwitt, V., McKinnon, E., Burrows, S., Rist, M., Leary, S., Lucas, M., Mallal, S. and Phillips, E. (2013) Abacavir impairs an HLA-B*5701-restricted CD8+ T Cell response to an immunodominant Epstein-Barr virus epitope. In: 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013), 3 - 6 March 2013, Atlanta, Georgia

Lucas, M. and Gaudieri, S. (2013) The role of biomarkers in the prevention of globally important diseases. Biomarkers in Medicine, 7 (3). pp. 331-332.

Luo, Y-B, Mitrpant, C., Johnsen, R., Fabian, V., Needham, M., Fletcher, S., Wilton, S.D. and Mastaglia, F.L. (2013) Investigation of splicing changes and post-translational processing of LMNA in sporadic inclusion body myositis. International Journal of Clinical and Experimental Pathology, 6 (9). pp. 1723-1733.

Ma, M.X., John, M. and Forbes, G.M. (2013) Diagnostic dilemmas in celiac disease. Expert Review of Gastroenterology & Hepatology, 7 (7). pp. 643-655.

Maker, G.L.ORCID: 0000-0003-1666-9377, Siva, B., Batty, K.T, Trengove, R.D., Ferrari, P. and Olynyk, J.K. (2013) Pharmacokinetics and safety of deferasirox in subjects with chronic kidney disease undergoing haemodialysis. Nephrology, 18 (3). pp. 188-193.

Mallal, S. (2013) Heterologous Immunity: A new model of drug hypersensitivity. In: 8th International Congress on Cutaneous Adverse Drug Reactions, 14 - 17 November 2013, Taipei, Taiwan.

Mallal, S. (2013) New research from Murdoch University shows people with HLA-C receptors can naturally resist the HIV virus but may suffer from Crohn's disease. [Radio Broadcast] [Creative Output]

Mallal, S. (2013) Personalised Immunology. In: 2013 Biomedical Scientific Advisory Board, 6 December 2013, Vanderbilt University, Nashville, TN.

Mallal, S. (2013) Personalized medicine: Unmet needs and opportunities. In: Clinical Pharmacology Fellows Conference, 3 December 2013, Division of Clinical Pharmacology, Vanderbilt University, Nashville.

Mallal, S. (2013) Prevention of HIV in 2023: Treatment as prevention, vaccines and cure. Can and will it be done? In: 16th Annual HIV Symposium, 1 November 2013, Nashville, TN.

Mallal, S. (2013) Role of heterologous immune responses in drug hypersensitivity, transplant rejection, infection and autoimmunity. In: Medicine Grand Rounds, 15 August 2013, Vanderbilt University, Nashville, TN.

Mallal, S. (2013) A potential cure for HIV. [Radio Broadcast] [Creative Output]

Mastaglia, F. (2013) Update in inflammatory myopathies. In: World Congress Neurology 2013, 21 - 26 September 2013, Vienna, Austria.

Mastaglia, F.L., Rojana-udomsart, A., James, I., Needham, M., Day, T.J., Kiers, L., Corbett, J.A., Saunders, A.M., Lutz, M.W. and Roses, A.D. (2013) Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms. Neuromuscular Disorders, 23 (12). pp. 969-974.

McKinnon, E. (2013) Exploring informative diversity in SPN-based association studies. In: International Biometric Society – Australasian Region Conference, “Biometrics by the Canals”, 1 - 5 December 2013, Mandurah, WA.

McKinnon, E., James, I. and Nolan, D. (2013) Analysis of censored duration intervals overlapping a fixed time point where censoring and survival times are correlated. In: 34th Annual Conference of the International Society for Clinical Biostatistics (ISCB) 2013, 25 - 29 August 2013, Munich, Germany.

Nakano, H., Chua, A.C.G., Klopcic, B.R.S., Ho, D.S., Fu, S.K., Forrest, C.H., Croft, K.D., Olynyk, J.K., Lawrance, I.C. and Trinder, D. (2013) Dietary iron enhances colonic inflammation and IL-6/IL-11-Stat3 signaling promoting colonic tumor development in mice. PloS one, 8 (11). e78850.

Nitschke, K., Barriga, A., Schmidt, J., Timm, J., Viazov, S., Kuntzen, T., Kim, A.Y., Lauer, G.M., Allen, T.M., Gaudieri, S., Rauch, A., Lange, C.M., Sarrazin, C., Eiermann, T., Sidney, J., Sette, A., Thimme, R., López, D. and Neumann-Haefelin, C. (2013) HLA-B∗27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope. Journal of Hepatology, 60 (1). pp. 22-29.

Nolan, D. (2013) How safe is contemporary ART? In: 25th Annual Conference of the Australasian Society for HIV Medicine (ASHM) 2013, 21 - 23 October 2013, Darwin, Australia.

Oddy, W.H., Herbison, C.E., Jacoby, P., Ambrosini, G.L., O'Sullivan, T.A., Ayonrinde, O.T., Olynyk, J.K., Black, L.J., Beilin, L.J., Mori, T.A., Hands, B.P. and Adams, L.A. (2013) The western dietary pattern is prospectively associated with non-alcoholic fatty liver disease in adolescence. The American Journal of Gastroenterology, 108 (5). pp. 778-785.

Olney, A., Almeida, C.M., Berry, C., John, M., Witt, C. and D'Orsogna, L. (2013) Stimulating HIV memory CD8+ T cells with allogeneic cell immunotherapy. In: ASMR WA Scientific Symposium, 5th June 2013, Perth, WA.

Pedrini, M.J., Seewann, A., Bennett, K.A., Marshall, B.J., Carroll, W.M. and Kermode, A.G. (2013) Asymptomatic course and resolution of PML during Natalizumab therapy with pre-emptive treatment for IRIS. In: PACTRIMS 2013, 6 - 8 November 2013, Kyoto, Japan.

Pedrini, M.J., Seewann, A., Bennett, K.A., Marshall, B.J., Carroll, W.M. and Kermode, A.G. (2013) Helicobacter pylori infection as a protective factor against multiple sclerosis development in Western Australians. In: PACTRIMS 2013, 6 - 8 November 2013, Kyoto, Japan.

Pedrini, M.J., Xu, W., Xu, Z., Carroll, W.M. and Kermode, A.G. (2013) Benign multiple sclerosis: A longitudinal follow-up study of large Western Australian cohort. In: PACTRIMS 2013, 6 - 8 November 2013, Kyoto, Japan.

Phillips, E. (2013) Antiretroviral therapy. Internal Medicine Journal, 43 . pp. 11-12.

Phillips, E. (2013) Battle advances in war against HIV. West Australian, 20 February 2013 .

Phillips, E. (2013) Pharmacogenomics of drug hypersensitivity in HIV: Evolution of knowledge. In: 8th iSCAR Meeting, 16 - 18 November 2013, Taipei, Taiwan.

Phillips, E. (2013) Prevention and prediction of drug allergy. In: National Institute of Allergy and Infectious Diseases/NIH, Workshop on Drug Allergy, 19 March 2013, Bethesda, Maryland, USA.

Phillips, E., Bartlett, J.A., Sanne, I., Lederman, M.M., Hinkle, J., Rousseau, F., Dunn, D., Pavlos, R., James, I., Mallal, S.A. and Haas, D.W. (2013) Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes, 62 (2). e55-e57.

Phillips, E.J. and Mallal, S.A. (2013) HLA-B*5701 and flucloxacillin associated drug-induced liver disease. AIDS, 27 (3). pp. 491-492.

Plauzolles, A., Lucas, M. and Gaudieri, S. (2013) Hepatitis C virus adaptation to T-cell immune pressure. The Scientific World Journal, 2013 . pp. 1-7.

Qiu, W., Pham, K., James, I., Nolan, D., Castley, A., Christiansen, F.T., Czarniak, P., Luo, Y., Wu, J., Garlepp, M., Wilton, S., Carroll, W.M., Mastaglia, F.L. and Kermode, A.G. (2013) The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort. Journal of Neuroimmunology, 261 (1-2). pp. 92-97.

Reeves, Karyn (2013) Founder effects and related issues in Host-viral association studies. PhD thesis, Murdoch University.

Rive, C.M., Bourke, J. and Phillips, E.J. (2013) Testing delayed drug hypersensitivity. Clinical Biochemist Reviews, 34 (1). pp. 15-38.

Rive, C.M., Bourke, J. and Phillips, E.J. (2013) Testing for drug hypersensitivity syndromes. Clinical Biochemist Reviews, 34 (1). pp. 15-38.

Rodríguez-Sáinz, C., Valor, L., Hernández, D.C., Gil, J., Carbone, J., Pascual-Bernaldez, M., Rodríguez-Alcántara, F., Martínez, I., Vicario, J.L., Mallal, S. and Fernández-Cruz, E. (2013) Flow cytometry analysis with a new FITC-Conjugated monoclonal antibody-3E12 for HLA-B*57:01 rapid screening in prevention of abacavir hypersensitivity in HIV-1–infected patients. HIV Clinical Trials, 14 (4). pp. 160-164.

Stiel, H. and John, M. (2013) Going Viral. Finalist in Best of Grand Rounds. In: Royal Australasian College of Physicians (RACP) Future Directions in Health Congress 2013, 26 - 29 May 2013, Perth, WA.

Strautins, K., Tschochner, M., James, I., Berry, C. and Nolan, D. (2013) Influence of gender, genetic factors and Epstein-Barr Virus antibody profiles, on Multiple Sclerosis risk. In: 23rd Annual Combined Biological Sciences Meeting (CBSM) 2013, 30 August 2013, University of Western Australia, Perth.

Strautins, K., Tschochner, M., James, I., Choo, L., Dunn, D.S., Pedrini, M. and Kermode, A. (2013) Combining genetic risk factors, gender And Anti-Epstein Barr Virus (EBV) antibody profiles, sing A Novel Anti-EBV Nuclear Antigen-1 (EBNA-1) B Cell Epitope ELISA, to stratify multiple sclerosis risk. In: PACTRIMS 2013, 6 - 8 November 2013, Kyoto, Japan.

Tirnitz-Parker, J., Glanfield, A., Olynyk, J. and Ramm, G. (2013) Iron and hepatic carcinogenesis. Critical Reviews in Oncogenesis, 18 (5). pp. 391-407.

Trubiano, J. and Phillips, E. (2013) Antimicrobial stewardshipʼs new weapon? A review of antibiotic allergy and pathways to ‘de-labeling'. Current Opinion in Infectious Diseases, 26 (6). pp. 526-537.

Tschochner, M., Leary, S., Strautins, K., Clark, H., Chopra, A., Choo, L., Carroll, W., Kermode, A. and Nolan, D. (2013) Identifying Epstein-Barr virus EBNA-1 sequence variation using 454 FLX technology in Multiple Sclerosis patient samples. In: Keystone Symposia on Molecular and Cellular Biology: Multiple Sclerosis, 11 - 16 January 2013, Big Sky, Montana USA.

Tschochner, M., Leary, S., Strautins, K., Clark, H., Cooper, D., Chopra, A., Choo, L., Carroll, W., Kermode, A. and Nolan, D. (2013) Multiple Sclerosis Patient Sequence Variation In Epstein-Barr Virus Nuclear Antigen 1. In: Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS) 2013, 6 - 8 November 2013, Kyoto, Japan.

Van Trigt, J., Clark, H., Watson, M.ORCID: 0000-0002-6438-9225 and Allan, J. (2013) Optimisation of a reporter cell line for assessing neutralising antibody titres to hepatitis C virus. In: 23rd Annual Combined Biological Sciences Meeting (CBSM) 2013, 30 August 2013, University of Western Australia, Perth.

Villarino, M.E., Moro, R., Borisov, A., Adkinson, N.F., Phillips, E., Shepherd, G., Ho, C., Weis, S.E. and Sterling, T.R. (2013) Hypersensitivity reactions among persons receiving a 3 month regimen of rifapentine plus isoniazid for treatment of latent tuberculosis infection (LTBI). In: 20th Conference on Retroviruses and Opportunistic Infections (CROI) 2013, 3 - 6 March 2013, Atlanta, Georgia.

Watson, M.ORCID: 0000-0002-6438-9225 (2013) Accurate identification of HCV sequence variants using deep sequencing with a primer ID. In: Australian Centre for HIV and Hepatitis Virology Research (ACH2) 4th Annual Workshop, 4 - 6 June 2008, Novotel Barossa Valley Resort, South Australia.

Worm, S.W., Bower, M., Reiss, P., Bonnet, F., Law, M., Fätkenheuer, G., d’Arminio Monforte, A., Abrams, D.I., Grulich, A., Fontas, E., Kirk, O., Furrer, H., De Wit, S., Phillips, A., Lundgren, J.D., Sabin, C.A. and Nolan, D. (2013) Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study. BMC Infectious Diseases, 13 (1).

Xu, W., li, R., Dai, Y., Wu, A., Wang, H., Cheng, C., Qiu, W., Lu, Z., Zhong, X., Shu, Y., Kermode, A.G. and Hu, X. (2013) IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis. Journal of Neuroimmunology, 261 (1-2). pp. 87-91.

Yagita, Y., Kuse, N., Kuroki, K., Gatanaga, H., Carlson, J. M., Chikata, T., Brumme, Z. L., Murakoshi, H., Akahoshi, T., Pfeifer, N., Mallal, S., John, M., Ose, T., Matsubara, H., Kanda, R., Fukunaga, Y., Honda, K., Kawashima, Y., Ariumi, Y., Oka, S., Maenaka, K. and Takiguchi, M. (2013) Distinct HIV-1 Escape Patterns Selected by Cytotoxic T Cells with Identical Epitope Specificity. Journal of Virology, 87 (4). pp. 2253-2263.

2012

Almeida, C.M., Bronke, C., Roberts, S.G., Ahmed, I., Keane, N.M., Chopra, A., James, I., Mallal, S., Heckerman, D. and John, M. (2012) Exploiting HLA in investigating T cell immunity in HIV-1 infection. In: 9th International Summer School (APHIA) 2012, 11 - 13 November 2013, Adelaide, SA.

Almeida, C.M., Bronke, C., Roberts, S.G., Ahmed, I., Keane, N.M., Chopra, A., James, I., Mallal, S., Heckerman, D. and John, M. (2012) T cell immunity in HIV-1 infection and vaccine design. In: APHIA, 13 November 2013, Adelaide, SA.

Baker, R.I., Harper, P. and McLintock, C. (2012) Avoiding adverse events with dabigatran by careful selection of eligible patients. The Medical Journal of Australia, 196 (7). pp. 431-432.

Bourke, J., Pavlos, R., Hollingsworth, P., McLean-Tooke, A., Horimoto, N., O'Brien, V., Edward, E. and Phillips, E. (2012) Penicillin de-labelling in tertiary clinics: Safe and efficacious but incomplete effectiveness. In: ASCIA 23rd Annual Scientific Meeting, 5 - 8 September 2012, Wellington, New Zealand.

Brockman, M.A., Chopera, D.R., Olvera, A., Brumme, C.J., Sela, J., Markle, T.J., Martin, E., Carlson, J.M., Le, A.Q., McGovern, R., Cheung, P.K., Kelleher, A.D., Jessen, H., Markowitz, M., Rosenberg, E., Frahm, N., Sanchez, J., Mallal, S., John, M., Harrigan, P.R., Heckerman, D., Brander, C., Walker, B.D. and Brumme, Z.L. (2012) Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity. Journal of Virology, 86 (12). pp. 6913-6923.

Carlson, J.M., Brumme, C.J., Martin, E., Listgarten, J., Brockman, M.A., Le, A.Q., Chui, C.K.S., Cotton, L.A., Knapp, D.J.H.F., Riddler, S.A., Haubrich, R., Nelson, G., Pfeifer, N., DeZiel, C.E., Heckerman, D., Apps, R., Carrington, M., Mallal, S., Harrigan, P.R., John, M. and Brumme, Z.L. (2012) Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1. Journal of Virology, 86 (24). pp. 13202-13216.

Chalmers, K.A., Knuiman, M.W., Divitini, M.L., Bruce, D.G., Olynyk, J.K. and Milward, E.A. (2012) Long-term mortality risks associated with mild anaemia in older persons: the Busselton Health Study. Age and Ageing, 41 (6). pp. 759-764.

Cheng, Y.-C., Anderson, C.D., Bione, S., Keene, K., Maguire, J.M., Nalls, M., Rasheed, A., Zeginigg, M., Attia, J., Baker, R., Barlera, S., Biffi, A., Bookman, E., Brott, T.G., Brown, R. D., Chen, F., Chen, W.-M., Ciusani, E., Cole, J.W., Cortellini, L., Danesh, J., Doheny, K., Ferrucci, L., Grazia Franzosi, M., Frossard, P., Furie, K.L., Golledge, J., Hankey, G.J., Hernandez, D., Holliday, E.G., Hsu, F.-C., Jannes, J., Kamal, A., Khan, M.S., Kittner, S.J., Koblar, S.A., Lewis, M., Lincz, L., Lisa, A., Matarin, M., Moscato, P., Mychaleckyj, J.C., Parati, E.A., Parolo, S., Pugh, E., Rost, N.S., Schallert, M., Schmidt, H., Scott, R.J., Sturm, J.W., Yadav, S., Zaidi, M., Boncoraglio, G.B., Levi, C.R., Meschia, J.F., Rosand, J., Sale, M., Saleheen, D., Schmidt, R., Sharma, P., Worrall, B. and Mitchell, B.D. (2012) Are myocardial infarction-associated single-nucleotide polymorphisms associated with ischemic stroke? Stroke, 43 (4). pp. 980-986.

Chikata, T., Carlson, J.M., Tamura, Y., Brumme, Z.L., Naruto, T., Hashimoto, M., Borghan, M.A., John, M., Mallal, S., Gatanaga, H., Oka, S. and Takiguchi, M. (2012) HLA-associated viral polymorphism in chronically HIV-1-Infected Japanese cohort: Analysis of four-digit HLA allele level. In: AIDS Vaccine 2012, 9 - 12 September 2012, Boston, U.S.A.

Chikata, T., Carlson, J.M., Tamura, Y., Brumme, Z.L., Naruto, T., Hashimoto, M., Borghan, M.A., John, M., Mallal, S., Gatanaga, H., Oka, S. and Yakiguchi, M. (2012) HLA-associated viral polymorphism in chronically HIV-1-infected Japanese cohort: analysis of four-digit HLA allele level. Retrovirology, 9 (Suppl 2).

Chopra, A., Cooper, D., Sharma, L., Choo, L., Blinco, J., Dunn, D., Leary, S., Watson, M.ORCID: 0000-0002-6438-9225 and Mallal, S. (2012) High throughput HLA sequence-based typing using Next Generation Sequencing. In: 22nd Annual Combined Biological Sciences Meeting, 24 August 2012, University of Western Australia, Perth.

Cooper, D., Chopra, A., Blinco, J., Jabara, C., Lemon, S., Barnard, R., Gaudieri, S., Watson, M.ORCID: 0000-0002-6438-9225 and Mallal, S. (2012) Accurate identification of HCV sequence variants using deep sequencing with a primer ID. In: 22nd Annual Combined Biological Sciences Meeting, 24 August 2012, University of Western Australia, Perth.

Cotton, L., Chopera, D., Penney, K., Carlson, J., Martin, E., Le, A., Kuang, T., Walker, B., Fuchs, J., Buchbinder, S., Wagner, T., John, M., Mallal, S., Koblin, B., Mayer, K., Poon, A., Brockman, M. and Brumme, Z. (2012) Limited evidence for alterations in Gag-mediated HIV replication capacity over the course of the North American epidemic (1979-Present). In: AIDS Vaccine 2012, 9 - 12 September 2012, Boston, U.S.A.

Cotton, L., Chopera, D., Penney, K., Carlson, J., Martin, E., Le, A., Kuang, T., Walker, B., Fuchs, J., Buchbinder, S., Wagner, T., John, M., Mallal, S., Koblin, B., Mayer, K., Poon, A., Brockman, M. and Brumme, Z. (2012) Limited evidence for alterations in Gag-mediated HIV replication capacity over the course of the North American epidemic (1979-present). Retrovirology, 9 (Suppl 2). P157.

D'Orsogna, L.J., van den Heuvel, H., van der Meer-Prins, E.M.W., Roelen, D.L., Doxiadis, I.I.N. and Claas, F.H.J. (2012) Stimulation of human EBV-and CMV-specific cytolytic effector function using allogeneic HLA molecules. The Journal of Immunology, 189 (10). pp. 4825-4831.

Deshpande, P., Lucas, M. and Gaudieri, S. (2012) Genetic variation of host immune response genes and their effect on Hepatitis C infection and treatment outcome. In: Caliskan, M., (ed.) Analysis of Genetic Variation in Animals. INTECHOpen, pp. 167-186.

Desmond, C.P., Gaudieri, S., James, I.R., Pfafferott, K., Chopra, A., Lau, G.K., Audsley, J., Day, C., Chivers, S., Gordon, A., Revill, P.A., Bowden, S., Ayres, A., Desmond, P.V., Thompson, A.J., Roberts, S. K., Locarnini, S.A., Mallal, S.A. and Lewin, S.R. (2012) Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease. Journal of Virology, 86 (2). pp. 1181-1192.

Duracinsky, M., Herrmann, S., Berzins, B., Armstrong, A.R., Kohli, R., Le Coeur, S., Diouf, A., Fournier, I., Schechter, M. and Chassany, O. (2012) The development of PROQOL-HIV: An international instrument to assess the health-related quality of life of persons living with HIV/AIDS. JAIDS Journal of Acquired Immune Deficiency Syndromes, 59 (5). pp. 498-505.

Duracinsky, M., Lalanne, C., Le Coeur, S., Herrmann, S., Berzins, B., Armstrong, A.R., Fai Lau, J.T., Fournier, I. and Chassany, O. (2012) Psychometric validation of the PROQOL-HIV questionnaire, a new health-related quality of life instrument–specific to HIV disease. JAIDS Journal of Acquired Immune Deficiency Syndromes, 59 (5). pp. 506-515.

Gan, E.K., Olynyk, J.K., Marsh, J.A., Ayonrinde, O.T., Mori, T.A., Beilin, L.J. and Adams, L. (2012) Factors affecting liver elastography in community-based young adults in the Raine study. In: The Liver Meeting 2012: American Association for the Study of Liver Diseases (AASLD) 63rd Annual Meeting, 9 - 13 November 2013, Boston, MA.

Gan, E.K., Olynyk, J.K., Marsh, J.A., Ayonrinde, O.T., Mori, T.A., Beilin, L.J. and Adams, L. (2012) Liver stiffness as a novel marker of metabolic syndrome? In: The Liver Meeting 2012: American Association for the Study of Liver Diseases (AASLD) 63rd Annual Meeting, 9 - 13 November 2013, Boston, MA.

Gaudieri, S., Lucas, M., Lucas, A., McKinnon, E., Albloushi, H., Rauch, A., di Iulio, J., Martino, D., Prescott, S.L. and Tulic, M.K. (2012) Genetic variations in IL28B and allergic disease in children. PLoS ONE, 7 (1). e30607.

Gaudieri, S., Tulic, M.K., Lucas, A. and Lucas, M. (2012) IFN-λ and IgE-mediated allergic disease: A potential future role? Biomarkers in Medicine, 6 (2). pp. 151-157.

Goot, K., Hazeldine, S., Bentley, P., Olynyk, J. and Crawford, D. (2012) Elevated serum ferriti: What should GPs know? Australian Family Physician, 41 (12). pp. 945-949.

Hammond, E., McKinnon, E., Glendenning, P., Williams, R., Mallal, S. and Phillips, E. (2012) Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIV. Clinical Endocrinology, 76 (2). pp. 201-206.

Herrmann, S., Wardrop, J., John, M., Gaudieri, S., Lucas, M., Mallal, S. and Nolan, D. (2012) The impact of visa status and Medicare eligibility on people diagnosed with HIV in Western Australia: a qualitative report. Sexual Health, 9 (5). pp. 407-413.

James, I. and McKinnon, E. (2012) Analysis of time to a threshold event based on visit-time data. In: Australian Statistical Conference 2012, 9 - 12 July 2012, Adelaide, SA.

James, I. and McKinnon, E. (2012) Exploratory survival analysis using longitudinal mixed-models. In: 33rd Annual Conference of the International Society for Clinical Biostatics, 19 - 23 August 2012, Bergen, Norway.

John, M. (2012) HIV diagnostic testing. In: ASHM educational day, 9 November 2012, Perth, WA.

Keane, N., Almeida, C., Chopra, A., Cooper, D., Demaine, E., Mallal, S. and John, M. (2012) Early changes in the CD8 T Cell immunodominance hierarchy in primary HIV infection prior to seroconversion. Retrovirology, 9 (Suppl 2).

Keane, N., Almeida, C., Roberts, S., Ahmad, I., Mallal, S. and John, M. (2012) Evaluation of the dual IFNγ/IL-2 fluorospot-assay with flow cytometry for detection of HLA-restricted HIV-specific T-cell responses in HIV controllers. Retrovirology, 9 (Suppl 2). P243.

Keane, N.M., Almeida, C., Chopra, A., Cooper, D., Demaine, E., Mallal, S. and John, M. (2012) Early changes in the CD8 T cell immunodominance hierarchy in primary HIV infection prior to seroconversion. In: AIDS Vaccine 2012, 9 - 12 September 2012, Boston, U.S.A.

Keane, N.M., Almeida, C., Roberts, S., Ahmad, I., Mallal, S. and John, M. (2012) Evaluation of the dual IFNγ/IL-2 Fluorospot-assay with flow cytometry for detection of HLA-restricted HIV-specific T-cell responses in HIV controllers. In: AIDS Vaccine 2012, 9 - 12 September 2012, Boston, U.S.A.

Keane, N.M., Roberts, S.G., Almeida, C.M., Krishnan, T., Chopra, A., Demaine, E., Laird, R., Tschochner, M., Carlson, J.M., Mallal, S., Heckerman, D., James, I. and John, M. (2012) High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection. Immunology and Cell Biology, 90 (2). pp. 224-234.

Kruger, P.C., Leahy, M.F. and Olynyk, J.K. (2012) Assessing iron overload: Are we there yet? Clinical Cancer Research, 18 (23). pp. 6395-6397.

Lucas, A., Lucas, M., Pavlos, R., Mallal, S. and Phillips, E. (2012) Abacavir reactive HLA-B*5701 restricted memory CD8+ T cells are present in abacavir unexposed donors. In: 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012), 5 - 8 March, Seattle, Washington, USA.

Lucas, M. and Gaudieri, S. (2012) The interferon family as biomarkers of disease: renaissance of the innate immune system. Biomarkers in Medicine, 6 (2). pp. 133-135.

Lucas, M., Lucas, A. and Gaudieri, S. (2012) New Diagnostics for Mycobacterium tuberculosis. In: Understanding Tuberculosis - Global Experiences and Innovative Approaches to the Diagnosis. InTech OPEN, pp. 239-256.

Mallal, S. (2012) Abacavir and the altered peptide repertoire model: clinical implications. In: Omics Australasia Symposium, 26 - 28 November 2012, Fremantle, WA.

Mallal, S. (2012) Beyond salvage therapy. In: Merck Sharp & Dohme HIV Expert Panel, 20 October 2012, Kuala Lumpur, Malaysia.

Mallal, S. (2012) Collaboration and Culture. In: SMHS Research Strategy Consultation, 18 October 2012, Fremantle, WA.

Mallal, S. (2012) Contemporary approaches to ART: Individualising therapy & avoiding Long-Term toxicity. In: ViiV Healthcare Lecture series, 26 - 27 October 2012, Guangzhou/Shanghai, China.

Mallal, S. (2012) Gene is out of the bottle. The Australian, 19 May 2012 .

Mallal, S. (2012) Long-term treatment considerations amongst the backbone HAART options and Making a difference in HIV patient's life. In: ViiV Healthcare Lecture series, 2 - 3 November 2012, Taiwan.

Mallal, S. (2012) Making a difference in HIV patient's life: What the Guidelines don't tell you. In: ViiV Healthcare Lecture series, 2 - 3 November 2012, Taiwan.

Mallal, S. (2012) PK Consideration in Treatment. In: HIV Global Therapeutic Expert Forum, 1 - 2 May 2012, Philadelphia, PA.

Mallal, S. (2012) Potential role of heterologous immunity in experiments of man and nature. In: Department of Immunology, University of Toronto, 7 February 2012, Ontario, Canada.

Mallal, S. (2012) What influence when life-long treatments start? Quality of survival: Seeking a way to find balance between efficiency and long term complication. In: ViiV Healthcare Lecture series, 23 October 2012, Seoul, South Korea.

Mallal, S. (2012) The paradigm shift in understanding of drug hypersensitivity: Implications for pre-clinical screening of compounds. In: MRL Safety Group Meeting, West Point, NY.

Mallal, S. (2012) A roadmap for translating Omics to improved clinical care and fundamental scientific insights. In: Omics Australasia Symposium, 26 - 28 November 2012, Fremantle, WA.

Mallal, S. and Phillips, E. (2012) Abacavir and the altered peptide repertoire model: Clinical implications. Journal of the International AIDS Society, 15 (6(Suppl 4)). p. 18119.

Mallal, S. and Phillips, E. (2012) Abacavir and the altered peptide repertoire model: Clinical implications. In: 11th International Congress on Drug Therapy in HIV Infection, 11 - 15 November 2012, Glasgow, Scotland.

McGettigan, B.D., Hew, M., Phillips, E. and McLean-Tooke, A. (2012) Sulphadiazine-induced renal stones in a 63-year-old HIV-infected man treated for toxoplasmosis. BMJ: Case Reports, 2012 (21 Sept 2012).

Nolan, D., Castley, A., Tschochner, M., James, I., Qiu, W., Sayer, D., Christiansen, F.T., Witt, C., Mastaglia, F., Carroll, W. and Kermode, A. (2012) Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk. Neurology, 79 (6). pp. 538-546.

Nolan, D., Mallal, S. and Reiss, P. (2012) Complications resulting from antiretroviral therapy for HIV infection. In: Volberding, P., Greene, W., Lange, J.M.A., Gallant, J.E. and Sewankambo, N., (eds.) Sande's HIV/AIDS Medicine: Medical Management of AIDS 2013. Elsevier Inc., pp. 177-191.

Ostrov, D.A., Grant, B.J., Pompeu, Y.A., Sidney, J., Harndahl, M., Southwood, S., Oseroff, C., Lu, S., Jakoncic, J., de Oliveira, C.A.F., Yang, L., Mei, H., Shi, L., Shabanowitz, J., English, A.M., Wriston, A., Lucas, A., Phillips, E., Mallal, S., Grey, H.M., Sette, A., Hunt, D.F., Buus, S. and Peters, B. (2012) Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proceedings of the National Academy of Sciences, 109 (25). pp. 9959-9964.

Pavlos, R., Mallal, S. and Phillips, E. (2012) HLA and pharmacogenetics of drug hypersensitivity. Pharmacogenomics, 13 (11). pp. 1285-1306.

Pavlos, R. and Phillips, E.J. (2012) Individualization of antiretroviral therapy. Pharmacogenomics and Personalized Medicine, 5 (1). pp. 1-17.

Phillips, E. (2012) Abacavir and nevirapine as two distinct models for HLA binding. In: European Association of Allergy and Clinical Immunology: 5th Drug Hypersensitivity Meeting, 14 April 2014, Munich, Germany.

Phillips, E. (2012) Antibiotic Allergy. In: Australasian Society for Infectious Diseases, Annual Scientific Meeting, 24 March 2012, Fremantle, WA.

Phillips, E. (2012) Contemporary approach to antiretroviral therapy: When to start, what to start with and what to switch to. In: Australasian Society for Infectious Diseases, Annual Scientific Meeting, 25 March 2012, Fremantle, WA.

Phillips, E. (2012) Pharmacogenomics and dosing individualization. In: Australasian Society of Clinical and Experimental Pharmacology and Toxicology Annual Scientific Meeting, 3 December 2012, Sydney, NSW.

Phillips, E. (2012) Role of pharmacogenomics in the safety of medicine. In: ARCS Scientific Congress, 28 September 2012, Canberra, ACT.

Phillips, E. (2012) Translation of pharmacogenetics into the clinic – The immunogenetics example. In: 16th Human Genome Meeting, 13 March 2012, Sydney, Australia.

Phillips, E. (2012) Translation of pharmacogenetics into the clinic: the immunogenetics example. In: Vanderbilt University: Visiting Professorship, Pharmacology Rounds, 21 August 2012, Nashville, TN.

Pompeu, Y.A., Stewart, J.D., Mallal, S., Phillips, E., Peters, B. and Ostrov, D.A. (2012) The structural basis of HLA-associated drug hypersensitivity syndromes. Immunological Reviews, 250 (1). pp. 158-166.

Rojana-udomsart, A., Castley, A., James, I., Needham, M., Scott, A., Day, T., Kiers, L., Corbett, A., Sue, C., Martinez, P., Christiansen, F. and Mastaglia, F.L. (2012) G.P.63 High-resolution analysis of HLA-DRB1 alleles and diplotypes in an Australian inclusion body myositis cohort. Neuromuscular Disorders, 22 (9-10). pp. 853-854.

Rojana-udomsart, A., James, I., Castley, A., Needham, M., Scott, A., Day, T., Kiers, L., Corbett, A., Sue, C., Witt, C., Martinez, P., Christiansen, F. and Mastaglia, F. (2012) High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: An analysis of disease-associated alleles and diplotypes. Journal of Neuroimmunology, 250 (1-2). pp. 77-82.

Seet, J.M., Ingram, P.R., Lie, K., Phillips, E.J. and Murray, R.J. (2012) Using antibiotics better: The healthy antimicrobial prescribing initiative (HAPI). In: Australian Society for Antimicrobials 13th Annual Scientific Meeting, 23 - 25 February 2012, Brisbane Convention & Exhibition Centre, Brisbane.

Shasha, D., Meseret, Y., Chopra, A., Cooper, D., James, I., Herrmann, S., Wolday, D., Maayan, S., Mallal, S. and John, M. (2012) Unique footprints of HLA class I on clade C HIV-1 in a cohort of Ethiopian patients. In: 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012), 5 - 8 March, Seattle, Washington, USA.

Strautins, K., Tschochner, M., Berry, C. and Nolan, D. (2012) Development of an anti-Epstein-Barr Virus nuclear antigen-1 ELISA and investigation of B-cell-epitope specific antibodies in Multiple Sclerosis patients. In: Murdoch University Postgraduate Student Association (MUPSA) Multidisciplinary Conference, 27 September 2012, Murdoch University, Murdoch.

Strautins, K., Tschochner, M., James, I., Berry, C.M. and Nolan, D. (2012) Epstein-Barr virus (EBV) - specific antibodies in multiple sclerosis patients, including targeted investigation of a candidate EBV nuclear antigen-1 (EBNA-1) B cell epitope. In: 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 10 - 13 October, Lyon, France.

Strautins, K., Tschochner, M., Nolan, D. and Berry, C. (2012) Investigating Epstein-Barr virus (EBV) antibodies in Multiple Sclerosis patients, and development of an anti-EBV nuclear antigen-1 B cell epitope ELISA. In: ASMR Medical Research Week, 7 June 2012, Perth, Western Australia.

Watson, M.ORCID: 0000-0002-6438-9225 (2012) Next generation Nucleic Acid Sequencing Wows and Woes. In: Departmental Seminar Series. UWA. Dept. of Anatomy and Human Biology, 15 May 2012, Perth, WA.

2011

Almeida, C.M., Bronke, C., Roberts, S.G., McKinnon, E., Keane, N.M., Chopra, A., Kadie, C., Carlson, J., Haas, D. W., Riddler, S. A., Haubrich, R., Heckerman, D., Mallal, S. and John, M. (2011) Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes. The Journal of Immunology, 187 (5). pp. 2502-2513.

Armstrong, A., Duracinsky, M., Lalanne, C., de Silva, M., Jamal, L., Herrmann, S., Carrieri, P., Davril, J. and Chassany, O. (2011) A new framework for understanding the impact of hepatitis C and its treatment on quality of life. In: ISPOR 14th Annual European Congress, 5 - 8 November, Madrid, Spain.

Brumme, C.J., Chan, B., Markle, T., Carlson, J., Martin, E., Le, Q.A., Penney, K., Rahman, M., Kuang, T., Nassab, P., Chopera, D.R., Markowitz, M., John, M., Mallal, S., Walker, B.D., Koblin, B., Mayer, K., Brockman, M.A., Poon Art, F.Y. and Brumme, Z.L. (2011) Molecular and functional consequences of immune-mediated evolution in HIV-1 Nef during the North American epidemic. In: AIDS Vaccine 2011, 12–15 September, 2011, Bangkok, Thailand.

Bull, R.A., Luciani, F., McElroy, K., Gaudieri, S., Pham, S.T., Chopra, A., Cameron, B., Maher, L., Dore, G.J., White, P.A. and Lloyd, A.R. (2011) Sequential bottlenecks drive viral evolution in early acute Hepatitis C virus infection. PLoS Pathogens, 7 (9). e1002243.

Castley, A., Tschochner, M., James, I., Kermode, A., Carroll, W., Sayer, D., Christiansen, F., Witt, C. and Nolan, D. (2011) Investigation of promoter HLA-DRB1 polymorphism in relation to a putative VDRE motif: HLA-DRB1 allele associations and influence on risk of multiple sclerosis. In: 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis, 19 – 22 October 2011, Amsterdam, Netherlands.

Chakera, A., Lucas, A. and Lucas, M. (2011) Surrogate markers of infection: interrogation of the immune system. Biomarkers in Medicine, 5 (2). pp. 131-148.

Cooper, D., Patsopoulos, N., Chopra, A., Watson, M.ORCID: 0000-0002-6438-9225, de Bakker, P. and Mallal, S. (2011) HLA Class I typing based on FLX 454 sequencing. In: 21st Annual Combined Biological Sciences Meeting, 26 August 2011, Perth, Western Australia.

Côté, H.C.F., Gerschenson, M., Walker, U.A., Miro, O., Garrabou, G., Hammond, E.L., Villarroya, J., Giralt, M., Villarroya, F., Cinque, P., Garcia-Arumi, E., Andreu, A.L., Pinti, M. and Cossarizza, A. (2011) Quality assessment of human mitochondrial DNA quantification: MITONAUTS, an international multicentre survey. Mitochondrion, 11 (3). pp. 520-527.

Dong, T., Zhang, Y., Xu, K. Y., Yan, H., James, I., Peng, Y., Blais, M.-E., Gaudieri, S., Chen, X., Lun, W., Wu, H., Qu, W. Y., Rostron, T., Li, N., Mao, Y., Mallal, S., Xu, X., McMichael, A., John, M. and Rowland-Jones, S. L. (2011) Extensive HLA-driven viral diversity following a narrow-source HIV-1 outbreak in rural China. Blood, 118 (1). pp. 98-106.

Gaudieri, S. (2011) Biomarkers that reflect immune activation or dysfunction will be important in the management of infectious diseases. Biomarkers in Medicine, 5 (2). pp. 109-112.

Haas, D.W., Kuritzkes, D.R., Ritchie, M.D., Amur, S., Gage, B.F., Maartens, G., Masys, D., Fellay, J., Phillips, E., Ribaudo, H.J., Freedberg, K.A., Petropoulos, C., Manolio, T.A., Gulick, R.M., Haubrich, R., Kim, P., Dehlinger, M., Abebe, R. and Telenti, A. (2011) Pharmacogenomics of HIV therapy: Summary of a workshop sponsored by the National Institute of Allergy and Infectious Diseases. HIV Clinical Trials, 12 (5). pp. 277-285.

Herrmann, S., John, M., Wardrop, J. and Nolan, D. (2011) Antiretroviral issues in temporary visa holders in Western Australia: A qualitative report on access, attitude and adherence. In: 23rd Annual Australasian Society for HIV Medicine Conference, 26 - 28 September, Canberra, Australia.

Herrmann, S., John, M., Wardrop, J. and Nolan, D. (2011) Experiences of people on temporary visas who are diagnosed with HIV in Western Australia. In: 23rd Annual Australasian Society for HIV Medicine Conference, 26 - 28 September, Canberra, Australia.

Herrmann, S., Lucas, M., John, M. and Nolan, D. (2011) Implementing medication adherence interventions into HIV clinical care: Implications for current research and other blood borne viruses. In: WA SiREN Research Symposium - Found or Lost in Translation, 6 May, Perth, Western Australia.

Hertz, T., Nolan, D., James, I., John, M., Gaudieri, S., Phillips, E., Huang, J., Riadi, G., Mallal, S. and Jojic, N. (2011) HLA class I binding and its relationship with evolutionary conservation in human proteins and viral proteomes. In: Keystone HIV Evolution Genomics & Pathogenesis, 20 - 25 March 2011, Whistler, British Columbia, Canada.

Hertz, T., Nolan, D., James, I., John, M., Gaudieri, S., Phillips, E.J., Huang, J.C., Riadi, G., Mallal, S. and Jojic, N. (2011) Mapping the Landscape of Host-Pathogen Coevolution: HLA Class I Binding and Its Relationship with Evolutionary Conservation in Human and Viral Proteins. Journal of Virology, 85 (3). pp. 1310-1321.

Keane, N.M. and John, M. (2011) Biomarkers of natural and vaccine immunity against HIV. Biomarkers in Medicine, 5 (2). pp. 113-116.

Keane, N.M., Pfafferott, K., Cooper, D., Chopra, A., Roberts, S.G., Sterrett, S., Leary, S., Demaine, E., Krishnan, T., Mallal, S., Bar, K., Shaw, G. and John, M. (2011) Limited acute CTL escape among three founder viruses in a case of acute heterosexual transmission of HIV-1 infections. In: 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention., 17 - 20 July, 2011, Rome, Italy.

Kostenko, L., Kjer-Nielsen, L., Nicholson, I., Hudson, F., Lucas, A., Foley, B., Chen, K., Lynch, K., Nguyen, J., Wu, A.H.B., Tait, B.D., Holdsworth, R., Mallal, S., Rossjohn, J., Bharadwaj, M. and McCluskey, J. (2011) Rapid screening for the detection of HLA-B57 and HLA-B58 in prevention of drug hypersensitivity. Tissue Antigens, 78 (1). pp. 11-20.

Lalanne, C., Armstrong, A.R., Herrmann, S., Chassany, O. and Duracinsky, M. (2011) How does health-related quality Of life relate to symptoms experienced in HIV patients treated with highly-active antiretroviral therapy? In: ISPOR 14th Annual European Congress, 5 - 8 November, Madrid, Spain.

Law, M.G., Woolley, I., Templeton, D.J., Roth, N., Chuah, J., Mulhall, B., Canavan, P., McManus, H., Cooper, D.A., Petoumenos, K. and Nolan, D. (2011) Trends in detectable viral load by calendar year in the Australian HIV observational database. Journal of the International AIDS Society, 14 (1). pp. 10-16.

Mallal, S. (2011) Are the best ART regimens for induction the best regimes for maintenance? In: Merck Satellite meeting ASHM, 27 September, 2011, Canberra, ACT, Australia.

Mallal, S. (2011) Co-evolution of HLA and viruses. In: Joint Forefront Lecture by Dr. Simon Mallal and Dr. Elizabeth Phillips, 4 March 2011, St. Paul's Hospital, Vancouver, British Columbia.

Mallal, S. (2011) Evolution of HIV therapy. In: HIV Treatment Updates. Body Positive New Zealand, 26 August, 2011, Pullman Hotel, Auckland, NZ.

Mallal, S. (2011) Lipoatrophy: forgotten but never forgiving. In: HIV Treatment Updates, Body Positive New Zealand, 26 August, 2011, Pullman Hotel, Auckland, NZ.

Mallal, S. (2011) Potential role of Heterologous Immunity in drug hypersensitivity. In: UWA School of Pathology & Laboratory Medicine, 17 June, 2011, Perth, Western Australia.

Mallal, S. (2011) Role of Heterologous Immunity in Transplantation Rejection and Drug Hypersensitivity. In: Merck Sharp & Dohme, May 6, 2011, West Point, NY, USA.

Mallal, S. (2011) Translational Pharmacogenetics: Pharmacogenomics of HIV/Antiretroviral Therapy at Institute of Immunology and Infectious Diseases. In: Satellite workshop in conjunction with ASCEPT conference, 4 December, 2011, Perth, Western Australia.

Merani, S., Petrovic, D., James, I., Chopra, A., Cooper, D., Freitas, E., Rauch, A., di Iulio, J., John, M., Lucas, M., Fitzmaurice, K., McKiernan, S., Norris, S., Kelleher, D., Klenerman, P. and Gaudieri, S. (2011) Effect of immune pressure on hepatitis C virus evolution: Insights from a single-source outbreak. Hepatology, 53 (2). pp. 396-405.

Pfafferott, K., Gaudieri, S., Ulsenheimer, A., James, I., Heeg, M., Nolan, D., John, M., Rauch, A., Mallal, S., Lucas, A.D., Klenerman, P., Diepolder, H.M. and Lucas, M. (2011) Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity. PLoS ONE, 6 (2). e16797.

Phillips, E. (2011) Immunogenetics and immunopathology of drug hypersensitivity. In: Joint Forefront Lecture by Dr. Simon Mallal and Dr. Elizabeth Phillips, 4 March 2011, St. Paul's Hospital, Vancouver, British Columbia.

Phillips, E., Keane, N., Blyth, C., Lucas, A., Pavlos, R., Lucas, M., McKinnon, E. and Mallal, S. (2011) Both HLA Class I restricted CD8+ and Class II restricted CD4+T Cells are implicated in the pathogenesis of nevirapine hypersensitivity. In: 51st Interscience Conference of Antimicrobial Agents and Chemotherapy, 17 - 20 September 2011, Chicago, IL.

Phillips, E.J., Chung, W-H, Mockenhaupt, M., Roujeau, J-C and Mallal, S. (2011) Drug hypersensitivity: Pharmacogenetics and clinical syndromes. Journal of Allergy and Clinical Immunology, 127 (3). S60-S66.

Phillips, E.J. and Mallal, S.A. (2011) HLA-B*1502 Screening and toxic effects of carbamazepine. New England Journal of Medicine, 365 (7). pp. 672-673.

Rive, C., Watson, M.ORCID: 0000-0002-6438-9225, Chopra, A., Cooper, D., Demaine, E. and Mallal, S. (2011) Development of a low bias target enrichment method to estimate viral variation using 454 sequencing. In: 21st Annual Combined Biological Sciences Meeting, 26 August 2011, Perth, Western Australia.

Suppiah, V., Gaudieri, S., Armstrong, N.J.ORCID: 0000-0002-4477-293X, O'Connor, K.S., Berg, T., Weltman, M., Abate, M.L., Spengler, U., Bassendine, M., Dore, G.J., Irving, W.L., Powell, E., Hellard, M., Riordan, S., Matthews, G., Sheridan, D., Nattermann, J., Smedile, A., Müller, T., Hammond, E., Dunn, D.S., Negro, F., Bochud, P-Y, Mallal, S., Ahlenstiel, G., Stewart, G.J., George, J. and Booth, D.R. (2011) IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic Hepatitis C virus infection in a European cohort: A cross-sectional study. PLoS Medicine, 8 (9). e1001092.

Tschochner, M., Leary, S. and Nolan, D. (2011) Identifying potential targets for Epstein-Barr virus-associated molecular mimicry in T cell-mediated autoimmunity of multiple sclerosis. In: 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis, 19 – 22 October 2011, Amsterdam, Netherlands.

2010

Almeida, C., Bronke, C., Roberts, S., McKinnon, E., Keane, N., Chopra, A., Kadie, C., Carlson, J., Haas, D., Riddler, S., Haubrich, R., Heckerman, D., Mallal, S. and John, M. (2010) HIV-1 adaptation leads to inflation of the HIV-specific CD8 T-cell response against HLA-adapted variant epitopes. In: Annual Meeting. Australasian Society for Immunology 2010, 5 - 9 December 2010, Perth, Western Australia.

Bauersachs, R. and Baker, R.I. (2010) Oral Rivaroxaban for Symptomatic Venous Thromboembolism. New England Journal of Medicine, 363 (26). pp. 2499-2510.

Fiessinger, J.N., Bounameaux, H., Cairols, M.A., Clement, D.L., Coccheri, S., Fletcher, J.P., Hoffmann, U., Turpie, A.G.G. and Baker, R.I. (2010) Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study. Journal of Thrombosis and Haemostasis, 8 (11). pp. 2369-2376.

Gaudieri, S., Tschochner, M., Cooper, D., Chopra, A., Merani, S., Witteck, A., Battegay, M., Günthard, H., Furrer, H., Rohrbach, J. and Rauch, A. (2010) Identification of HCV minority species in HIV/HCV coinfected individuals using deep sequencing technology: relevance for new anti-HCV drugs and host immune responses to HCV. In: The 17th International Meeting on Hepatitis C Virus and Related Diseases., 10 - 14 September 2010, Yokohama, Japan.

Graeme, J. and Baker, R.I. (2010) B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. The Lancet Neurology, 9 (9). pp. 855-865.

Hammond, E., Lucas, A., Lucas, M., Phillips, E. and Gaudieri, S. (2010) Vaniprevir: HCV NS3/4A protease inhibitor treatment of hepatitis C. Drugs of the Future, 35 (10). pp. 803-813.

Herrmann, S., Williams, L., McKinnon, E. and Nolan, D. (2010) Vulnerable populations: Substance use in the WA HIV Cohort Study. In: 17th Western Australian Drug and Alcohol Symposium, 30 August - 1 September, Fremantle, Western Australia.

Herrmann, S.E., McKinnon, E.J., Williams, L.J., John, M., Mallal, S., Lucas, M. and Nolan, D.A. (2010) Use of alcohol, nicotine and other drugs in the Western Australian HIV Cohort study. Sexual Health, 9 (2). pp. 199-201.

Hilner, J. E., Perdue, L. H., Sides, E. G., Pierce, J. J., Wagner, A. M., Aldrich, A., Loth, A., Albret, L., Wagenknecht, L. E., Nierras, C., Akolkar, B., Gaudieri, S., James, I., McKinnon, E. and Nolan, D. (2010) Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC). Clinical Trials, 7 (1 Suppl). S5-S32.

Hull, Russell D., Schellong, S.M, Monreal, M., Samama, M.M., Nicol, P, Vicaut, E, Turpie, A.G., Yusen, R.D. and Baker, R. (2010) Extended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility. Annals of Internal Medicine, 153 (1). p. 8.

James, I., Hepworth, A. and KcKinnon, E. (2010) Correlation estimation with bivariate censored data. In: Annual Conference of the International Society of Clinical Biostatistics., 30 August – 2 September 2010, Montpellier, France..

John, M., Heckerman, D., James, I., Park, L.P., Carlson, J.M., Chopra, A., Gaudieri, S., Nolan, D., Haas, D.W., Riddler, S.A., Haubrich, R. and Mallal, S. (2010) Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs. The Journal of Immunology, 184 (8). pp. 4368-4377.

Keane, N.M., Pfafferott, K., Cooper, D., Roberts, S.G., Chopra, A., Demaine, E., Krishan, T., Mallal, S. and John, M. (2010) FLX 454 deep sequencing of HLA-restricted viral epitope sequences in acute HIV infection identifies sites of selection. In: 40th Annual Scientific Meeting for the Australasian Society for Immunology, 5 - 9 December 2010, Perth, Australia.

Keane, N.M., Pfafferott, K., Cooper, D., Roberts, S.G., Chopra, A., Demaine, E., Krishnan, T., Mallal, S. and John, M. (2010) HIV-1 adaptation to early HLA restricted immune responses in acute heterosexual transmission. In: 22nd Annual Conference of the Australasian Society for HIV Medicine, 20 - 22 October 2010, Sydney, Australia

Lassen, M.R., Gallus, A., Raskob, G.E., Pineo, G., Chen, D., Ramirez, L.M. and Baker, R.I. (2010) Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement. New England Journal of Medicine, 363 (26). pp. 2487-2498.

Li, H., Bar, K.J., Chen, Y., Hahn, B.H., Pfafferott, K., John, M., Mallal, S. and Shaw, G.M. (2010) Molecular identification of transmitted/founder viruses by single genome amplification following percutaneous occupational exposure to HIV-1. In: AIDS Vaccine Conference, 28 September – 1 October 2010, Altanta, USA..

Lucas, A., Lucas, M., Mallal, S. and Phillips, E. (2010) Antigen specific CD8+T cells in abacavir hypersensitiviy can become oligoclonal, CD43Io+/-CD127hi. In: 40th Australasian Society of Immunology Annual Scientific Meeting, 5 - 9 December 2010, Perth, W.A.

Lucas, A.D., Lucas, M., Mallal, S. and Phillips, E.J. (2010) Antigen specific CD8+ T-cells in abacavir hypersensitivity are oligoclonal and CD34lo. In: 40th Annual Scientific Meeting for the Australasian Society for Immunology, 5-9 December 2010, Perth, Australia.

Mallal, S. (2010) Co-evolution of HLA and viruses. In: Seminar presentation, 29 October 2010, Marshall Centre, University of Western Australia, Perth, Australia..

Mallal, S. (2010) Drivers of excellence in clinical care. In: Leadership WA Conference, 16 June 2010, Perth, Australia..

Mallal, S. (2010) Further insights into the genetic predisposition to abacavir hypersensitivity. In: 4th International Drug Hypersensitivity Meeting, 22 - 25 April 2010, Rome, Italy.

Mallal, S. (2010) Pharmacogenomics and adverse reactions. In: 16th World Congress of Basic and Clinical Pharmacology, 17 - 23 July 2010, Copenhagen, Denmark..

Mallal, S. (2010) Translation of Personalized Medicine into the Clinic: Difficult but not Impossible. In: Seminar presentation, 27 October 2010, Sir Charles Gairdner Hospital, Perth, Australia..

Mallal, S. (2010) Translation of personalized medicine into the clinic: Difficult but not impossible. In: Univation, 4 November, 2010., Royal Perth Hospital, Perth, Western Australia.

Mallal, S. (2010) The pharmacogenetics of drug hypersensitivity. In: 16th World Congress of Basic and Clinical Pharmacology, 17 - 23 July 2010, Copenhagen, Denmark.

Martin, A., Amin, J., Cooper, D.A., Carr, A., Kelleher, A.D., Bloch, M., Baker, D., Woolley, I., Emery, S. and Nolan, D. (2010) Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: A randomized clinical trial. AIDS, 24 (17). pp. 2657-2663.

McGettigan, B.D., McKinnon, E., Mallal, S., French, M., Hammond, E., Nolan, D. and Phillips, E.J. (2010) Association between low 25(OH) vitamin D levels, antiretroviral therapy and metabolic profile in a cohort of treated ahd therapy naive HIV positive patients in Western Australia. In: 22nd Annual Conference of the Australasian Society for HIV Medicine, 20 - 22 October 2010, Sydney, Australia.

Pereyra, F., Jia, X., McLaren, P.J., Telenti, A., de Bakker, P.I.W., Walker, B.D., Ripke, S., Brumme, C.J., Pulit, S.L., Carrington, M., Kadie, C.M., Carlson, J.M., Heckerman, D., Graham, R.R., Plenge, R.M., Deeks, S.G., Gianniny, L., Crawford, G., Sullivan, J., Gonzalez, E., Davies, L., Camargo, A., Moore, J.M, Beattie, N., Gupta, S., Crenshaw, A., Burtt, N.P., Guiducci, C., Gupta, N., Gao, X., Qi, Y., Yuki, Y., Piechocka-Trocha, A., Cutrell, E., Rosenberg, R., Moss, K.L., Lemay, P., O'Leary, J., Schaefer, T., Verma, P., Tóth, I., Block, B., Baker, B., Rothchild, A., Lian, J., Proudfoot, J., Alvino, D.M.L., Vine, S., Addo, M.M., Allen, T.M., Altfeld, M., Henn, M.R., Le Gall, S., Streeck, H., Haas, D.W., Kuritzkes, D.R., Robbins, G.K., Shafer, R.W., Gulick, R.M., Shikuma, C.M., Haubrich, R., Riddler, S., Sax, P.E., Daar, E.S., Ribaudo, H.J., Agan, B., Agarwal, S., Ahern, R.L., Allen, B.L., Altidor, S., Altschuler, E.L., Ambardar, S., Anastos, K., Anderson, B., Anderson, V., Andrady, U., Antoniskis, D., Bangsberg, D., Barbaro, D., Barrie, W., Bartczak, J., Barton, S., Basden, P., Basgoz, N., Bazner, S., Bellos, N.C., Benson, A.M., Berger, J., Bernard, N.F., Bernard, A.M., Birch, C., Bodner, S.J., Bolan, R.K., Boudreaux, E.T., Bradley, M., Braun, J.F., Brndjar, J.E., Brown, S.J., Brown, K., Brown, S.T., Burack, J., Bush, L.M., Cafaro, V., Campbell, O., Campbell, J., Carlson, R.H., Carmichael, J.K., Casey, K.K., Cavacuiti, C., Celestin, G., Chambers, S.T., Chez, N., Chirch, L.M., Cimoch, P.J., Cohen, D., Cohn, L.E., Conway, B., Cooper, D.A., Cornelson, B., Cox, D.T., Cristofano, M.V., Cuchural, G., Czartoski, J.L., Dahman, J.M., Daly, J.S., Davis, B.T., Davis, K., Davod, S.M., DeJesus, E., Dietz, C.A., Dunham, E., Dunn, M.E., Ellerin, T.B., Eron, J.J., Fangman, J.J.W., Farel, C.E., Ferlazzo, H., Fidler, S., Fleenor-Ford, A., Frankel, R., Freedberg, K.A., French, N.K., Fuchs, J.D., Fuller, J.D., Gaberman, J., Gallant, J.E., Gandhi, R.T., García, E., Garmon, D., Gathe, J.C., Gaultier, C.R., Gebre, W., Gilman, F.D., Gilson, I., Goepfert, P.A., Gottlieb, M.S., Goulston, C., Groger, R.K., Gurley, T.D., Haber, S., Hardwicke, R., Hardy, W.D., Harrigan, P.R., Hawkins, T.N., Heath, S., Hecht, F.M., Henry, W.K., Hladek, M., Hoffman, R.P., Horton, J.M., Hsu, R.K., Huhn, G.D., Hunt, P., Hupert, M.J., Illeman, M.L., Jaeger, H., Jellinger, R.M., John, M., Johnson, J.A., Johnson, K.L., Johnson, H., Johnson, K., Joly, J., Jordan, W.C., Kauffman, C.A., Khanlou, H., Killian, R.K., Kim, A.Y., Kim, D.D., Kinder, C.A., Kirchner, J.T., Kogelman, L., Kojic, E.M., Korthuis, P.T., Kurisu, W., Kwon, D.S., LaMar, M., Lampiris, H., Lanzafame, M., Lederman, M.M., Lee, D.M., Lee, J.M.L., Lee, M.J., Lee, E.T.Y., Lemoine, J., Levy, J.A., Llibre, J.M., Liguori, M.A., Little, S.J., Liu, A.Y., Lopez, A.J., Loutfy, M.R., Loy, D., Mohammed, D.Y., Man, A., Mansour, M.K., Marconi, V.C., Markowitz, M., Marques, R., Martin, J.N., Martin, H.L., Mayer, K.H., McElrath, M.J., McGhee, T.A., McGovern, B.H., McGowan, K., McIntyre, D., Mcleod, G.X., Menezes, P., Mesa, G., Metroka, C.E., Meyer-Olson, D., Miller, A.O., Montgomery, K., Mounzer, K.C., Nagami, E.H., Nagin, I., Nahass, R.G., Nelson, M.O., Nielsen, C., Norene, D.L., O'Connor, D.H., Ojikutu, B.O., Okulicz, J., Oladehin, O.O., Oldfield, E.C., Olender, S.A., Ostrowski, M., Owen, W.F., Pae, E., Parsonnet, J., Pavlatos, A.M., Perlmutter, A.M., Pierce, M.N., Pincus, J.M., Pisani, L., Price, L.J., Proia, L., Prokesch, R.C., Pujet, H.C., Ramgopal, M., Rathod, A., Rausch, M., Ravishankar, J., Rhame, F.S., Richards, C.S., Richman, D.D., Rodes, B., Rodriguez, M., Rose, R.C., Rosenberg, E.S., Rosenthal, D., Ross, P.E., Rubin, D.S., Rumbaugh, E., Saenz, L., Salvaggio, M.R., Sanchez, W.C., Sanjana, V.M., Santiago, S., Schmidt, W., Schuitemaker, H., Sestak, P.M., Shalit, P., Shay, W., Shirvani, V.N., Silebi, V.I., Sizemore, J.M., Skolnik, P.R., Sokol-Anderson, M., Sosman, J.M., Stabile, P., Stapleton, J.T., Starrett, S., Stein, F., Stellbrink, H-J, Sterman, F.L., Stone, V.E., Stone, D.R., Tambussi, G., Taplitz, R.A., Tedaldi, E.M., Telenti, A., Theisen, W., Torres, R., Tosiello, L., Tremblay, C., Tribble, M.A., Trinh, P.D., Tsao, A., Ueda, P., Vaccaro, A., Valadas, E., Vanig, T.J., Vecino, I., Vega, V.M., Veikley, W., Wade, B.H., Walworth, C., Wanidworanun, C., Ward, D.J., Warner, D.A., Weber, R.D., Webster, D., Weis, S., Wheeler, D.A., White, D.J., Wilkins, E., Winston, A., Wlodaver, C.G., van't Wout, A., Wright, D.P., Yang, O.O., Yurdin, D.L., Zabukovic, B.W., Zachary, K.C., Zeeman, B. and Zhao, M. (2010) The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science, 330 (6010). pp. 1551-1557.

Perry, J.R., Julian, J.A., Laperriere, N.J., Geerts, W., Agnelli, G., Rogers, L.R., Malkin, M.G., Sawaya, R., Baker, R., Falanga, A., Parpia, S., Finche, T. and Levine, M.N. (2010) PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. Journal of Thrombosis and Haemostasis, 8 (9). pp. 1959-1965.

Pfafferott, K., Merani, S., Rauch, A., Baccala, M., Mallal, S., Baker, R., Gaudieri, S. and Lucas, M. (2010) One step closer to a CTL-based HCV vaccine. In: The Australian Centre for HIV and Hepatitis Virology Research (ACH2) 6th National Workshop, 23 - 25 June 2010, Yarra Valley, Australia.

Phillips, E. (2010) The pharmacogenetics of drug hypersensitivity. In: WorldPharma 2010 – Bridging Basic and Clinical Pharmacology (16th World Congress of Basic & Clinical Pharmacology), 17 - 23 July 2010, Copenhagen, Denmark.

Phillips, E., Lucas, M., Keane, N., Lucas, A., McKinnon, E. and Mallal, S. (2010) HLA-B*35 is associated with nevirapine hypersensitivity in the contemporary Western Australian HIV cohort study. In: 4th International Drug Hypersensitivity Meeting, 22 - 25 April 2010, Rome, Italy.

Phillips, E.J. and Mallal, S. (2010) Immunology of drug hypersensitivity reactions. In: 40th Annual Scientific Meeting for the Australasian Society for Immunology, 5-9 December 2010, Perth, Australia.

Phillips, E.J. and Mallal, S. (2010) Pharmacogenetics of drug hypersensitivity. Pharmacogenomics, 11 (7). pp. 973-987.

Phillips, E.J. and Mallal, S.A. (2010) Abacavir. In: Wu, A.H.B. and Kiang-Teck, J.Y., (eds.) Pharmacogenomic Testing in Current Clinical Practice. Humana Press, New York, U.S.A, pp. 201-212.

Phillips, E.J. and Mallal, S.A. (2010) HLA and drug reactions. In: Mehra, N.K., Kaur, G., McCluskey, J., Christiansen, F.T. and Claas, F.H.J., (eds.) The HLA Complex in Biology and Medicine: A Resource Book. Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India, pp. 332-349.

Tschochner, M., Rohrbach, J., Cooper, D., Merani, S., Chopra, A., Witteck, A., Battegay, M., Furrer, H., Günthard, H., Mallal, S., Rauch, A. and Gaudieri, S. (2010) Characterisation of hepatitis C virus evolution in HIV/HCV coinfected individuals using deep sequencing technology: Relevance for new antiviral drugs and disease outcome. In: 22nd Annual Conference of the Australasian Society for HIV Medicine, 20 - 22 October 2010, Sydney, Australia

Tschochner, M., rohrbach, J., Cooper, D., Merani, S., Chopra, A., Witteck, A., Battegay, M., Furrer, H., Günthard, H., Mallal, S., Rauch, A. and Gaudieri, S. (2010) Characterization of hepatitis C virus evolution in HIV-HCV coinfected individuals using deep sequencing technology: relevance for new antiviral drugs and disease outcome. In: Australasian HIV/AIDS Conference 2010 – 22nd Annual Conference of the Australasian Society for HIV Medicine, 20 - 22 October 2010, Sydney, Australia.

Wilson, G.F.V., Chopra, A., Watson, M.ORCID: 0000-0002-6438-9225 and Mallal, S. (2010) Front end modification of library preparation for GS FLX to minimize cost, sample loss and labour. In: Combined Biological Sciences Meeting., 28 August 2010, UWA Perth, Western Australia.

2009

Almeida, C., Bronke, C., Roberts, S., Cooper, D., Corkery, M., McKinnon, E., Ahmad, I., Keane, N., Chopra, A., Mallal, S., John, M. and Heckerman, D. (2009) Identification of multiple novel HIV-specific T-cell epitopes using HLA-associated HIV polymorphisms. In: 39th Annual Scientific Meeting of the Australasian Society for Immunology 2009, 6 - 10 December 2009, Gold Coast, QLD.

Almeida, C., Bronke, C., Roberts, S.G., Ahmad, I., Keane, N.M., Chopra, A., James, I., Mallal, S., Heckerman, D. and John, M. (2009) Identification of multiple novel HIV-specific T-cell epitopes using HLA-associated HIV polymorphisms. In: AIDS Vaccine 2009, 19 - 22 October 2009, Paris, France.

Barrett, J.C., Clayton, D.G., Concannon, P., Akolkar, B., Cooper, J.D., Erlich, H.A., Julier, C., Morahan, G., Nerup, J., Nierras, C., Plagnol, V., Pociot, F., Schuilenburg, H., Smyth, D.J., Stevens, H., Todd, J.A., Walker, N.M., Rich, S.S., Gaudieri, S., James, I., McKinnon, E. and Nolan, D. (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nature Genetics, 41 (6). pp. 703-707.

Chaubey, S.K., Sinha, A.K., Phillips, E., Russell, D.B. and Falhammar, H. (2009) Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection. Sexual Health, 6 (3). pp. 254-257.

Chopra, A., Watson, M.ORCID: 0000-0002-6438-9225, Cooper, D., Leary, S., John, M. and Mallal, S. (2009) High throughput long amplicon sequencing, assembly and reference mapping of HIV genome using the GS FLX sequencer. In: 21st Annual Conference of the Australasian Society for HIV Medicine (ASHM), 9 - 11 September, Brisbane, Australia.

Dunkley, S.M., Russell, S.J., Rowell, J.A., Barnes, C.D., Baker, R.I., Sarson, M.I. and Street, A.M. (2009) A consensus statement on the management of pregnancy and delivery in women who are carriers of or have bleeding disorders. The Medical journal of Australia, 191 (8). pp. 460-3.

Falster, K., Petoumenos, K., Chuah, J., Mijch, A., Mulhall, B., Kelly, M., Cooper, D.A. and Mallal, S. (2009) Poor baseline immune function predicts an incomplete immune response to combination antiretroviral treatment despite sustained viral suppression. JAIDS Journal of Acquired Immune Deficiency Syndromes, 50 (3). pp. 307-313.

Favaloro, E.J., Thom, J., Patterson, D., Just, S., Dixon, T., Koutts, J., Baccala, M., Rowell, J. and Baker, R. (2009) Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: Differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays? Thrombosis Research, 123 (6). pp. 862-868.

Fellay, J., Ge, D., Shianna, K.V., Colombo, S., Ledergerber, B., Cirulli, E.T., Urban, T.J., Zhang, K., Gumbs, C.E., Smith, J. P., Castagna, A., Cozzi-Lepri, A., De Luca, A., Easterbrook, P., Günthard, H.F., Mallal, S., Mussini, C., Dalmau, J., Martinez-Picado, J., Miro, J.M., Obel, N., Wolinsky, S.M., Martinson, J.J., Detels, R., Margolick, J.B., Jacobson, L.P., Descombes, P., Antonarakis, S.E., Beckmann, J.S., O'Brien, S.J., Letvin, N.L., McMichael, A.J., Haynes, B.F., Carrington, M., Feng, S., Telenti, A., Goldstein, D.B. and McCarthy, M.I. (2009) Common genetic variation and the control of HIV-1 in humans. PLoS Genetics, 5 (12). e1000791.

Gaudieri, S., Rauch, A., James, I., Pfafferott, K., Baker, R., Cheng, W., McCaughan, G., Shackel, N., Jeffrey, G., Mollinson, L., Mallal, S., Furrer, H., Günthard, H., Hirschel, B., Klenerman, P., Nolan, D., John, M. and Lucas, M. (2009) Co-localisation of hepatitis C virus drug-resistant mutations and immune-driven adaptations: Relevance to therapy outcome. In: 19th Annual Combined Biological Sciences Meeting 2009, 28 August 2009, Perth, Western Australia.

Gaudieri, S., Rauch, A., James, I., Pfafferott, K., Cheng, W., McCaughan, G., Jeffrey, G., Mollison, L., Furrer, H., Günthard, H., Hirschel, B., Klenerman, P., Mallal, S., Nolan, D., John, M. and Lucas, M. (2009) Divergent adaptation of Hepatitis C virus genotypes to HLA-restricted immune pressure: relevance to HCV infection and vaccine design. In: 16th International Symposium on Hepatitis C Virus & Related Viruses, 3 - 7 October 2009, Nice, France.

Herrmann, S., Duracinsky, M., Lalanne, C., Acquadro, C., Mallal, S. and Nolan, D. (2009) Health-related quality of life in the WA HIV Cohort: 2008. In: 21st Annual Conference of the Australasian Society for HIV Medicine (ASHM), 9 - 11 September, Brisbane, Australia.

Herrmann, S., Williams, L., McKinnon, E. and Nolan, D. (2009) Substance use in the WA HIV Cohort: 2002-2008. In: 21st Annual Conference of the Australasian Society for HIV Medicine (ASHM), 9 - 11 September, Brisbane, Australia.

Hooper, A.J.., Robertson, K., Ng, L., Kattampallil, J.S., Latchem, D., Willsher, P.C., Thom, J., Baker, R.I. and Burnett, J.R. (2009) A novel ABCA1 nonsense mutation, R1270X, in Tangier disease associated with an unrecognised bleeding tendency. Clinica Chimica Acta, 409 (1-2). pp. 136-139.

James, I. and McKinnon, E. (2009) Estimation of natural HIV disease progression incorporating unknown infection dates. In: 30th Conference of the International Society for Clinical Biostatistics, 23 - 27 August 2009, Prague, Czech Republic.

John, M. (2009) HIV immunogen design. In: PTVDC Plenary Meeting, 23 - 25 April 2009, Vienna, Austria.

Kesselring, A.M., Wit, F.W., Sabin, C.A., Lundgren, J.D., Gill, M.J., Gatell, J.M., Rauch, A., Montaner, J.S., de Wolf, F., Reiss, P., Mocroft, A. and Phillips, E. (2009) Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy. AIDS, 23 (13). pp. 1689-1699.

Lee, M.H., Anderson, J., Stocker, S.L., Williams, K.M., Graham, G.G., Phillips, E.J., Nolan, D. and Day, R.O. (2009) A tale of two brothers: A familial study of risk factors to allopurinol-induced Stevens-Johnson Syndrome. In: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Conference 2009, 29 November - 2 December 2009, Sydney Convention Centre, Sydney.

Lippert, E., Girodon, F., Hammond, E., Jelinek, J., Reading, N.S., Fehse, B., Hanlon, K., Hermans, M., Richardson, C., Swierczek, S., Ugo, V., Carillo, S., Harrivel, V., Marzac, C., Pietra, D., Sobas, M., Mounier, M., Migeon, M., Ellard, S., Kroger, N., Herrmann, R., Prchal, J.T., Skoda, R.C. and Hermouet, S. (2009) Concordance of assays designed for the quantification of JAK2V617F: a multicenter study. Haematologica, 94 (1). pp. 38-45.

Lucas, M., Pfafferott, K., Baker, R., Baccala, M., Herrmann, S. and Gaudieri, S. (2009) HCV-specific T-cell responses reflect Hepatitis C infection outcome following multiple exposures to the virus. In: Australian Centre for HIV & Hepatitis Virology Research (ACH2) 5th National Workshop, 3 - 5 June, Terrigal, NSW, Australia.

Lucas, M., Pfafferott, K., Baker, R., Cheng, W., Mollison, L., Baccala, M., Miczkova, S., Nazareth, S., Herrmann, S., Rauch, A. and Gaudieri, S. (2009) Correlates of infection outcome following multiple exposures to the Hepatitis C virus. In: 16th International Symposium on Hepatitis C Virus & Related Viruses, 3 - 7 October, Nice, France.

Mallal, S. (2009) HLA-B*5701 screening for abacavir hypersensitivity: Immunopathogenesis and Laboratory implementation. In: Pharmacogenetics workshop at the Russian Central Scientific Epidemiology Institute, 23 June 2009, Moscow, Russia.

Mallal, S. (2009) Pharmacogenetic testing for predicting at risk patients: Genotyping and flow cytometry of HLA-B. In: Annual Meeting of the American Association of Clinical Chemistry (AACC) 2009, 19 - 23 July 2009, Chicago, IL.

McKinnon, E. and James, I. (2009) Retrospective matching analysis of induction/maintenance HIV treatment strategies. In: 30th Conference of the International Society for Clinical Biostatistics, 23 - 27 August 2009, Prague, Czech Republic.

Needham, M., Scott, A., James, I., Day, T., Kiers, L., Corbett, A., Witt, C., Garlepp, M., Allcock, R., Laing, N., Christiansen, F. and Mastaglia, F. (2009) Epistatic interactions between alleles at the DRB1 locus influence both susceptibility to sIBM and clinical phenotype. In: World Muscle Society Congress, 9 - 12 September 2009, Geneva, Switzerland.

Nolan, D. and Mallal, S. (2009) EBV and MS: Lessons from hepatitis and HIV. In: 10th Biennial Scientific Conferene on "Progress on MS Research" - MSRA Conference 2009, 15 - 17 October 2009, Sydney, Australia.

Pearson, L., Thom, J., Adams, M., Oostryck, R., Krueger, R., Yong, G. and Baker, R. (2009) A rapid flow cytometric technique for the detection of platelet-monocyte complexes, activated platelets and platelet-derived microparticles. International Journal of Laboratory Hematology, 31 (4). pp. 430-439.

Pfafferott, K., Gaudieri, S., Ulsenheimer, A., John, M., James, I., Heeg, M., Nolan, D., Rauch, A., Lucas, A., Klenerman, P., Diepolder, H.M. and Lucas, M. (2009) Divergent pattern of viral evolution and escape dynamics in acute and early HCV and HIV infection. In: Australasian Virology Group Meeting, 13 - 17 December 2009, Mantra Erskine Resort, Lorne, VIC.

Phillips, E. (2009) Avoiding catastrophic drug toxicities: ‘Drugs that cause hypersensitivity reactions'. In: 2009 Annual Meeting of the American Association of Clinical Chemistry, 22 July 2009, Chicago, Illinois, USA.

Phillips, E. (2009) Human Genes and Adverse Drug Reactions: when genetics meets practical medicine needs: Pharmacogenetics and ADRs: a practical perspective. In: Pharmacogenetics workshop at the Russian Central Scientific Epidemiology Institute., 23 June 2009, Moscow, Russia.

Phillips, E. (2009) Using pharmacogenetics to prevent adverse drug reactions. In: Australian Pharmacogenomics Summit (invited Plenary), 31 July 2009, Sydney, Australia.

Phillips, E. (2009) The pharmacogenetics of drug hypersensitivity: personalizing medicine and predicting the unpredictable? In: WAMSG Medication Safety Symposium, 14 July 2009, Perth, Australia.

Phillips, E.J. (2009) Drugs that cause hypersensitivity reactions: Personalising medicine & Predicting the unpredictable. In: Annual Meeting of the American Association of Clinical Chemistry (AACC) 2009, 19 - 23 July 2009, Chicago, IL.

Phillips, E.J. (2009) Overcoming the barrier of clinical translation: The Abacavir example. In: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Conference 2009, 29 November - 2 December 2009, Sydney Convention Centre, Sydney.

Phillips, E.J. and Mallal, S. (2009) HLA and drug-induced toxicity. Current Opinion in Molecular Therapeutics, 11 (3). pp. 231-242.

Phillips, E.J. and Mallal, S. (2009) Personalizing antiretroviral therapy: is it a reality? Personalized Medicine, 6 (4). pp. 393-408.

Roberts, S., Almeida, C., Bronke, C., Ahmad, I., Keane, N., Chopra, A., Mallal, S., John, M., Heckerman, D. and Mallal, S. (2009) Screening for HIV responses using optimal epitopes predicted by HLA-viral sequence polymorphism associations. In: 21st Annual Conference of the Australasian Society for HIV Medicine (ASHM), 9 - 11 September, Brisbane, Australia.

Schulman, S., Kearon, C., Kakkar, A.K., Mismetti, P., Schellong, S., Eriksson, H., Baanstra, D., Schnee, J., Goldhaber, S.Z. and Baker, R.I. (2009) Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism. New England Journal of Medicine, 361 (24). pp. 2342-2352.

Tschochner, M., James, I., Almeida, C., Keane, N., Roberts, S., Bronke, C., Chopra, A., Maiden, T., Ahmad, I., Gaudieri, S., Mallal, S., Rauch, A., John, M., Furrer, H. and Günthard, H. (2009) Effects of HIV-1 immune selection on susceptability to integrase inhibitor resistance. In: 12th European AIDS Conference (EACS) 2009, 11 - 14 November 2009, Cologne, Germany.

Tschochner, M., James, I., Almeida, C., Keane, N.M., Roberts, S., Bronke, C., Chopra, A., Maiden, T., Ahmed, I.F., Gaudieri, S., Furrer, H., Günthard, H.F., Mallal, S., Rauch, A. and John, M. (2009) Effects of HIV-1 immune selection on susceptibility to integrase inhibitor resistance. In: 12th European AIDS Conference (EACS), 11 - 14 November 2009, Cologne, Germany.

Wu, J., Qui, W., James, I., Joseph, J., Carroll, W., Christiansen, F., Mastaglia, F. and Kermode, A. (2009) Frequency of HLA-DRB1 alleles and disease-modifying effects in a large West Australian multiple sclerosis cohort. In: Australian & New Zealand Association of Neurologists Annual Scientific Meeting, 18 - 21 May 2009, Christchurch, New Zealand.

2008

Buller, H., Deitchman, D., Prins, M., Segers, A. and Baker, R.I. (2008) Efficacy and safety of the oral direct factorXa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study. Journal of Thrombosis and Haemostasis, 6 (8). pp. 1313-1318.

D'Arminio Monforte, A., Abrams, D., Pradier, C., Weber, R., Reiss, P., Bonnet, F., Kirk, O., Law, M., De Wit, S., Friis-Moller, N., Phillips, A., Sabin, C., Lundgren, J. and Mallal, S. (2008) HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS, 22 (16). pp. 2143-2153.

Flanagan, D., MacLellan, D., Gibbs, H., Baker, R. and Fletcher, J. (2008) The insidious hazard of hospitalisation: Venous thromboembolism. Medicine Today, 9 (9). pp. 16-26.

Gardiner, E.E., Al-Tamimi, M., Mu, F.-T., <